KR102065332B1 - Dye composition comprising a non-glycosyl iridoid compound and a particular aldehyde or imine, dyeing process and device therefor - Google Patents
Dye composition comprising a non-glycosyl iridoid compound and a particular aldehyde or imine, dyeing process and device therefor Download PDFInfo
- Publication number
- KR102065332B1 KR102065332B1 KR1020147011554A KR20147011554A KR102065332B1 KR 102065332 B1 KR102065332 B1 KR 102065332B1 KR 1020147011554 A KR1020147011554 A KR 1020147011554A KR 20147011554 A KR20147011554 A KR 20147011554A KR 102065332 B1 KR102065332 B1 KR 102065332B1
- Authority
- KR
- South Korea
- Prior art keywords
- group
- radical
- radicals
- optionally substituted
- alkyl
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 120
- 150000001875 compounds Chemical class 0.000 title claims abstract description 80
- 150000002466 imines Chemical class 0.000 title claims abstract description 24
- 238000000034 method Methods 0.000 title claims abstract description 24
- 238000004043 dyeing Methods 0.000 title claims description 12
- 230000008569 process Effects 0.000 title abstract description 7
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 title description 6
- 125000003147 glycosyl group Chemical group 0.000 title description 2
- -1 (hydroxy) methyl Chemical group 0.000 claims abstract description 148
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 53
- 125000000623 heterocyclic group Chemical group 0.000 claims abstract description 45
- 125000005842 heteroatom Chemical group 0.000 claims abstract description 41
- 229920006395 saturated elastomer Polymers 0.000 claims abstract description 32
- 150000004676 glycans Chemical class 0.000 claims abstract description 30
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 29
- 239000005017 polysaccharide Substances 0.000 claims abstract description 28
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 27
- 150000001299 aldehydes Chemical class 0.000 claims abstract description 23
- 125000002091 cationic group Chemical group 0.000 claims abstract description 18
- 239000000419 plant extract Substances 0.000 claims abstract description 15
- 239000000835 fiber Substances 0.000 claims abstract description 14
- 229920001542 oligosaccharide Polymers 0.000 claims abstract description 13
- 150000002482 oligosaccharides Chemical class 0.000 claims abstract description 13
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 7
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 claims abstract description 4
- 239000008103 glucose Substances 0.000 claims abstract description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 3
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims abstract 2
- 229910052757 nitrogen Inorganic materials 0.000 claims description 59
- 150000003254 radicals Chemical class 0.000 claims description 53
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 42
- 125000003118 aryl group Chemical group 0.000 claims description 38
- 229910052760 oxygen Inorganic materials 0.000 claims description 31
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 25
- 229910052799 carbon Inorganic materials 0.000 claims description 21
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 15
- 240000004414 Genipa americana Species 0.000 claims description 14
- 235000004407 Genipa americana Nutrition 0.000 claims description 14
- 230000002378 acidificating effect Effects 0.000 claims description 13
- 150000001450 anions Chemical class 0.000 claims description 11
- 239000001301 oxygen Substances 0.000 claims description 11
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 11
- 229910052783 alkali metal Inorganic materials 0.000 claims description 9
- 125000004432 carbon atom Chemical group C* 0.000 claims description 9
- 241000196324 Embryophyta Species 0.000 claims description 8
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims description 8
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 7
- 229910019142 PO4 Inorganic materials 0.000 claims description 7
- 239000012453 solvate Substances 0.000 claims description 7
- 125000004070 6 membered heterocyclic group Chemical group 0.000 claims description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims description 6
- 102000011782 Keratins Human genes 0.000 claims description 6
- 108010076876 Keratins Proteins 0.000 claims description 6
- 125000003172 aldehyde group Chemical group 0.000 claims description 6
- 150000001340 alkali metals Chemical class 0.000 claims description 6
- 150000001342 alkaline earth metals Chemical class 0.000 claims description 6
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical compound [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 claims description 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 5
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 4
- MDFFNEOEWAXZRQ-UHFFFAOYSA-N aminyl Chemical compound [NH2] MDFFNEOEWAXZRQ-UHFFFAOYSA-N 0.000 claims description 4
- 239000000460 chlorine Substances 0.000 claims description 4
- 229910052801 chlorine Inorganic materials 0.000 claims description 4
- 238000009472 formulation Methods 0.000 claims description 4
- 230000003287 optical effect Effects 0.000 claims description 4
- 230000005855 radiation Effects 0.000 claims description 4
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 3
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims description 3
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 claims description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical class OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 3
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 3
- 229910052794 bromium Inorganic materials 0.000 claims description 3
- 125000005843 halogen group Chemical group 0.000 claims description 3
- CBOIHMRHGLHBPB-UHFFFAOYSA-N hydroxymethyl Chemical compound O[CH2] CBOIHMRHGLHBPB-UHFFFAOYSA-N 0.000 claims description 3
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical compound [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 claims description 3
- 150000007522 mineralic acids Chemical class 0.000 claims description 3
- 150000007524 organic acids Chemical class 0.000 claims description 3
- 150000003890 succinate salts Chemical class 0.000 claims description 3
- 229910052723 transition metal Inorganic materials 0.000 claims description 3
- 150000003624 transition metals Chemical class 0.000 claims description 3
- 125000006832 (C1-C10) alkylene group Chemical group 0.000 claims description 2
- SLRMQYXOBQWXCR-UHFFFAOYSA-N 2154-56-5 Chemical group [CH2]C1=CC=CC=C1 SLRMQYXOBQWXCR-UHFFFAOYSA-N 0.000 claims description 2
- 240000009300 Apodytes dimidiata Species 0.000 claims description 2
- OCUCCJIRFHNWBP-IYEMJOQQSA-L Copper gluconate Chemical class [Cu+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OCUCCJIRFHNWBP-IYEMJOQQSA-L 0.000 claims description 2
- 241000594365 Randia <angiosperm> Species 0.000 claims description 2
- 230000037338 UVA radiation Effects 0.000 claims description 2
- 241000990144 Veronica persica Species 0.000 claims description 2
- 150000005840 aryl radicals Chemical group 0.000 claims description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 claims description 2
- 150000004649 carbonic acid derivatives Chemical class 0.000 claims description 2
- 150000001805 chlorine compounds Chemical class 0.000 claims description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-L fumarate(2-) Chemical class [O-]C(=O)\C=C\C([O-])=O VZCYOOQTPOCHFL-OWOJBTEDSA-L 0.000 claims description 2
- 150000003893 lactate salts Chemical class 0.000 claims description 2
- 150000002891 organic anions Chemical class 0.000 claims description 2
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims description 2
- 125000001174 sulfone group Chemical group 0.000 claims description 2
- 150000003467 sulfuric acid derivatives Chemical class 0.000 claims description 2
- 125000002373 5 membered heterocyclic group Chemical group 0.000 claims 2
- 229910017053 inorganic salt Inorganic materials 0.000 claims 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical class OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims 1
- 241001576736 Tarenna attenuata Species 0.000 claims 1
- 150000001242 acetic acid derivatives Chemical class 0.000 claims 1
- CKLJMWTZIZZHCS-REOHCLBHSA-L aspartate group Chemical class N[C@@H](CC(=O)[O-])C(=O)[O-] CKLJMWTZIZZHCS-REOHCLBHSA-L 0.000 claims 1
- 239000002537 cosmetic Substances 0.000 claims 1
- 125000001976 hemiacetal group Chemical group 0.000 claims 1
- 125000001183 hydrocarbyl group Chemical group 0.000 claims 1
- 150000004679 hydroxides Chemical class 0.000 claims 1
- 229940049920 malate Drugs 0.000 claims 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-L malate(2-) Chemical compound [O-]C(=O)C(O)CC([O-])=O BJEPYKJPYRNKOW-UHFFFAOYSA-L 0.000 claims 1
- 235000021317 phosphate Nutrition 0.000 claims 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 claims 1
- 150000004760 silicates Chemical class 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 abstract description 20
- 229910052739 hydrogen Inorganic materials 0.000 abstract description 20
- 150000002431 hydrogen Chemical class 0.000 abstract description 10
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract description 9
- 150000001768 cations Chemical class 0.000 abstract description 4
- 150000002373 hemiacetals Chemical group 0.000 abstract description 4
- 125000003342 alkenyl group Chemical group 0.000 abstract description 2
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 abstract 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 abstract 1
- 125000000547 substituted alkyl group Chemical group 0.000 abstract 1
- 125000003107 substituted aryl group Chemical group 0.000 abstract 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 35
- 150000003839 salts Chemical class 0.000 description 33
- 150000003335 secondary amines Chemical class 0.000 description 28
- 150000001412 amines Chemical class 0.000 description 20
- 230000001590 oxidative effect Effects 0.000 description 19
- 239000000975 dye Substances 0.000 description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 17
- 239000000284 extract Substances 0.000 description 17
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 17
- 239000007800 oxidant agent Substances 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 11
- 239000002585 base Substances 0.000 description 10
- 229920000642 polymer Polymers 0.000 description 10
- 229910052717 sulfur Inorganic materials 0.000 description 10
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 9
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 9
- 239000000982 direct dye Substances 0.000 description 9
- 125000000524 functional group Chemical group 0.000 description 9
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 9
- 239000011593 sulfur Substances 0.000 description 9
- 239000004215 Carbon black (E152) Substances 0.000 description 8
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 8
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 8
- 150000001721 carbon Chemical group 0.000 description 8
- 125000000664 diazo group Chemical group [N-]=[N+]=[*] 0.000 description 8
- 235000019441 ethanol Nutrition 0.000 description 8
- 229930195733 hydrocarbon Natural products 0.000 description 8
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 8
- 229920002472 Starch Polymers 0.000 description 7
- 125000000129 anionic group Chemical group 0.000 description 7
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 7
- 235000010980 cellulose Nutrition 0.000 description 7
- 229920002678 cellulose Polymers 0.000 description 7
- 239000001913 cellulose Substances 0.000 description 7
- 150000002430 hydrocarbons Chemical group 0.000 description 7
- 125000005647 linker group Chemical group 0.000 description 7
- 125000000018 nitroso group Chemical group N(=O)* 0.000 description 7
- 230000003647 oxidation Effects 0.000 description 7
- 238000007254 oxidation reaction Methods 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 235000019698 starch Nutrition 0.000 description 7
- 239000008107 starch Substances 0.000 description 7
- 150000003573 thiols Chemical class 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 108010025188 Alcohol oxidase Proteins 0.000 description 6
- 235000017286 Melicoccus bijugatus Nutrition 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 239000008186 active pharmaceutical agent Substances 0.000 description 6
- 125000004414 alkyl thio group Chemical group 0.000 description 6
- 235000013399 edible fruits Nutrition 0.000 description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 6
- 239000010452 phosphate Substances 0.000 description 6
- 238000006467 substitution reaction Methods 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 5
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 5
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 5
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 5
- 229920002907 Guar gum Polymers 0.000 description 5
- 229920001202 Inulin Polymers 0.000 description 5
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical class [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 description 5
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 5
- 229940024606 amino acid Drugs 0.000 description 5
- 235000001014 amino acid Nutrition 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 5
- 229910002091 carbon monoxide Inorganic materials 0.000 description 5
- 125000004122 cyclic group Chemical group 0.000 description 5
- 235000010417 guar gum Nutrition 0.000 description 5
- 239000000665 guar gum Substances 0.000 description 5
- 229960002154 guar gum Drugs 0.000 description 5
- 150000004677 hydrates Chemical class 0.000 description 5
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 5
- 229940029339 inulin Drugs 0.000 description 5
- 150000003141 primary amines Chemical class 0.000 description 5
- CUYKNJBYIJFRCU-UHFFFAOYSA-N 3-aminopyridine Chemical compound NC1=CC=CN=C1 CUYKNJBYIJFRCU-UHFFFAOYSA-N 0.000 description 4
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 4
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 4
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 4
- 0 CC(C)(*(*)*)C(C)(*)C(C)(C)C(*)(*)N* Chemical compound CC(C)(*(*)*)C(C)(*)C(C)(C)C(*)(*)N* 0.000 description 4
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 4
- ZNZYKNKBJPZETN-WELNAUFTSA-N Dialdehyde 11678 Chemical compound N1C2=CC=CC=C2C2=C1[C@H](C[C@H](/C(=C/O)C(=O)OC)[C@@H](C=C)C=O)NCC2 ZNZYKNKBJPZETN-WELNAUFTSA-N 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 4
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 4
- 125000003368 amide group Chemical group 0.000 description 4
- 229910021529 ammonia Inorganic materials 0.000 description 4
- 238000004040 coloring Methods 0.000 description 4
- 238000009833 condensation Methods 0.000 description 4
- 230000005494 condensation Effects 0.000 description 4
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 4
- 229910052742 iron Inorganic materials 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 150000002978 peroxides Chemical class 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- 239000011591 potassium Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 238000001228 spectrum Methods 0.000 description 4
- 229940095064 tartrate Drugs 0.000 description 4
- 235000012141 vanillin Nutrition 0.000 description 4
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 4
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 4
- BKMMTJMQCTUHRP-UHFFFAOYSA-N 2-aminopropan-1-ol Chemical compound CC(N)CO BKMMTJMQCTUHRP-UHFFFAOYSA-N 0.000 description 3
- JUAGHBASZWRMQH-UHFFFAOYSA-N 2-diethoxyphosphorylethanamine Chemical compound CCOP(=O)(CCN)OCC JUAGHBASZWRMQH-UHFFFAOYSA-N 0.000 description 3
- 108010043325 Aryl-alcohol dehydrogenase Proteins 0.000 description 3
- QQVDJLLNRSOCEL-UHFFFAOYSA-N Ciliatine Natural products [NH3+]CCP(O)([O-])=O QQVDJLLNRSOCEL-UHFFFAOYSA-N 0.000 description 3
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 3
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 3
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 3
- 239000004472 Lysine Substances 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 150000008052 alkyl sulfonates Chemical class 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 229940009098 aspartate Drugs 0.000 description 3
- 229940077388 benzenesulfonate Drugs 0.000 description 3
- SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- ORTFAQDWJHRMNX-UHFFFAOYSA-N hydroxidooxidocarbon(.) Chemical group O[C]=O ORTFAQDWJHRMNX-UHFFFAOYSA-N 0.000 description 3
- 229960003646 lysine Drugs 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- ATHGHQPFGPMSJY-UHFFFAOYSA-N spermidine Chemical compound NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 description 3
- 125000001424 substituent group Chemical group 0.000 description 3
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 3
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 3
- 229960004441 tyrosine Drugs 0.000 description 3
- 229920002554 vinyl polymer Polymers 0.000 description 3
- FQCNOURLMNHAQN-UHFFFAOYSA-N (1-azaniumyl-2-phenylethyl)-hydroxyphosphinate Chemical compound OP(=O)(O)C(N)CC1=CC=CC=C1 FQCNOURLMNHAQN-UHFFFAOYSA-N 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
- WYTZZXDRDKSJID-UHFFFAOYSA-N (3-aminopropyl)triethoxysilane Chemical compound CCO[Si](OCC)(OCC)CCCN WYTZZXDRDKSJID-UHFFFAOYSA-N 0.000 description 2
- 125000006274 (C1-C3)alkoxy group Chemical group 0.000 description 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 2
- 125000004760 (C1-C4) alkylsulfonylamino group Chemical group 0.000 description 2
- MGRVRXRGTBOSHW-UHFFFAOYSA-N (aminomethyl)phosphonic acid Chemical compound NCP(O)(O)=O MGRVRXRGTBOSHW-UHFFFAOYSA-N 0.000 description 2
- 150000000185 1,3-diols Chemical class 0.000 description 2
- FJLUATLTXUNBOT-UHFFFAOYSA-N 1-Hexadecylamine Chemical compound CCCCCCCCCCCCCCCCN FJLUATLTXUNBOT-UHFFFAOYSA-N 0.000 description 2
- BMVXCPBXGZKUPN-UHFFFAOYSA-N 1-hexanamine Chemical compound CCCCCCN BMVXCPBXGZKUPN-UHFFFAOYSA-N 0.000 description 2
- DDHUNHGZUHZNKB-UHFFFAOYSA-N 2,2-dimethylpropane-1,3-diamine Chemical compound NCC(C)(C)CN DDHUNHGZUHZNKB-UHFFFAOYSA-N 0.000 description 2
- GFAZBXKENDSJEB-UHFFFAOYSA-N 2,5-dihydroxy-3-methoxy-6-methylcyclohexa-2,5-diene-1,4-dione Chemical compound COC1=C(O)C(=O)C(C)=C(O)C1=O GFAZBXKENDSJEB-UHFFFAOYSA-N 0.000 description 2
- GHKSKVKCKMGRDU-UHFFFAOYSA-N 2-(3-aminopropylamino)ethanol Chemical compound NCCCNCCO GHKSKVKCKMGRDU-UHFFFAOYSA-N 0.000 description 2
- NWYYWIJOWOLJNR-UHFFFAOYSA-N 2-Amino-3-methyl-1-butanol Chemical compound CC(C)C(N)CO NWYYWIJOWOLJNR-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- FUOOLUPWFVMBKG-UHFFFAOYSA-N 2-Aminoisobutyric acid Chemical compound CC(C)(N)C(O)=O FUOOLUPWFVMBKG-UHFFFAOYSA-N 0.000 description 2
- HONKEGXLWUDTCF-UHFFFAOYSA-N 2-amino-2-methyl-4-phosphonobutanoic acid Chemical compound OC(=O)C(N)(C)CCP(O)(O)=O HONKEGXLWUDTCF-UHFFFAOYSA-N 0.000 description 2
- VPSSPAXIFBTOHY-UHFFFAOYSA-N 2-amino-4-methylpentan-1-ol Chemical compound CC(C)CC(N)CO VPSSPAXIFBTOHY-UHFFFAOYSA-N 0.000 description 2
- DYGRPJWAYXRMQZ-UHFFFAOYSA-N 2-aminopropan-2-ylphosphonic acid Chemical compound CC(C)(N)P(O)(O)=O DYGRPJWAYXRMQZ-UHFFFAOYSA-N 0.000 description 2
- GFQBSQXXHYLABK-UHFFFAOYSA-N 2-aminopropanediamide Chemical compound NC(=O)C(N)C(N)=O GFQBSQXXHYLABK-UHFFFAOYSA-N 0.000 description 2
- KQIGMPWTAHJUMN-UHFFFAOYSA-N 3-aminopropane-1,2-diol Chemical compound NCC(O)CO KQIGMPWTAHJUMN-UHFFFAOYSA-N 0.000 description 2
- LDSJMFGYNFIFRK-UHFFFAOYSA-N 3-azaniumyl-2-hydroxy-4-phenylbutanoate Chemical compound OC(=O)C(O)C(N)CC1=CC=CC=C1 LDSJMFGYNFIFRK-UHFFFAOYSA-N 0.000 description 2
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 2
- DQORFBNFNLHVIM-UHFFFAOYSA-N 3-diethoxyphosphorylpropan-1-amine Chemical compound CCOP(=O)(OCC)CCCN DQORFBNFNLHVIM-UHFFFAOYSA-N 0.000 description 2
- 108010039779 3-hydroxybenzyl-alcohol dehydrogenase Proteins 0.000 description 2
- XMXLBDNVSIHRRA-UHFFFAOYSA-N 4,5-dimethyl-1,3-thiazol-2-amine Chemical compound CC=1N=C(N)SC=1C XMXLBDNVSIHRRA-UHFFFAOYSA-N 0.000 description 2
- PLIKAWJENQZMHA-UHFFFAOYSA-N 4-aminophenol Chemical compound NC1=CC=C(O)C=C1 PLIKAWJENQZMHA-UHFFFAOYSA-N 0.000 description 2
- GYQDOAKHUGURPD-UHFFFAOYSA-N 5,7-Dihydroxy-2-(4-hydroxyphenyl)-1-benzopyrylium chloride Chemical compound [Cl-].C1=CC(O)=CC=C1C1=CC=C(C(O)=CC(O)=C2)C2=[O+]1 GYQDOAKHUGURPD-UHFFFAOYSA-N 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- 108010046256 Aryl-alcohol oxidase Proteins 0.000 description 2
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 2
- 125000003830 C1- C4 alkylcarbonylamino group Chemical group 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 229920001661 Chitosan Polymers 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 229920002307 Dextran Polymers 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 2
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 2
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 2
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
- VLJNHYLEOZPXFW-BYPYZUCNSA-N L-prolinamide Chemical compound NC(=O)[C@@H]1CCCN1 VLJNHYLEOZPXFW-BYPYZUCNSA-N 0.000 description 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 2
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 description 2
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 2
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 2
- 108010039918 Polylysine Proteins 0.000 description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
- WUGQZFFCHPXWKQ-UHFFFAOYSA-N Propanolamine Chemical compound NCCCO WUGQZFFCHPXWKQ-UHFFFAOYSA-N 0.000 description 2
- 244000180577 Sambucus australis Species 0.000 description 2
- 235000018734 Sambucus australis Nutrition 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
- 239000004473 Threonine Substances 0.000 description 2
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
- DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 235000011054 acetic acid Nutrition 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 229960003767 alanine Drugs 0.000 description 2
- 235000004279 alanine Nutrition 0.000 description 2
- 125000004457 alkyl amino carbonyl group Chemical group 0.000 description 2
- 125000003282 alkyl amino group Chemical group 0.000 description 2
- 229940045714 alkyl sulfonate alkylating agent Drugs 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- CBTVGIZVANVGBH-UHFFFAOYSA-N aminomethyl propanol Chemical compound CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 description 2
- 229920013822 aminosilicone Polymers 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 229960003121 arginine Drugs 0.000 description 2
- 235000009697 arginine Nutrition 0.000 description 2
- 229960001230 asparagine Drugs 0.000 description 2
- 235000009582 asparagine Nutrition 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 108010047754 beta-Glucosidase Proteins 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- VHRGRCVQAFMJIZ-UHFFFAOYSA-N cadaverine Chemical compound NCCCCCN VHRGRCVQAFMJIZ-UHFFFAOYSA-N 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 2
- 150000001735 carboxylic acids Chemical class 0.000 description 2
- DGQLVPJVXFOQEV-JNVSTXMASA-N carminic acid Chemical compound OC1=C2C(=O)C=3C(C)=C(C(O)=O)C(O)=CC=3C(=O)C2=C(O)C(O)=C1[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O DGQLVPJVXFOQEV-JNVSTXMASA-N 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 2
- 229960002433 cysteine Drugs 0.000 description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
- 235000018417 cysteine Nutrition 0.000 description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 125000004494 ethyl ester group Chemical group 0.000 description 2
- GATNOFPXSDHULC-UHFFFAOYSA-N ethylphosphonic acid Chemical compound CCP(O)(O)=O GATNOFPXSDHULC-UHFFFAOYSA-N 0.000 description 2
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 2
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 2
- 229960002743 glutamine Drugs 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- 239000000118 hair dye Substances 0.000 description 2
- 229960002885 histidine Drugs 0.000 description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-M hydrogensulfate Chemical compound OS([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 2
- 125000002883 imidazolyl group Chemical group 0.000 description 2
- 125000001041 indolyl group Chemical group 0.000 description 2
- JXDYKVIHCLTXOP-UHFFFAOYSA-N isatin Chemical compound C1=CC=C2C(=O)C(=O)NC2=C1 JXDYKVIHCLTXOP-UHFFFAOYSA-N 0.000 description 2
- KQPYUDDGWXQXHS-UHFFFAOYSA-N juglone Chemical compound O=C1C=CC(=O)C2=C1C=CC=C2O KQPYUDDGWXQXHS-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229910052744 lithium Inorganic materials 0.000 description 2
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- OGFXBIXJCWAUCH-UHFFFAOYSA-N meso-secoisolariciresinol Natural products C1=2C=C(O)C(OC)=CC=2CC(CO)C(CO)C1C1=CC=C(O)C(OC)=C1 OGFXBIXJCWAUCH-UHFFFAOYSA-N 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 229960004452 methionine Drugs 0.000 description 2
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 2
- VAMXMNNIEUEQDV-UHFFFAOYSA-N methyl anthranilate Chemical compound COC(=O)C1=CC=CC=C1N VAMXMNNIEUEQDV-UHFFFAOYSA-N 0.000 description 2
- 229910052750 molybdenum Inorganic materials 0.000 description 2
- 239000011733 molybdenum Substances 0.000 description 2
- 150000002772 monosaccharides Chemical class 0.000 description 2
- PHQOGHDTIVQXHL-UHFFFAOYSA-N n'-(3-trimethoxysilylpropyl)ethane-1,2-diamine Chemical compound CO[Si](OC)(OC)CCCNCCN PHQOGHDTIVQXHL-UHFFFAOYSA-N 0.000 description 2
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 2
- 150000003891 oxalate salts Chemical class 0.000 description 2
- 235000013808 oxidized starch Nutrition 0.000 description 2
- 229960005190 phenylalanine Drugs 0.000 description 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
- IEQIEDJGQAUEQZ-UHFFFAOYSA-N phthalocyanine Chemical compound N1C(N=C2C3=CC=CC=C3C(N=C3C4=CC=CC=C4C(=N4)N3)=N2)=C(C=CC=C2)C2=C1N=C1C2=CC=CC=C2C4=N1 IEQIEDJGQAUEQZ-UHFFFAOYSA-N 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 229920000656 polylysine Polymers 0.000 description 2
- 229920005862 polyol Polymers 0.000 description 2
- 150000004804 polysaccharides Polymers 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 229960002429 proline Drugs 0.000 description 2
- BBNQQADTFFCFGB-UHFFFAOYSA-N purpurin Chemical compound C1=CC=C2C(=O)C3=C(O)C(O)=CC(O)=C3C(=O)C2=C1 BBNQQADTFFCFGB-UHFFFAOYSA-N 0.000 description 2
- WDGFFVCWBZVLCE-UHFFFAOYSA-N purpurogallin Chemical compound C1=CC=C(O)C(=O)C2=C1C=C(O)C(O)=C2O WDGFFVCWBZVLCE-UHFFFAOYSA-N 0.000 description 2
- KIDHWZJUCRJVML-UHFFFAOYSA-N putrescine Chemical compound NCCCCN KIDHWZJUCRJVML-UHFFFAOYSA-N 0.000 description 2
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 2
- 229960001153 serine Drugs 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 125000004434 sulfur atom Chemical group 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 229960002898 threonine Drugs 0.000 description 2
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
- XFNJVJPLKCPIBV-UHFFFAOYSA-N trimethylenediamine Chemical compound NCCCN XFNJVJPLKCPIBV-UHFFFAOYSA-N 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 229960004799 tryptophan Drugs 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- 229960003487 xylose Drugs 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 description 1
- FIAINKIUSZGVGX-UHFFFAOYSA-N (1-amino-1-oxopropan-2-yl)azanium;chloride Chemical compound Cl.CC(N)C(N)=O FIAINKIUSZGVGX-UHFFFAOYSA-N 0.000 description 1
- OZTDKZBAEQVCEE-UHFFFAOYSA-N (1-amino-2,2-dimethylpropyl)phosphonic acid Chemical compound CC(C)(C)C(N)P(O)(O)=O OZTDKZBAEQVCEE-UHFFFAOYSA-N 0.000 description 1
- NOQKPEWLSMCOFU-UHFFFAOYSA-N (1-amino-2-methylbutyl)phosphonic acid Chemical compound CCC(C)C(N)P(O)(O)=O NOQKPEWLSMCOFU-UHFFFAOYSA-N 0.000 description 1
- LWUPGGUBUSYFTG-UHFFFAOYSA-N (1-aminocyclohexa-2,4-dien-1-yl)methylphosphonic acid Chemical compound OP(=O)(O)CC1(N)CC=CC=C1 LWUPGGUBUSYFTG-UHFFFAOYSA-N 0.000 description 1
- PDNZJLMPXLQDPL-UHFFFAOYSA-N (1-aminocyclopentyl)methanol Chemical compound OCC1(N)CCCC1 PDNZJLMPXLQDPL-UHFFFAOYSA-N 0.000 description 1
- FBXFXDVQDQRPCE-UHFFFAOYSA-N (1-aminocyclopentyl)phosphonic acid Chemical compound OP(=O)(O)C1(N)CCCC1 FBXFXDVQDQRPCE-UHFFFAOYSA-N 0.000 description 1
- HGCAUCAWEADMPM-UHFFFAOYSA-N (1-azaniumyl-3-methylbutyl)-hydroxyphosphinate Chemical compound CC(C)CC(N)P(O)(O)=O HGCAUCAWEADMPM-UHFFFAOYSA-N 0.000 description 1
- NANISUSRVMESCE-UHFFFAOYSA-N (2-amino-3-methylbutan-2-yl)phosphonic acid Chemical compound CC(C)C(C)(N)P(O)(O)=O NANISUSRVMESCE-UHFFFAOYSA-N 0.000 description 1
- KWJBICIXCAFUTO-UHFFFAOYSA-N (2-amino-4-methylpentan-2-yl)phosphonic acid;hydrate Chemical compound O.CC(C)CC(C)(N)P(O)(O)=O KWJBICIXCAFUTO-UHFFFAOYSA-N 0.000 description 1
- AATHETVNBJBFKM-UHFFFAOYSA-N (2-methoxy-2-oxoethyl)azanium;bromide Chemical compound [Br-].COC(=O)C[NH3+] AATHETVNBJBFKM-UHFFFAOYSA-N 0.000 description 1
- IYHCZJFYAQETNX-QTVWNMPRSA-N (2S,3S,4S,5R)-2-[amino(hydroxy)methyl]-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound NC(O)[C@H]1O[C@H](CO)[C@@H](O)[C@@H]1O IYHCZJFYAQETNX-QTVWNMPRSA-N 0.000 description 1
- AIYVJLPYZQDCKV-ZJIMSODOSA-N (2r)-2,6-diaminohexanamide;dihydrochloride Chemical compound Cl.Cl.NCCCC[C@@H](N)C(N)=O AIYVJLPYZQDCKV-ZJIMSODOSA-N 0.000 description 1
- OBSIQMZKFXFYLV-MRVPVSSYSA-N (2r)-2-amino-3-phenylpropanamide Chemical compound NC(=O)[C@H](N)CC1=CC=CC=C1 OBSIQMZKFXFYLV-MRVPVSSYSA-N 0.000 description 1
- VSPSRRBIXFUMOU-NUBCRITNSA-N (2r)-2-amino-4-methylpentanamide;hydrochloride Chemical compound Cl.CC(C)C[C@@H](N)C(N)=O VSPSRRBIXFUMOU-NUBCRITNSA-N 0.000 description 1
- LYMQLFYWIDCFLC-RZFWHQLPSA-N (2r)-2-amino-5-(diaminomethylideneamino)pentanamide;dihydrochloride Chemical compound Cl.Cl.NC(=O)[C@H](N)CCCN=C(N)N LYMQLFYWIDCFLC-RZFWHQLPSA-N 0.000 description 1
- FIAINKIUSZGVGX-HSHFZTNMSA-N (2r)-2-aminopropanamide;hydrochloride Chemical compound Cl.C[C@@H](N)C(N)=O FIAINKIUSZGVGX-HSHFZTNMSA-N 0.000 description 1
- WCWOEQFAYSXBRK-VFUOTHLCSA-N (2r,3r,4s,5s,6r)-2-amino-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound N[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O WCWOEQFAYSXBRK-VFUOTHLCSA-N 0.000 description 1
- GJFIBNOHCLHAOT-UOYQFSTFSA-N (2r,3s,4s,5s,6s)-4-amino-2-(hydroxymethyl)-6-methoxyoxane-3,5-diol Chemical compound CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@@H]1O GJFIBNOHCLHAOT-UOYQFSTFSA-N 0.000 description 1
- AIYVJLPYZQDCKV-XRIGFGBMSA-N (2s)-2,6-diaminohexanamide;dihydrochloride Chemical compound Cl.Cl.NCCCC[C@H](N)C(N)=O AIYVJLPYZQDCKV-XRIGFGBMSA-N 0.000 description 1
- ZAFCADKAZRAFFU-JTQLQIEISA-N (2s)-2-[[2-(methylazaniumyl)acetyl]amino]-3-phenylpropanoate Chemical compound C[NH2+]CC(=O)N[C@H](C([O-])=O)CC1=CC=CC=C1 ZAFCADKAZRAFFU-JTQLQIEISA-N 0.000 description 1
- WUABIBPBBSTOPQ-RZFWHQLPSA-N (2s)-2-amino-2-methyl-3-sulfanylpropanoic acid;dihydrochloride Chemical compound Cl.Cl.SC[C@](N)(C)C(O)=O WUABIBPBBSTOPQ-RZFWHQLPSA-N 0.000 description 1
- UMMQVDUMUMBTAV-YFKPBYRVSA-N (2s)-2-amino-3-(1h-imidazol-5-yl)propanamide Chemical compound NC(=O)[C@@H](N)CC1=CN=CN1 UMMQVDUMUMBTAV-YFKPBYRVSA-N 0.000 description 1
- BOWGIBPKWVKHTA-QRPNPIFTSA-N (2s)-2-amino-3-(4-hydroxyphenyl)propanamide;hydrobromide Chemical compound Br.NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 BOWGIBPKWVKHTA-QRPNPIFTSA-N 0.000 description 1
- YDIMJFKFXYQUBZ-QRPNPIFTSA-N (2s)-2-amino-3-(4-hydroxyphenyl)propanamide;hydrochloride Chemical compound Cl.NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 YDIMJFKFXYQUBZ-QRPNPIFTSA-N 0.000 description 1
- VSPSRRBIXFUMOU-JEDNCBNOSA-N (2s)-2-amino-4-methylpentanamide;hydrochloride Chemical compound Cl.CC(C)C[C@H](N)C(N)=O VSPSRRBIXFUMOU-JEDNCBNOSA-N 0.000 description 1
- LYMQLFYWIDCFLC-FHNDMYTFSA-N (2s)-2-amino-5-(diaminomethylideneamino)pentanamide;dihydrochloride Chemical compound Cl.Cl.NC(=O)[C@@H](N)CCCNC(N)=N LYMQLFYWIDCFLC-FHNDMYTFSA-N 0.000 description 1
- XMQUEQJCYRFIQS-YFKPBYRVSA-N (2s)-2-amino-5-ethoxy-5-oxopentanoic acid Chemical compound CCOC(=O)CC[C@H](N)C(O)=O XMQUEQJCYRFIQS-YFKPBYRVSA-N 0.000 description 1
- SLBULRLSTNDQED-DKWTVANSSA-N (2s)-2-aminobutanediamide;hydrochloride Chemical compound Cl.NC(=O)[C@@H](N)CC(N)=O SLBULRLSTNDQED-DKWTVANSSA-N 0.000 description 1
- SPTYYKPZSWYQDT-JEDNCBNOSA-N (2s)-2-aminohexanamide;hydrochloride Chemical compound Cl.CCCC[C@H](N)C(N)=O SPTYYKPZSWYQDT-JEDNCBNOSA-N 0.000 description 1
- LWHHAVWYGIBIEU-LURJTMIESA-N (2s)-2-methylpyrrolidin-1-ium-2-carboxylate Chemical compound [O-]C(=O)[C@]1(C)CCC[NH2+]1 LWHHAVWYGIBIEU-LURJTMIESA-N 0.000 description 1
- UTEYHKAJNNCEDX-VIFPVBQESA-N (2s)-3-(4-hydroxyphenyl)-2-(methoxyamino)propanoic acid Chemical compound CON[C@H](C(O)=O)CC1=CC=C(O)C=C1 UTEYHKAJNNCEDX-VIFPVBQESA-N 0.000 description 1
- OCASMTZDEUOLQA-WWPIYYJJSA-N (2s)-n-[2-(1h-imidazol-5-yl)ethyl]pyrrolidine-2-carboxamide;dihydrochloride Chemical compound Cl.Cl.O=C([C@H]1NCCC1)NCCC1=CN=CN1 OCASMTZDEUOLQA-WWPIYYJJSA-N 0.000 description 1
- PZUOEYPTQJILHP-GBXIJSLDSA-N (2s,3r)-2-amino-3-hydroxybutanamide Chemical compound C[C@@H](O)[C@H](N)C(N)=O PZUOEYPTQJILHP-GBXIJSLDSA-N 0.000 description 1
- SAOZPTBFWAEJQL-FHAQVOQBSA-N (2s,3s)-2-amino-3-methylpentanamide;hydrochloride Chemical compound Cl.CC[C@H](C)[C@H](N)C(N)=O SAOZPTBFWAEJQL-FHAQVOQBSA-N 0.000 description 1
- GSZQTIFGANBTNF-UHFFFAOYSA-N (3-aminopropyl)phosphonic acid Chemical compound NCCCP(O)(O)=O GSZQTIFGANBTNF-UHFFFAOYSA-N 0.000 description 1
- OZSJLLVVZFTDEY-UHFFFAOYSA-N (3-hydroxy-1-methoxy-1-oxobutan-2-yl)azanium;chloride Chemical compound Cl.COC(=O)C(N)C(C)O OZSJLLVVZFTDEY-UHFFFAOYSA-N 0.000 description 1
- QHGUCRYDKWKLMG-QMMMGPOBSA-N (R)-octopamine Chemical compound NC[C@H](O)C1=CC=C(O)C=C1 QHGUCRYDKWKLMG-QMMMGPOBSA-N 0.000 description 1
- ZENZJGDPWWLORF-UHFFFAOYSA-N (Z)-9-Octadecenal Natural products CCCCCCCCC=CCCCCCCCC=O ZENZJGDPWWLORF-UHFFFAOYSA-N 0.000 description 1
- ISQSUCKLLKRTBZ-UHFFFAOYSA-N (phosphonomethylamino)methylphosphonic acid Chemical compound OP(O)(=O)CNCP(O)(O)=O ISQSUCKLLKRTBZ-UHFFFAOYSA-N 0.000 description 1
- QGLWBTPVKHMVHM-KTKRTIGZSA-N (z)-octadec-9-en-1-amine Chemical compound CCCCCCCC\C=C/CCCCCCCCN QGLWBTPVKHMVHM-KTKRTIGZSA-N 0.000 description 1
- DTOUUUZOYKYHEP-UHFFFAOYSA-N 1,3-bis(2-ethylhexyl)-5-methyl-1,3-diazinan-5-amine Chemical compound CCCCC(CC)CN1CN(CC(CC)CCCC)CC(C)(N)C1 DTOUUUZOYKYHEP-UHFFFAOYSA-N 0.000 description 1
- UYBWIEGTWASWSR-UHFFFAOYSA-N 1,3-diaminopropan-2-ol Chemical compound NCC(O)CN UYBWIEGTWASWSR-UHFFFAOYSA-N 0.000 description 1
- WZCQRUWWHSTZEM-UHFFFAOYSA-N 1,3-phenylenediamine Chemical compound NC1=CC=CC(N)=C1 WZCQRUWWHSTZEM-UHFFFAOYSA-N 0.000 description 1
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 1
- 229940035437 1,3-propanediol Drugs 0.000 description 1
- CBCKQZAAMUWICA-UHFFFAOYSA-N 1,4-phenylenediamine Chemical compound NC1=CC=C(N)C=C1 CBCKQZAAMUWICA-UHFFFAOYSA-N 0.000 description 1
- UIQSKEDQPSEGAU-UHFFFAOYSA-N 1-Aminoethylphosphonic Acid Chemical compound CC(N)P(O)(O)=O UIQSKEDQPSEGAU-UHFFFAOYSA-N 0.000 description 1
- UAEPDDGDPAPPHZ-UHFFFAOYSA-N 1-aminobutylphosphonic acid Chemical compound CCCC(N)P(O)(O)=O UAEPDDGDPAPPHZ-UHFFFAOYSA-N 0.000 description 1
- NXTPDFMZKSLVRK-UHFFFAOYSA-N 1-aminopentylphosphonic acid Chemical compound CCCCC(N)P(O)(O)=O NXTPDFMZKSLVRK-UHFFFAOYSA-N 0.000 description 1
- HXKKHQJGJAFBHI-UHFFFAOYSA-N 1-aminopropan-2-ol Chemical compound CC(O)CN HXKKHQJGJAFBHI-UHFFFAOYSA-N 0.000 description 1
- ODMTWOKJHVPSLP-UHFFFAOYSA-N 1-azaniumylhexyl(hydroxy)phosphinate Chemical compound CCCCCC(N)P(O)(O)=O ODMTWOKJHVPSLP-UHFFFAOYSA-N 0.000 description 1
- DELJNDWGTWHHFA-UHFFFAOYSA-N 1-azaniumylpropyl(hydroxy)phosphinate Chemical compound CCC(N)P(O)(O)=O DELJNDWGTWHHFA-UHFFFAOYSA-N 0.000 description 1
- UHDGCWIWMRVCDJ-UHFFFAOYSA-N 1-beta-D-Xylofuranosyl-NH-Cytosine Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(CO)O1 UHDGCWIWMRVCDJ-UHFFFAOYSA-N 0.000 description 1
- ARXJGSRGQADJSQ-UHFFFAOYSA-N 1-methoxypropan-2-ol Chemical compound COCC(C)O ARXJGSRGQADJSQ-UHFFFAOYSA-N 0.000 description 1
- XDFZKQJLNGNJAN-UHFFFAOYSA-N 1-methylbenzimidazol-2-amine Chemical compound C1=CC=C2N(C)C(N)=NC2=C1 XDFZKQJLNGNJAN-UHFFFAOYSA-N 0.000 description 1
- YWUNGYFXNDOGNZ-UHFFFAOYSA-N 1-phenylpiperazin-2-one Chemical compound O=C1CNCCN1C1=CC=CC=C1 YWUNGYFXNDOGNZ-UHFFFAOYSA-N 0.000 description 1
- DEPDDPLQZYCHOH-UHFFFAOYSA-N 1h-imidazol-2-amine Chemical compound NC1=NC=CN1 DEPDDPLQZYCHOH-UHFFFAOYSA-N 0.000 description 1
- JVVRJMXHNUAPHW-UHFFFAOYSA-N 1h-pyrazol-5-amine Chemical compound NC=1C=CNN=1 JVVRJMXHNUAPHW-UHFFFAOYSA-N 0.000 description 1
- POAGFQOGFRYOFM-UHFFFAOYSA-N 2,2,5,5-tetramethylpyrrolidine-3-carboxamide Chemical compound CC1(C)CC(C(N)=O)C(C)(C)N1 POAGFQOGFRYOFM-UHFFFAOYSA-N 0.000 description 1
- UWMHHZFHBCYGCV-UHFFFAOYSA-N 2,3,2-tetramine Chemical compound NCCNCCCNCCN UWMHHZFHBCYGCV-UHFFFAOYSA-N 0.000 description 1
- YHUUZKCUQVILTK-UHFFFAOYSA-N 2,3-dimethylpyridin-4-amine Chemical compound CC1=NC=CC(N)=C1C YHUUZKCUQVILTK-UHFFFAOYSA-N 0.000 description 1
- OGNSCSPNOLGXSM-UHFFFAOYSA-N 2,4-diaminobutyric acid Chemical compound NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
- KMHSUNDEGHRBNV-UHFFFAOYSA-N 2,4-dichloropyrimidine-5-carbonitrile Chemical compound ClC1=NC=C(C#N)C(Cl)=N1 KMHSUNDEGHRBNV-UHFFFAOYSA-N 0.000 description 1
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 1
- IYYBXKYCCZFNEE-UHFFFAOYSA-N 2-(2-acetylhydrazinyl)ethanesulfonic acid Chemical compound CC(=O)NNCCS(O)(=O)=O IYYBXKYCCZFNEE-UHFFFAOYSA-N 0.000 description 1
- STKYPAFSDFAEPH-UHFFFAOYSA-N 2-(2-aminoacetamido)-3-methylbutanoic acid Chemical compound CC(C)C(C(O)=O)NC(=O)CN STKYPAFSDFAEPH-UHFFFAOYSA-N 0.000 description 1
- GIAFURWZWWWBQT-UHFFFAOYSA-N 2-(2-aminoethoxy)ethanol Chemical compound NCCOCCO GIAFURWZWWWBQT-UHFFFAOYSA-N 0.000 description 1
- PNROREDTZJCOHF-UHFFFAOYSA-N 2-(3,5-dichlorophenoxy)acetonitrile Chemical compound ClC1=CC(Cl)=CC(OCC#N)=C1 PNROREDTZJCOHF-UHFFFAOYSA-N 0.000 description 1
- CYOIAXUAIXVWMU-UHFFFAOYSA-N 2-[2-aminoethyl(2-hydroxyethyl)amino]ethanol Chemical compound NCCN(CCO)CCO CYOIAXUAIXVWMU-UHFFFAOYSA-N 0.000 description 1
- JUCGVCVPNPBJIG-UHFFFAOYSA-N 2-amino-1-phenylpropane-1,3-diol Chemical compound OCC(N)C(O)C1=CC=CC=C1 JUCGVCVPNPBJIG-UHFFFAOYSA-N 0.000 description 1
- IOAOAKDONABGPZ-UHFFFAOYSA-N 2-amino-2-ethylpropane-1,3-diol Chemical compound CCC(N)(CO)CO IOAOAKDONABGPZ-UHFFFAOYSA-N 0.000 description 1
- UXFQFBNBSPQBJW-UHFFFAOYSA-N 2-amino-2-methylpropane-1,3-diol Chemical compound OCC(N)(C)CO UXFQFBNBSPQBJW-UHFFFAOYSA-N 0.000 description 1
- UDQCRUSSQAXPJY-UHFFFAOYSA-N 2-amino-3-(1h-indol-3-yl)propan-1-ol Chemical compound C1=CC=C2C(CC(CO)N)=CNC2=C1 UDQCRUSSQAXPJY-UHFFFAOYSA-N 0.000 description 1
- XDEHMKQLKPZERH-UHFFFAOYSA-N 2-amino-3-methylbutanamide Chemical compound CC(C)C(N)C(N)=O XDEHMKQLKPZERH-UHFFFAOYSA-N 0.000 description 1
- STVVMTBJNDTZBF-UHFFFAOYSA-N 2-amino-3-phenylpropan-1-ol Chemical compound OCC(N)CC1=CC=CC=C1 STVVMTBJNDTZBF-UHFFFAOYSA-N 0.000 description 1
- LBTABPSJONFLPO-UHFFFAOYSA-N 2-amino-3-phosphonopropanoic acid Chemical compound OC(=O)C(N)CP(O)(O)=O LBTABPSJONFLPO-UHFFFAOYSA-N 0.000 description 1
- WKNMKGVLOWGGOU-UHFFFAOYSA-N 2-aminoacetamide;hydron;chloride Chemical compound Cl.NCC(N)=O WKNMKGVLOWGGOU-UHFFFAOYSA-N 0.000 description 1
- JWYUFVNJZUSCSM-UHFFFAOYSA-N 2-aminobenzimidazole Chemical compound C1=CC=C2NC(N)=NC2=C1 JWYUFVNJZUSCSM-UHFFFAOYSA-N 0.000 description 1
- JCBPETKZIGVZRE-UHFFFAOYSA-N 2-aminobutan-1-ol Chemical compound CCC(N)CO JCBPETKZIGVZRE-UHFFFAOYSA-N 0.000 description 1
- VXLFIQRFFTWWCL-UHFFFAOYSA-N 2-aminobutan-2-ylphosphonic acid Chemical compound CCC(C)(N)P(O)(O)=O VXLFIQRFFTWWCL-UHFFFAOYSA-N 0.000 description 1
- DWHMPBALQYTJFJ-UHFFFAOYSA-N 2-aminobutanedioic acid;hydrochloride Chemical compound Cl.OC(=O)C(N)CC(O)=O DWHMPBALQYTJFJ-UHFFFAOYSA-N 0.000 description 1
- DPEOTCPCYHSVTC-UHFFFAOYSA-N 2-aminohexan-1-ol Chemical compound CCCCC(N)CO DPEOTCPCYHSVTC-UHFFFAOYSA-N 0.000 description 1
- KPIVDNYJNOPGBE-UHFFFAOYSA-N 2-aminonicotinic acid Chemical compound NC1=NC=CC=C1C(O)=O KPIVDNYJNOPGBE-UHFFFAOYSA-N 0.000 description 1
- ULCCDZGGHWFJMU-UHFFFAOYSA-N 2-aminopentan-2-ylphosphonic acid Chemical compound CCCC(C)(N)P(O)(O)=O ULCCDZGGHWFJMU-UHFFFAOYSA-N 0.000 description 1
- CDAWCLOXVUBKRW-UHFFFAOYSA-N 2-aminophenol Chemical compound NC1=CC=CC=C1O CDAWCLOXVUBKRW-UHFFFAOYSA-N 0.000 description 1
- KJJPLEZQSCZCKE-UHFFFAOYSA-N 2-aminopropane-1,3-diol Chemical compound OCC(N)CO KJJPLEZQSCZCKE-UHFFFAOYSA-N 0.000 description 1
- BMTSZVZQNMNPCT-UHFFFAOYSA-N 2-aminopyridin-3-ol Chemical compound NC1=NC=CC=C1O BMTSZVZQNMNPCT-UHFFFAOYSA-N 0.000 description 1
- ICSNLGPSRYBMBD-UHFFFAOYSA-N 2-aminopyridine Chemical compound NC1=CC=CC=N1 ICSNLGPSRYBMBD-UHFFFAOYSA-N 0.000 description 1
- MWGATWIBSKHFMR-UHFFFAOYSA-N 2-anilinoethanol Chemical compound OCCNC1=CC=CC=C1 MWGATWIBSKHFMR-UHFFFAOYSA-N 0.000 description 1
- ZTTWHZHBPDYSQB-UHFFFAOYSA-N 2-azaniumyl-3-(1h-indol-3-yl)-2-methylpropanoate Chemical compound C1=CC=C2C(CC(N)(C)C(O)=O)=CNC2=C1 ZTTWHZHBPDYSQB-UHFFFAOYSA-N 0.000 description 1
- DDOQBQRIEWHWBT-UHFFFAOYSA-N 2-azaniumyl-4-phosphonobutanoate Chemical compound OC(=O)C(N)CCP(O)(O)=O DDOQBQRIEWHWBT-UHFFFAOYSA-N 0.000 description 1
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 description 1
- UESHPQPPVLJYLU-UHFFFAOYSA-N 2-ethylpiperidine-1-carboxylic acid Chemical compound CCC1CCCCN1C(O)=O UESHPQPPVLJYLU-UHFFFAOYSA-N 0.000 description 1
- FSJOLBAFVKSQQJ-UHFFFAOYSA-N 2-ethylpyrazol-3-amine Chemical compound CCN1N=CC=C1N FSJOLBAFVKSQQJ-UHFFFAOYSA-N 0.000 description 1
- BHZFOIHRKRXWLL-UHFFFAOYSA-N 2-methylheptan-1-amine Chemical compound CCCCCC(C)CN BHZFOIHRKRXWLL-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- NIBXVTMWHMMKGV-UHFFFAOYSA-N 2-trimethylsilylethanamine Chemical compound C[Si](C)(C)CCN NIBXVTMWHMMKGV-UHFFFAOYSA-N 0.000 description 1
- IFPJFPROEPHIMI-UHFFFAOYSA-N 3-(2-hydroxyethylamino)propan-1-ol Chemical compound OCCCNCCO IFPJFPROEPHIMI-UHFFFAOYSA-N 0.000 description 1
- CXMYWOCYTPKBPP-UHFFFAOYSA-N 3-(3-hydroxypropylamino)propan-1-ol Chemical compound OCCCNCCCO CXMYWOCYTPKBPP-UHFFFAOYSA-N 0.000 description 1
- CRZNAZZXMBDMBS-UHFFFAOYSA-N 3-(hydroxyamino)propylphosphonic acid Chemical compound ONCCCP(O)(O)=O CRZNAZZXMBDMBS-UHFFFAOYSA-N 0.000 description 1
- BMUDPLZKKRQECS-UHFFFAOYSA-K 3-[18-(2-carboxyethyl)-8,13-bis(ethenyl)-3,7,12,17-tetramethylporphyrin-21,24-diid-2-yl]propanoic acid iron(3+) hydroxide Chemical compound [OH-].[Fe+3].[N-]1C2=C(C)C(CCC(O)=O)=C1C=C([N-]1)C(CCC(O)=O)=C(C)C1=CC(C(C)=C1C=C)=NC1=CC(C(C)=C1C=C)=NC1=C2 BMUDPLZKKRQECS-UHFFFAOYSA-K 0.000 description 1
- ADXWWNMHZFPXKW-UHFFFAOYSA-N 3-[3-(trifluoromethyl)phenoxy]azetidine Chemical compound FC(F)(F)C1=CC=CC(OC2CNC2)=C1 ADXWWNMHZFPXKW-UHFFFAOYSA-N 0.000 description 1
- CMAQTHNYOAJTHQ-JTQLQIEISA-N 3-[[(2s)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]propanoic acid Chemical compound OC(=O)CCNC(=O)[C@@H](N)CC1=CC=C(O)C=C1 CMAQTHNYOAJTHQ-JTQLQIEISA-N 0.000 description 1
- FDGAEAYZQQCBRN-UHFFFAOYSA-N 3-amino-4-methoxybenzoic acid Chemical compound COC1=CC=C(C(O)=O)C=C1N FDGAEAYZQQCBRN-UHFFFAOYSA-N 0.000 description 1
- PECYZEOJVXMISF-UHFFFAOYSA-N 3-aminoalanine Chemical compound [NH3+]CC(N)C([O-])=O PECYZEOJVXMISF-UHFFFAOYSA-N 0.000 description 1
- XFDUHJPVQKIXHO-UHFFFAOYSA-N 3-aminobenzoic acid Chemical compound NC1=CC=CC(C(O)=O)=C1 XFDUHJPVQKIXHO-UHFFFAOYSA-N 0.000 description 1
- CWLKGDAVCFYWJK-UHFFFAOYSA-N 3-aminophenol Chemical compound NC1=CC=CC(O)=C1 CWLKGDAVCFYWJK-UHFFFAOYSA-N 0.000 description 1
- IYGAMTQMILRCCI-UHFFFAOYSA-N 3-aminopropane-1-thiol Chemical compound NCCCS IYGAMTQMILRCCI-UHFFFAOYSA-N 0.000 description 1
- ZSEGSUBKDDEALH-UHFFFAOYSA-N 3-aminothiolan-2-one;hydron;chloride Chemical compound Cl.NC1CCSC1=O ZSEGSUBKDDEALH-UHFFFAOYSA-N 0.000 description 1
- UJOYFRCOTPUKAK-UHFFFAOYSA-N 3-ammonio-3-phenylpropanoate Chemical compound [O-]C(=O)CC([NH3+])C1=CC=CC=C1 UJOYFRCOTPUKAK-UHFFFAOYSA-N 0.000 description 1
- RGDQRXPEZUNWHX-UHFFFAOYSA-N 3-methylpyridin-2-amine Chemical compound CC1=CC=CN=C1N RGDQRXPEZUNWHX-UHFFFAOYSA-N 0.000 description 1
- HBBDWCSTXMXFMV-UHFFFAOYSA-N 3-piperidin-4-yloxypropanoic acid Chemical compound OC(=O)CCOC1CCNCC1 HBBDWCSTXMXFMV-UHFFFAOYSA-N 0.000 description 1
- RWLDCNACDPTRMY-UHFFFAOYSA-N 3-triethoxysilyl-n-(3-triethoxysilylpropyl)propan-1-amine Chemical compound CCO[Si](OCC)(OCC)CCCNCCC[Si](OCC)(OCC)OCC RWLDCNACDPTRMY-UHFFFAOYSA-N 0.000 description 1
- SJECZPVISLOESU-UHFFFAOYSA-N 3-trimethoxysilylpropan-1-amine Chemical compound CO[Si](OC)(OC)CCCN SJECZPVISLOESU-UHFFFAOYSA-N 0.000 description 1
- PFRLCKFENIXNMM-UHFFFAOYSA-N 3-trimethylsilylpropan-1-amine Chemical compound C[Si](C)(C)CCCN PFRLCKFENIXNMM-UHFFFAOYSA-N 0.000 description 1
- DBLDQZASZZMNSL-UHFFFAOYSA-N 4-(2-amino-3-hydroxypropyl)phenol Chemical compound OCC(N)CC1=CC=C(O)C=C1 DBLDQZASZZMNSL-UHFFFAOYSA-N 0.000 description 1
- OPUJAKVDYGQVHP-UHFFFAOYSA-N 4-(butylamino)butan-1-ol Chemical compound CCCCNCCCCO OPUJAKVDYGQVHP-UHFFFAOYSA-N 0.000 description 1
- DPBWFNDFMCCGGJ-UHFFFAOYSA-N 4-Piperidine carboxamide Chemical compound NC(=O)C1CCNCC1 DPBWFNDFMCCGGJ-UHFFFAOYSA-N 0.000 description 1
- NFPYJDZQOKCYIE-UHFFFAOYSA-N 4-amino-3-hydroxybenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1O NFPYJDZQOKCYIE-UHFFFAOYSA-N 0.000 description 1
- ICDQYZQNKWKLMF-UHFFFAOYSA-N 4-amino-3-methoxy-2-methylbenzoic acid Chemical compound COC1=C(N)C=CC(C(O)=O)=C1C ICDQYZQNKWKLMF-UHFFFAOYSA-N 0.000 description 1
- JNFGLYJROFAOQP-UHFFFAOYSA-N 4-amino-3-methoxybenzoic acid Chemical compound COC1=CC(C(O)=O)=CC=C1N JNFGLYJROFAOQP-UHFFFAOYSA-N 0.000 description 1
- HACQKMWYOKGLET-UHFFFAOYSA-N 4-amino-4-(3-hydroxypropyl)heptane-1,7-diol Chemical compound OCCCC(N)(CCCO)CCCO HACQKMWYOKGLET-UHFFFAOYSA-N 0.000 description 1
- SODXFOVXZATGPJ-UHFFFAOYSA-N 4-amino-4-phosphonobutanoic acid Chemical compound OP(=O)(O)C(N)CCC(O)=O SODXFOVXZATGPJ-UHFFFAOYSA-N 0.000 description 1
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 1
- WUBBRNOQWQTFEX-UHFFFAOYSA-N 4-aminosalicylic acid Chemical compound NC1=CC=C(C(O)=O)C(O)=C1 WUBBRNOQWQTFEX-UHFFFAOYSA-N 0.000 description 1
- SWDDLRSGGCWDPH-UHFFFAOYSA-N 4-triethoxysilylbutan-1-amine Chemical compound CCO[Si](OCC)(OCC)CCCCN SWDDLRSGGCWDPH-UHFFFAOYSA-N 0.000 description 1
- URWUCPSDBLQGSH-UHFFFAOYSA-N 5-iodo-1h-indazole-3-carbonitrile Chemical compound IC1=CC=C2NN=C(C#N)C2=C1 URWUCPSDBLQGSH-UHFFFAOYSA-N 0.000 description 1
- SUTWPJHCRAITLU-UHFFFAOYSA-N 6-aminohexan-1-ol Chemical compound NCCCCCCO SUTWPJHCRAITLU-UHFFFAOYSA-N 0.000 description 1
- UUVDJIWRSIJEBS-UHFFFAOYSA-N 6-methoxypyridin-3-amine Chemical compound COC1=CC=C(N)C=N1 UUVDJIWRSIJEBS-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- QFIIYGZAUXVPSZ-UHFFFAOYSA-N 8-(2,4-dihydroxy-6-methylanilino)-2-(2,4-dihydroxy-6-methylphenyl)imino-7-hydroxy-1,9-dimethyldibenzofuran-3-one Chemical compound CC1=CC(=CC(=C1NC2=C(C3=C(C=C2O)OC4=CC(=O)C(=NC5=C(C=C(C=C5C)O)O)C(=C43)C)C)O)O QFIIYGZAUXVPSZ-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 description 1
- 108700001448 Aldo-keto reductase family 1 member A1 Proteins 0.000 description 1
- RGCKGOZRHPZPFP-UHFFFAOYSA-N Alizarin Natural products C1=CC=C2C(=O)C3=C(O)C(O)=CC=C3C(=O)C2=C1 RGCKGOZRHPZPFP-UHFFFAOYSA-N 0.000 description 1
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- ZKMZBAABQFUXFE-UHFFFAOYSA-O Apigeninidin Natural products C1=CC(O)=CC=C1C1=CC=C(C(O)=CC(O)=C2)C2=[O+]1 ZKMZBAABQFUXFE-UHFFFAOYSA-O 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 description 1
- BWKDAAFSXYPQOS-UHFFFAOYSA-N Benzaldehyde glyceryl acetal Chemical compound O1CC(O)COC1C1=CC=CC=C1 BWKDAAFSXYPQOS-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 108010071778 Benzoylformate decarboxylase Proteins 0.000 description 1
- JXYACYYPACQCDM-UHFFFAOYSA-N Benzyl glycinate Chemical compound NCC(=O)OCC1=CC=CC=C1 JXYACYYPACQCDM-UHFFFAOYSA-N 0.000 description 1
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 235000011331 Brassica Nutrition 0.000 description 1
- 241000219198 Brassica Species 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- AUXMWYRZQPIXCC-UHFFFAOYSA-N CC(N)C(O)=O.CC(C)CC(N)C(O)=O Chemical compound CC(N)C(O)=O.CC(C)CC(N)C(O)=O AUXMWYRZQPIXCC-UHFFFAOYSA-N 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 241000208828 Caprifoliaceae Species 0.000 description 1
- 108090000489 Carboxy-Lyases Proteins 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- WLYGSPLCNKYESI-RSUQVHIMSA-N Carthamin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@@]1(O)C(O)=C(C(=O)\C=C\C=2C=CC(O)=CC=2)C(=O)C(\C=C\2C([C@](O)([C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(O)=C(C(=O)\C=C\C=3C=CC(O)=CC=3)C/2=O)=O)=C1O WLYGSPLCNKYESI-RSUQVHIMSA-N 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 108010024679 Coniferyl-alcohol dehydrogenase Proteins 0.000 description 1
- 241000142975 Cornaceae Species 0.000 description 1
- MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 description 1
- 244000303965 Cyamopsis psoralioides Species 0.000 description 1
- UHDGCWIWMRVCDJ-PSQAKQOGSA-N Cytidine Natural products O=C1N=C(N)C=CN1[C@@H]1[C@@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-PSQAKQOGSA-N 0.000 description 1
- BOWUOGIPSRVRSJ-RXMQYKEDSA-N D-2-aminohexano-6-lactam Chemical compound N[C@@H]1CCCCNC1=O BOWUOGIPSRVRSJ-RXMQYKEDSA-N 0.000 description 1
- NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 description 1
- OMNVYXHOSHNURL-UHFFFAOYSA-N DL-alanyl-DL-phenylalanine Chemical compound CC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 OMNVYXHOSHNURL-UHFFFAOYSA-N 0.000 description 1
- UJVHVMNGOZXSOZ-UHFFFAOYSA-N DL-alpha-amino-beta-methylaminopropionic acid Natural products CNCC(N)C(O)=O UJVHVMNGOZXSOZ-UHFFFAOYSA-N 0.000 description 1
- MHZGKXUYDGKKIU-UHFFFAOYSA-N Decylamine Chemical compound CCCCCCCCCCN MHZGKXUYDGKKIU-UHFFFAOYSA-N 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 229920002085 Dialdehyde starch Polymers 0.000 description 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- 108010016626 Dipeptides Proteins 0.000 description 1
- 108700035271 EC 1.1.1.2 Proteins 0.000 description 1
- 108700035017 EC 1.1.1.71 Proteins 0.000 description 1
- 241000208421 Ericaceae Species 0.000 description 1
- TWLLPUMZVVGILS-UHFFFAOYSA-N Ethyl 2-aminobenzoate Chemical compound CCOC(=O)C1=CC=CC=C1N TWLLPUMZVVGILS-UHFFFAOYSA-N 0.000 description 1
- KIWBPDUYBMNFTB-UHFFFAOYSA-N Ethyl hydrogen sulfate Chemical compound CCOS(O)(=O)=O KIWBPDUYBMNFTB-UHFFFAOYSA-N 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 241000221017 Euphorbiaceae Species 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- KWBASGHXHPTPGU-UHFFFAOYSA-N Genipic acid Natural products OC(=O)CC1CCC2=C1C(O)OC2 KWBASGHXHPTPGU-UHFFFAOYSA-N 0.000 description 1
- AZKVWQKMDGGDSV-BCMRRPTOSA-N Genipin Chemical compound COC(=O)C1=CO[C@@H](O)[C@@H]2C(CO)=CC[C@H]12 AZKVWQKMDGGDSV-BCMRRPTOSA-N 0.000 description 1
- XNIJPPBKASPAIZ-UHFFFAOYSA-N Genipinic acid Chemical compound OC1OCC2=C1C(C(C(=O)OC)C(O)=O)CC2 XNIJPPBKASPAIZ-UHFFFAOYSA-N 0.000 description 1
- XNIJPPBKASPAIZ-ZYAQMDEOSA-N Genipinic acid Natural products O=C(OC)[C@H](C(=O)O)[C@H]1C=2[C@@H](O)OCC=2CC1 XNIJPPBKASPAIZ-ZYAQMDEOSA-N 0.000 description 1
- 241001071804 Gentianaceae Species 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 108010043428 Glycine hydroxymethyltransferase Proteins 0.000 description 1
- 102000002667 Glycine hydroxymethyltransferase Human genes 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- FFFHZYDWPBMWHY-UHFFFAOYSA-N HOMOCYSTEINE Chemical compound OC(=O)C(N)CCS FFFHZYDWPBMWHY-UHFFFAOYSA-N 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920001612 Hydroxyethyl starch Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 235000000177 Indigofera tinctoria Nutrition 0.000 description 1
- ZUKLFFYDSALIQW-MSUKCBDUSA-N Iridoid glycoside Chemical compound [H][C@]12CC[C@H](C(O)=O)[C@@]1([H])[C@H](OC1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)OC=C2 ZUKLFFYDSALIQW-MSUKCBDUSA-N 0.000 description 1
- PWWVAXIEGOYWEE-UHFFFAOYSA-N Isophenergan Chemical compound C1=CC=C2N(CC(C)N(C)C)C3=CC=CC=C3SC2=C1 PWWVAXIEGOYWEE-UHFFFAOYSA-N 0.000 description 1
- UJVHVMNGOZXSOZ-VKHMYHEASA-N L-BMAA Chemical compound CNC[C@H](N)C(O)=O UJVHVMNGOZXSOZ-VKHMYHEASA-N 0.000 description 1
- ZQISRDCJNBUVMM-UHFFFAOYSA-N L-Histidinol Natural products OCC(N)CC1=CN=CN1 ZQISRDCJNBUVMM-UHFFFAOYSA-N 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- XBGGUPMXALFZOT-UHFFFAOYSA-N L-Tyrosine, N-glycyl- Chemical compound NCC(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 XBGGUPMXALFZOT-UHFFFAOYSA-N 0.000 description 1
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 description 1
- IFQSXNOEEPCSLW-DKWTVANSSA-N L-cysteine hydrochloride Chemical compound Cl.SC[C@H](N)C(O)=O IFQSXNOEEPCSLW-DKWTVANSSA-N 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- 239000004158 L-cystine Substances 0.000 description 1
- 235000019393 L-cystine Nutrition 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- LCGISIDBXHGCDW-VKHMYHEASA-N L-glutamine amide Chemical compound NC(=O)[C@@H](N)CCC(N)=O LCGISIDBXHGCDW-VKHMYHEASA-N 0.000 description 1
- ZQISRDCJNBUVMM-YFKPBYRVSA-N L-histidinol Chemical compound OC[C@@H](N)CC1=CNC=N1 ZQISRDCJNBUVMM-YFKPBYRVSA-N 0.000 description 1
- AEFLONBTGZFSGQ-VKHMYHEASA-N L-isoglutamine Chemical compound NC(=O)[C@@H](N)CCC(O)=O AEFLONBTGZFSGQ-VKHMYHEASA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- GSYTVXOARWSQSV-BYPYZUCNSA-N L-methioninamide Chemical compound CSCC[C@H](N)C(N)=O GSYTVXOARWSQSV-BYPYZUCNSA-N 0.000 description 1
- OBSIQMZKFXFYLV-QMMMGPOBSA-N L-phenylalanine amide Chemical compound NC(=O)[C@@H](N)CC1=CC=CC=C1 OBSIQMZKFXFYLV-QMMMGPOBSA-N 0.000 description 1
- ZFOMKMMPBOQKMC-KXUCPTDWSA-N L-pyrrolysine Chemical compound C[C@@H]1CC=N[C@H]1C(=O)NCCCC[C@H]([NH3+])C([O-])=O ZFOMKMMPBOQKMC-KXUCPTDWSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 108010029541 Laccase Proteins 0.000 description 1
- 244000208060 Lawsonia inermis Species 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 241001113846 Loganiaceae Species 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- 108030006769 Methanol dehydrogenases Proteins 0.000 description 1
- 108030002912 Methylglutamate dehydrogenases Proteins 0.000 description 1
- YXOLAZRVSSWPPT-UHFFFAOYSA-N Morin Chemical compound OC1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 YXOLAZRVSSWPPT-UHFFFAOYSA-N 0.000 description 1
- FQWRAVYMZULPNK-UHFFFAOYSA-N N(5)-[(Z)-amino(hydroxyimino)methyl]ornithine Chemical compound OC(=O)C(N)CCCNC(N)=NO FQWRAVYMZULPNK-UHFFFAOYSA-N 0.000 description 1
- HOKKHZGPKSLGJE-GSVOUGTGSA-N N-Methyl-D-aspartic acid Chemical compound CN[C@@H](C(O)=O)CC(O)=O HOKKHZGPKSLGJE-GSVOUGTGSA-N 0.000 description 1
- YPIGGYHFMKJNKV-UHFFFAOYSA-N N-ethylglycine Chemical compound CC[NH2+]CC([O-])=O YPIGGYHFMKJNKV-UHFFFAOYSA-N 0.000 description 1
- KZNQNBZMBZJQJO-UHFFFAOYSA-N N-glycyl-L-proline Natural products NCC(=O)N1CCCC1C(O)=O KZNQNBZMBZJQJO-UHFFFAOYSA-N 0.000 description 1
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 1
- OPKOKAMJFNKNAS-UHFFFAOYSA-N N-methylethanolamine Chemical compound CNCCO OPKOKAMJFNKNAS-UHFFFAOYSA-N 0.000 description 1
- MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 1
- 229930182559 Natural dye Natural products 0.000 description 1
- RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 description 1
- REYJJPSVUYRZGE-UHFFFAOYSA-N Octadecylamine Chemical compound CCCCCCCCCCCCCCCCCCN REYJJPSVUYRZGE-UHFFFAOYSA-N 0.000 description 1
- QHGUCRYDKWKLMG-MRVPVSSYSA-N Octopamine Natural products NC[C@@H](O)C1=CC=C(O)C=C1 QHGUCRYDKWKLMG-MRVPVSSYSA-N 0.000 description 1
- 241000207834 Oleaceae Species 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 239000004218 Orcein Substances 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
- 229920002201 Oxidized cellulose Polymers 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 108700020962 Peroxidase Proteins 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 108010036076 Phenylpyruvate decarboxylase Proteins 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-L Phosphate ion(2-) Chemical compound OP([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-L 0.000 description 1
- 229920001744 Polyaldehyde Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 1
- 108010011939 Pyruvate Decarboxylase Proteins 0.000 description 1
- 241001107098 Rubiaceae Species 0.000 description 1
- 240000000513 Santalum album Species 0.000 description 1
- 235000008632 Santalum album Nutrition 0.000 description 1
- 108010077895 Sarcosine Proteins 0.000 description 1
- 239000004115 Sodium Silicate Substances 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 240000006394 Sorghum bicolor Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- MKRNVBXERAPZOP-UHFFFAOYSA-N Starch acetate Chemical compound O1C(CO)C(OC)C(O)C(O)C1OCC1C(OC2C(C(O)C(OC)C(CO)O2)OC(C)=O)C(O)C(O)C(OC2C(OC(C)C(O)C2O)CO)O1 MKRNVBXERAPZOP-UHFFFAOYSA-N 0.000 description 1
- 241000594377 Tarenna Species 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- PLZVEHJLHYMBBY-UHFFFAOYSA-N Tetradecylamine Chemical compound CCCCCCCCCCCCCCN PLZVEHJLHYMBBY-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- FNYLWPVRPXGIIP-UHFFFAOYSA-N Triamterene Chemical compound NC1=NC2=NC(N)=NC(N)=C2N=C1C1=CC=CC=C1 FNYLWPVRPXGIIP-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- NLKUJNGEGZDXGO-XVKPBYJWSA-N Tyr-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 NLKUJNGEGZDXGO-XVKPBYJWSA-N 0.000 description 1
- 108010092464 Urate Oxidase Proteins 0.000 description 1
- GJNDXQBALKCYSZ-RYUDHWBXSA-N Val-Phe Chemical compound CC(C)[C@H]([NH3+])C(=O)N[C@H](C([O-])=O)CC1=CC=CC=C1 GJNDXQBALKCYSZ-RYUDHWBXSA-N 0.000 description 1
- 241000792902 Valerianaceae Species 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- NOUDPBCEONUCOV-FJXQXJEOSA-N [(2s)-1-ethoxy-4-methyl-1-oxopentan-2-yl]azanium;chloride Chemical compound Cl.CCOC(=O)[C@@H](N)CC(C)C NOUDPBCEONUCOV-FJXQXJEOSA-N 0.000 description 1
- MEPPEQYZDYSWQO-UHFFFAOYSA-N [1-(1-aminoethyl)cyclohexyl]phosphonic acid Chemical compound NC(C)C1(CCCCC1)P(O)(O)=O MEPPEQYZDYSWQO-UHFFFAOYSA-N 0.000 description 1
- WOBDANBSEWOYKN-UHFFFAOYSA-N [1-amino-3-(1h-indol-3-yl)-1-oxopropan-2-yl]azanium;chloride Chemical compound Cl.C1=CC=C2C(CC(N)C(N)=O)=CNC2=C1 WOBDANBSEWOYKN-UHFFFAOYSA-N 0.000 description 1
- COZCKUUEUXAVCK-UHFFFAOYSA-N [3-[(3-ethoxy-3-oxopropyl)carbamoyl]phenyl]boronic acid Chemical compound CCOC(=O)CCNC(=O)C1=CC=CC(B(O)O)=C1 COZCKUUEUXAVCK-UHFFFAOYSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 150000001241 acetals Chemical class 0.000 description 1
- 159000000021 acetate salts Chemical class 0.000 description 1
- CFBOHTFVUPKHJE-UHFFFAOYSA-N acetic acid;2-aminoacetamide Chemical compound CC(O)=O.NCC(N)=O CFBOHTFVUPKHJE-UHFFFAOYSA-N 0.000 description 1
- 239000002535 acidifier Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 108010048916 alcohol dehydrogenase (acceptor) Proteins 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- HFVAFDPGUJEFBQ-UHFFFAOYSA-M alizarin red S Chemical compound [Na+].O=C1C2=CC=CC=C2C(=O)C2=C1C=C(S([O-])(=O)=O)C(O)=C2O HFVAFDPGUJEFBQ-UHFFFAOYSA-M 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 150000008041 alkali metal carbonates Chemical class 0.000 description 1
- 125000003806 alkyl carbonyl amino group Chemical group 0.000 description 1
- 125000005600 alkyl phosphonate group Chemical group 0.000 description 1
- 125000005103 alkyl silyl group Chemical group 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 125000005263 alkylenediamine group Chemical group 0.000 description 1
- 150000004716 alpha keto acids Chemical class 0.000 description 1
- HYOWVAAEQCNGLE-UHFFFAOYSA-N alpha-Methylphenylalanine Chemical compound OC(=O)C(N)(C)CC1=CC=CC=C1 HYOWVAAEQCNGLE-UHFFFAOYSA-N 0.000 description 1
- OYTKINVCDFNREN-UHFFFAOYSA-N amifampridine Chemical compound NC1=CC=NC=C1N OYTKINVCDFNREN-UHFFFAOYSA-N 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229960004050 aminobenzoic acid Drugs 0.000 description 1
- 229960004909 aminosalicylic acid Drugs 0.000 description 1
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- 235000012501 ammonium carbonate Nutrition 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 150000001449 anionic compounds Chemical class 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 239000001000 anthraquinone dye Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 125000005228 aryl sulfonate group Chemical group 0.000 description 1
- JHLHNYVMZCADTC-LOSJGSFVSA-N asimadoline Chemical compound C([C@@H](N(C)C(=O)C(C=1C=CC=CC=1)C=1C=CC=CC=1)C=1C=CC=CC=1)N1CC[C@H](O)C1 JHLHNYVMZCADTC-LOSJGSFVSA-N 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229960005274 benzocaine Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-QZABAPFNSA-N beta-D-glucosamine Chemical compound N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-QZABAPFNSA-N 0.000 description 1
- 102000006995 beta-Glucosidase Human genes 0.000 description 1
- VYTBDSUNRJYVHL-UHFFFAOYSA-N beta-Hydrojuglone Natural products O=C1CCC(=O)C2=C1C=CC=C2O VYTBDSUNRJYVHL-UHFFFAOYSA-N 0.000 description 1
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
- DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 1
- ICVPXOZTKDAJJZ-UHFFFAOYSA-N bis(diethoxyphosphoryl)methanamine Chemical compound CCOP(=O)(OCC)C(N)P(=O)(OCC)OCC ICVPXOZTKDAJJZ-UHFFFAOYSA-N 0.000 description 1
- HHKZCCWKTZRCCL-UHFFFAOYSA-N bis-tris propane Chemical compound OCC(CO)(CO)NCCCNC(CO)(CO)CO HHKZCCWKTZRCCL-UHFFFAOYSA-N 0.000 description 1
- UWHUTZOCTZJUKC-JKSUJKDBSA-N brazilin Chemical compound C12=CC(O)=C(O)C=C2C[C@]2(O)[C@H]1C1=CC=C(O)C=C1OC2 UWHUTZOCTZJUKC-JKSUJKDBSA-N 0.000 description 1
- UWHUTZOCTZJUKC-CVEARBPZSA-N brazilin Natural products C12=CC(O)=C(O)C=C2C[C@@]2(O)[C@@H]1C1=CC=C(O)C=C1OC2 UWHUTZOCTZJUKC-CVEARBPZSA-N 0.000 description 1
- SXDBWCPKPHAZSM-UHFFFAOYSA-M bromate Inorganic materials [O-]Br(=O)=O SXDBWCPKPHAZSM-UHFFFAOYSA-M 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 125000001951 carbamoylamino group Chemical group C(N)(=O)N* 0.000 description 1
- CREMABGTGYGIQB-UHFFFAOYSA-N carbon carbon Chemical compound C.C CREMABGTGYGIQB-UHFFFAOYSA-N 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 150000007942 carboxylates Chemical group 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 235000012730 carminic acid Nutrition 0.000 description 1
- 239000004106 carminic acid Substances 0.000 description 1
- 229940114118 carminic acid Drugs 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 125000003636 chemical group Chemical group 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 229940099898 chlorophyllin Drugs 0.000 description 1
- 235000019805 chlorophyllin Nutrition 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 229960002173 citrulline Drugs 0.000 description 1
- 235000013477 citrulline Nutrition 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- MPMSMUBQXQALQI-UHFFFAOYSA-N cobalt phthalocyanine Chemical compound [Co+2].C12=CC=CC=C2C(N=C2[N-]C(C3=CC=CC=C32)=N2)=NC1=NC([C]1C=CC=CC1=1)=NC=1N=C1[C]3C=CC=CC3=C2[N-]1 MPMSMUBQXQALQI-UHFFFAOYSA-N 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 229920001940 conductive polymer Polymers 0.000 description 1
- 238000007596 consolidation process Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000004148 curcumin Substances 0.000 description 1
- 235000012754 curcumin Nutrition 0.000 description 1
- 229940109262 curcumin Drugs 0.000 description 1
- OOTFVKOQINZBBF-UHFFFAOYSA-N cystamine Chemical compound CCSSCCN OOTFVKOQINZBBF-UHFFFAOYSA-N 0.000 description 1
- 229940099500 cystamine Drugs 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- UHDGCWIWMRVCDJ-ZAKLUEHWSA-N cytidine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-ZAKLUEHWSA-N 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- KWDSFGYQALRPMG-UHFFFAOYSA-N delta-N-Hydroxy-L-orginin Natural products OC(=O)C(N)CCCN(O)C(N)=N KWDSFGYQALRPMG-UHFFFAOYSA-N 0.000 description 1
- 239000000412 dendrimer Substances 0.000 description 1
- 229920000736 dendritic polymer Polymers 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- WSEQLMQNPBNMSL-FJXQXJEOSA-N diethyl (2s)-2-aminopentanedioate;hydron;chloride Chemical compound Cl.CCOC(=O)CC[C@H](N)C(=O)OCC WSEQLMQNPBNMSL-FJXQXJEOSA-N 0.000 description 1
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 1
- 229940075557 diethylene glycol monoethyl ether Drugs 0.000 description 1
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 1
- PNLXWGDXZOYUKB-WCCKRBBISA-N dimethyl (2s)-2-aminobutanedioate;hydrochloride Chemical compound Cl.COC(=O)C[C@H](N)C(=O)OC PNLXWGDXZOYUKB-WCCKRBBISA-N 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- YRIUSKIDOIARQF-UHFFFAOYSA-N dodecyl benzenesulfonate Chemical compound CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 YRIUSKIDOIARQF-UHFFFAOYSA-N 0.000 description 1
- 229940071161 dodecylbenzenesulfonate Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- PQGVTLQEKCJXKF-RGMNGODLSA-N ethyl (2s)-2-amino-3-methylbutanoate;hydron;chloride Chemical compound Cl.CCOC(=O)[C@@H](N)C(C)C PQGVTLQEKCJXKF-RGMNGODLSA-N 0.000 description 1
- FPFQPLFYTKMCHN-PPHPATTJSA-N ethyl (2s)-2-amino-3-phenylpropanoate;hydron;chloride Chemical compound Cl.CCOC(=O)[C@@H](N)CC1=CC=CC=C1 FPFQPLFYTKMCHN-PPHPATTJSA-N 0.000 description 1
- KCJWBTUELSKUFA-GDVGLLTNSA-N ethyl (2s)-3-aminopyrrolidine-2-carboxylate Chemical compound CCOC(=O)[C@H]1NCCC1N KCJWBTUELSKUFA-GDVGLLTNSA-N 0.000 description 1
- BQULAXAVRFIAHN-UHFFFAOYSA-N ethyl 2-amino-3-(4-hydroxyphenyl)propanoate;hydron;chloride Chemical compound Cl.CCOC(=O)C(N)CC1=CC=C(O)C=C1 BQULAXAVRFIAHN-UHFFFAOYSA-N 0.000 description 1
- FTURCWPZLPUMLY-UHFFFAOYSA-N ethyl 2-amino-4-sulfanylbutanoate Chemical compound CCOC(=O)C(N)CCS FTURCWPZLPUMLY-UHFFFAOYSA-N 0.000 description 1
- JCXLZWMDXJFOOI-UHFFFAOYSA-N ethyl 2-aminopropanoate;hydron;chloride Chemical compound [Cl-].CCOC(=O)C(C)[NH3+] JCXLZWMDXJFOOI-UHFFFAOYSA-N 0.000 description 1
- USZCLVNQMQEOBA-UHFFFAOYSA-N ethyl 3-amino-3-(carbamoylamino)butanoate Chemical compound CCOC(=O)CC(C)(N)NC(N)=O USZCLVNQMQEOBA-UHFFFAOYSA-N 0.000 description 1
- RJCGNNHKSNIUAT-UHFFFAOYSA-N ethyl 3-aminopropanoate;hydron;chloride Chemical compound Cl.CCOC(=O)CCN RJCGNNHKSNIUAT-UHFFFAOYSA-N 0.000 description 1
- CXVQSUBJMYZELD-UHFFFAOYSA-N ethyl 4-aminobutanoate;hydrochloride Chemical compound [Cl-].CCOC(=O)CCC[NH3+] CXVQSUBJMYZELD-UHFFFAOYSA-N 0.000 description 1
- JMHQESARJMGVCZ-UHFFFAOYSA-N ethyl 4-hydroxypyrrolidine-2-carboxylate Chemical compound CCOC(=O)C1CC(O)CN1 JMHQESARJMGVCZ-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- YAGKRVSRTSUGEY-UHFFFAOYSA-N ferricyanide Chemical compound [Fe+3].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] YAGKRVSRTSUGEY-UHFFFAOYSA-N 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- YQGDEPYYFWUPGO-UHFFFAOYSA-N gamma-amino-beta-hydroxybutyric acid Chemical compound [NH3+]CC(O)CC([O-])=O YQGDEPYYFWUPGO-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- KWBASGHXHPTPGU-CDUCUWFYSA-N genipic acid Chemical compound C([C@H]1CC(O)=O)CC2=C1[C@@H](O)OC2 KWBASGHXHPTPGU-CDUCUWFYSA-N 0.000 description 1
- AZKVWQKMDGGDSV-UHFFFAOYSA-N genipin Natural products COC(=O)C1=COC(O)C2C(CO)=CCC12 AZKVWQKMDGGDSV-UHFFFAOYSA-N 0.000 description 1
- 229940049906 glutamate Drugs 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- BEBCJVAWIBVWNZ-UHFFFAOYSA-N glycinamide Chemical compound NCC(N)=O BEBCJVAWIBVWNZ-UHFFFAOYSA-N 0.000 description 1
- 229960002449 glycine Drugs 0.000 description 1
- KZNQNBZMBZJQJO-YFKPBYRVSA-N glyclproline Chemical compound NCC(=O)N1CCC[C@H]1C(O)=O KZNQNBZMBZJQJO-YFKPBYRVSA-N 0.000 description 1
- YMAWOPBAYDPSLA-UHFFFAOYSA-N glycylglycine Chemical compound [NH3+]CC(=O)NCC([O-])=O YMAWOPBAYDPSLA-UHFFFAOYSA-N 0.000 description 1
- 108010077515 glycylproline Proteins 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 229940029575 guanosine Drugs 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229940109738 hematin Drugs 0.000 description 1
- 125000001072 heteroaryl group Chemical group 0.000 description 1
- NAQMVNRVTILPCV-UHFFFAOYSA-N hexane-1,6-diamine Chemical compound NCCCCCCN NAQMVNRVTILPCV-UHFFFAOYSA-N 0.000 description 1
- XXMIOPMDWAUFGU-UHFFFAOYSA-N hexane-1,6-diol Chemical compound OCCCCCCO XXMIOPMDWAUFGU-UHFFFAOYSA-N 0.000 description 1
- 229960004867 hexetidine Drugs 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- NDBQJIBNNUJNHA-UHFFFAOYSA-N hydron;methyl 2-amino-3-hydroxypropanoate;chloride Chemical compound [Cl-].COC(=O)C([NH3+])CO NDBQJIBNNUJNHA-UHFFFAOYSA-N 0.000 description 1
- SWVMLNPDTIFDDY-UHFFFAOYSA-N hydron;methyl 2-amino-3-phenylpropanoate;chloride Chemical compound Cl.COC(=O)C(N)CC1=CC=CC=C1 SWVMLNPDTIFDDY-UHFFFAOYSA-N 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 239000001341 hydroxy propyl starch Substances 0.000 description 1
- 125000005113 hydroxyalkoxy group Chemical group 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229940050526 hydroxyethylstarch Drugs 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 229920013818 hydroxypropyl guar gum Polymers 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 235000013828 hydroxypropyl starch Nutrition 0.000 description 1
- 229920000587 hyperbranched polymer Polymers 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 229940097275 indigo Drugs 0.000 description 1
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910001412 inorganic anion Inorganic materials 0.000 description 1
- 150000004694 iodide salts Chemical class 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229930182489 iridoid glycoside Natural products 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229940102253 isopropanolamine Drugs 0.000 description 1
- JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 1
- CXORMDKZEUMQHX-UHFFFAOYSA-N kermesic acid Chemical compound O=C1C2=C(O)C(O)=CC(O)=C2C(=O)C2=C1C=C(O)C(C(O)=O)=C2C CXORMDKZEUMQHX-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229960003136 leucine Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- XGZVUEUWXADBQD-UHFFFAOYSA-L lithium carbonate Chemical compound [Li+].[Li+].[O-]C([O-])=O XGZVUEUWXADBQD-UHFFFAOYSA-L 0.000 description 1
- 229910052808 lithium carbonate Inorganic materials 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 150000002688 maleic acid derivatives Chemical class 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- IMYZQPCYWPFTAG-IQJOONFLSA-N mecamylamine Chemical compound C1C[C@@H]2C(C)(C)[C@@](NC)(C)[C@H]1C2 IMYZQPCYWPFTAG-IQJOONFLSA-N 0.000 description 1
- 229960002525 mecamylamine Drugs 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- VEEIFXWJNCAVEQ-RGMNGODLSA-N methyl (2s)-2-amino-3-(1h-imidazol-5-yl)propanoate;hydrochloride Chemical compound Cl.COC(=O)[C@@H](N)CC1=CNC=N1 VEEIFXWJNCAVEQ-RGMNGODLSA-N 0.000 description 1
- VXYFARNRGZWHTJ-FVGYRXGTSA-N methyl (2s)-2-amino-3-(4-hydroxyphenyl)propanoate;hydrochloride Chemical compound Cl.COC(=O)[C@@H](N)CC1=CC=C(O)C=C1 VXYFARNRGZWHTJ-FVGYRXGTSA-N 0.000 description 1
- HQEIPVHJHZTMDP-JEDNCBNOSA-N methyl (2s)-pyrrolidine-2-carboxylate;hydrochloride Chemical compound Cl.COC(=O)[C@@H]1CCCN1 HQEIPVHJHZTMDP-JEDNCBNOSA-N 0.000 description 1
- CFJYPWQHBLMCCU-WCCKRBBISA-N methyl (4s)-4,5-diamino-5-oxopentanoate;hydrochloride Chemical compound Cl.COC(=O)CC[C@H](N)C(N)=O CFJYPWQHBLMCCU-WCCKRBBISA-N 0.000 description 1
- GRRAMKXEZLMNOK-UHFFFAOYSA-N methyl 2-amino-3-(5-hydroxy-1h-indol-3-yl)propanoate;hydrochloride Chemical compound Cl.C1=C(O)C=C2C(CC(N)C(=O)OC)=CNC2=C1 GRRAMKXEZLMNOK-UHFFFAOYSA-N 0.000 description 1
- CEMZBWPSKYISTN-UHFFFAOYSA-N methyl 2-amino-3-methylbutanoate Chemical compound COC(=O)C(N)C(C)C CEMZBWPSKYISTN-UHFFFAOYSA-N 0.000 description 1
- VSDUZFOSJDMAFZ-UHFFFAOYSA-N methyl 2-amino-3-phenylpropanoate Chemical compound COC(=O)C(N)CC1=CC=CC=C1 VSDUZFOSJDMAFZ-UHFFFAOYSA-N 0.000 description 1
- SZJUWKPNWWCOPG-UHFFFAOYSA-N methyl 2-anilinoacetate Chemical compound COC(=O)CNC1=CC=CC=C1 SZJUWKPNWWCOPG-UHFFFAOYSA-N 0.000 description 1
- IOPLHGOSNCJOOO-UHFFFAOYSA-N methyl 3,4-diaminobenzoate Chemical compound COC(=O)C1=CC=C(N)C(N)=C1 IOPLHGOSNCJOOO-UHFFFAOYSA-N 0.000 description 1
- LZXXNPOYQCLXRS-UHFFFAOYSA-N methyl 4-aminobenzoate Chemical compound COC(=O)C1=CC=C(N)C=C1 LZXXNPOYQCLXRS-UHFFFAOYSA-N 0.000 description 1
- QVDXUKJJGUSGLS-LURJTMIESA-N methyl L-leucinate Chemical compound COC(=O)[C@@H](N)CC(C)C QVDXUKJJGUSGLS-LURJTMIESA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- ODQZNBWVRPKMKN-UHFFFAOYSA-N methyl piperazine-2-carboxylate Chemical compound COC(=O)C1CNCCN1 ODQZNBWVRPKMKN-UHFFFAOYSA-N 0.000 description 1
- JZMJDSHXVKJFKW-UHFFFAOYSA-M methyl sulfate(1-) Chemical compound COS([O-])(=O)=O JZMJDSHXVKJFKW-UHFFFAOYSA-M 0.000 description 1
- HSMRCPIZVMDSHN-UHFFFAOYSA-N methylaminomethylphosphonic acid Chemical compound CNCP(O)(O)=O HSMRCPIZVMDSHN-UHFFFAOYSA-N 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 1
- YAHRDLICUYEDAU-UHFFFAOYSA-N methylhexaneamine Chemical compound CCC(C)CC(C)N YAHRDLICUYEDAU-UHFFFAOYSA-N 0.000 description 1
- 229950000752 methylhexaneamine Drugs 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 229940045641 monobasic sodium phosphate Drugs 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 1
- 235000007708 morin Nutrition 0.000 description 1
- FPFKERZHIGFTEI-UHFFFAOYSA-N n'-(2-trimethoxysilylethyl)ethane-1,2-diamine Chemical compound CO[Si](OC)(OC)CCNCCN FPFKERZHIGFTEI-UHFFFAOYSA-N 0.000 description 1
- INJVFBCDVXYHGQ-UHFFFAOYSA-N n'-(3-triethoxysilylpropyl)ethane-1,2-diamine Chemical compound CCO[Si](OCC)(OCC)CCCNCCN INJVFBCDVXYHGQ-UHFFFAOYSA-N 0.000 description 1
- AMVXVPUHCLLJRE-UHFFFAOYSA-N n'-(3-trimethoxysilylpropyl)hexane-1,6-diamine Chemical compound CO[Si](OC)(OC)CCCNCCCCCCN AMVXVPUHCLLJRE-UHFFFAOYSA-N 0.000 description 1
- NHBRUUFBSBSTHM-UHFFFAOYSA-N n'-[2-(3-trimethoxysilylpropylamino)ethyl]ethane-1,2-diamine Chemical compound CO[Si](OC)(OC)CCCNCCNCCN NHBRUUFBSBSTHM-UHFFFAOYSA-N 0.000 description 1
- XMMDVXFQGOEOKH-UHFFFAOYSA-N n'-dodecylpropane-1,3-diamine Chemical compound CCCCCCCCCCCCNCCCN XMMDVXFQGOEOKH-UHFFFAOYSA-N 0.000 description 1
- ONCPEIKLFULSSA-UHFFFAOYSA-N n'-ethylbutane-1,4-diamine Chemical compound CCNCCCCN ONCPEIKLFULSSA-UHFFFAOYSA-N 0.000 description 1
- QHJABUZHRJTCAR-UHFFFAOYSA-N n'-methylpropane-1,3-diamine Chemical compound CNCCCN QHJABUZHRJTCAR-UHFFFAOYSA-N 0.000 description 1
- UQUPIHHYKUEXQD-UHFFFAOYSA-N n,n′-dimethyl-1,3-propanediamine Chemical compound CNCCCNC UQUPIHHYKUEXQD-UHFFFAOYSA-N 0.000 description 1
- DESVYRJXTAYBFA-UHFFFAOYSA-N n-(2-aminoethyl)dodecanamide Chemical compound CCCCCCCCCCCC(=O)NCCN DESVYRJXTAYBFA-UHFFFAOYSA-N 0.000 description 1
- FTQWRYSLUYAIRQ-UHFFFAOYSA-N n-[(octadecanoylamino)methyl]octadecanamide Chemical compound CCCCCCCCCCCCCCCCCC(=O)NCNC(=O)CCCCCCCCCCCCCCCCC FTQWRYSLUYAIRQ-UHFFFAOYSA-N 0.000 description 1
- DVYVMJLSUSGYMH-UHFFFAOYSA-N n-methyl-3-trimethoxysilylpropan-1-amine Chemical compound CNCCC[Si](OC)(OC)OC DVYVMJLSUSGYMH-UHFFFAOYSA-N 0.000 description 1
- PGYBGJMNJXCWKW-UHFFFAOYSA-N n-methyl-n'-(3-trimethoxysilylpropyl)ethane-1,2-diamine Chemical compound CNCCNCCC[Si](OC)(OC)OC PGYBGJMNJXCWKW-UHFFFAOYSA-N 0.000 description 1
- BGWFQRDYRSCOCO-UHFFFAOYSA-N n-methylheptan-2-amine Chemical compound CCCCCC(C)NC BGWFQRDYRSCOCO-UHFFFAOYSA-N 0.000 description 1
- 239000000978 natural dye Substances 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- BVOCPVIXARZNQN-UHFFFAOYSA-N nipecotamide Chemical compound NC(=O)C1CCCNC1 BVOCPVIXARZNQN-UHFFFAOYSA-N 0.000 description 1
- XJLSEXAGTJCILF-UHFFFAOYSA-N nipecotic acid Chemical compound OC(=O)C1CCCNC1 XJLSEXAGTJCILF-UHFFFAOYSA-N 0.000 description 1
- FJDUDHYHRVPMJZ-UHFFFAOYSA-N nonan-1-amine Chemical compound CCCCCCCCCN FJDUDHYHRVPMJZ-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- FWWQKRXKHIRPJY-UHFFFAOYSA-N octadecyl aldehyde Natural products CCCCCCCCCCCCCCCCCC=O FWWQKRXKHIRPJY-UHFFFAOYSA-N 0.000 description 1
- IOQPZZOEVPZRBK-UHFFFAOYSA-N octan-1-amine Chemical compound CCCCCCCCN IOQPZZOEVPZRBK-UHFFFAOYSA-N 0.000 description 1
- QNIVIMYXGGFTAK-UHFFFAOYSA-N octodrine Chemical compound CC(C)CCCC(C)N QNIVIMYXGGFTAK-UHFFFAOYSA-N 0.000 description 1
- 229960001465 octodrine Drugs 0.000 description 1
- 229960001576 octopamine Drugs 0.000 description 1
- 239000003605 opacifier Substances 0.000 description 1
- 235000019248 orcein Nutrition 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 229940107304 oxidized cellulose Drugs 0.000 description 1
- 239000001254 oxidized starch Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229960000292 pectin Drugs 0.000 description 1
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 1
- JRKICGRDRMAZLK-UHFFFAOYSA-L persulfate group Chemical group S(=O)(=O)([O-])OOS(=O)(=O)[O-] JRKICGRDRMAZLK-UHFFFAOYSA-L 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- JSSXHAMIXJGYCS-UHFFFAOYSA-N piperazin-4-ium-2-carboxylate Chemical compound OC(=O)C1CNCCN1 JSSXHAMIXJGYCS-UHFFFAOYSA-N 0.000 description 1
- 229920001308 poly(aminoacid) Polymers 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- SSOLNOMRVKKSON-UHFFFAOYSA-N proguanil Chemical compound CC(C)\N=C(/N)N=C(N)NC1=CC=C(Cl)C=C1 SSOLNOMRVKKSON-UHFFFAOYSA-N 0.000 description 1
- HVVNJUAVDAZWCB-UHFFFAOYSA-N prolinol Chemical compound OCC1CCCN1 HVVNJUAVDAZWCB-UHFFFAOYSA-N 0.000 description 1
- 229960003910 promethazine Drugs 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 125000001422 pyrrolinyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 238000007348 radical reaction Methods 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000007142 ring opening reaction Methods 0.000 description 1
- 229940043230 sarcosine Drugs 0.000 description 1
- 229910052706 scandium Inorganic materials 0.000 description 1
- SIXSYDAISGFNSX-UHFFFAOYSA-N scandium atom Chemical compound [Sc] SIXSYDAISGFNSX-UHFFFAOYSA-N 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 description 1
- 229910052911 sodium silicate Inorganic materials 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 229940063673 spermidine Drugs 0.000 description 1
- PFNFFQXMRSDOHW-UHFFFAOYSA-N spermine Chemical compound NCCCNCCCCNCCCN PFNFFQXMRSDOHW-UHFFFAOYSA-N 0.000 description 1
- 229940032147 starch Drugs 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 229940105131 stearamine Drugs 0.000 description 1
- 150000003457 sulfones Chemical class 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 150000003892 tartrate salts Chemical class 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- XJJBXZIKXFOMLP-UHFFFAOYSA-N tert-butyl pyrrolidine-2-carboxylate Chemical compound CC(C)(C)OC(=O)C1CCCN1 XJJBXZIKXFOMLP-UHFFFAOYSA-N 0.000 description 1
- 229940026510 theanine Drugs 0.000 description 1
- 150000007970 thio esters Chemical class 0.000 description 1
- 229940104230 thymidine Drugs 0.000 description 1
- 229940113082 thymine Drugs 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-M toluene-4-sulfonate Chemical compound CC1=CC=C(S([O-])(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-M 0.000 description 1
- 125000005490 tosylate group Chemical group 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 229960001288 triamterene Drugs 0.000 description 1
- ZMCBYSBVJIMENC-UHFFFAOYSA-N tricaine Chemical compound CCOC(=O)C1=CC=CC(N)=C1 ZMCBYSBVJIMENC-UHFFFAOYSA-N 0.000 description 1
- YVWPNDBYAAEZBF-UHFFFAOYSA-N trimethylsilylmethanamine Chemical compound C[Si](C)(C)CN YVWPNDBYAAEZBF-UHFFFAOYSA-N 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- UOCLRXFKRLRMKV-UHFFFAOYSA-N trolnitrate phosphate Chemical compound OP(O)(O)=O.OP(O)(O)=O.[O-][N+](=O)OCCN(CCO[N+]([O-])=O)CCO[N+]([O-])=O UOCLRXFKRLRMKV-UHFFFAOYSA-N 0.000 description 1
- PQFMNVGMJJMLAE-UHFFFAOYSA-N tyrosinamide Chemical compound NC(=O)C(N)CC1=CC=C(O)C=C1 PQFMNVGMJJMLAE-UHFFFAOYSA-N 0.000 description 1
- 229940035893 uracil Drugs 0.000 description 1
- DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 1
- AQLJVWUFPCUVLO-UHFFFAOYSA-N urea hydrogen peroxide Chemical compound OO.NC(N)=O AQLJVWUFPCUVLO-UHFFFAOYSA-N 0.000 description 1
- 229940045145 uridine Drugs 0.000 description 1
- 229960004295 valine Drugs 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- HSRXSKHRSXRCFC-UHFFFAOYSA-N valyl-alanine Chemical compound CC(C)C(N)C(=O)NC(C)C(O)=O HSRXSKHRSXRCFC-UHFFFAOYSA-N 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
- GPPXJZIENCGNKB-UHFFFAOYSA-N vanadium Chemical compound [V]#[V] GPPXJZIENCGNKB-UHFFFAOYSA-N 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002888 zwitterionic surfactant Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/10—Preparations for permanently dyeing the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Cosmetics (AREA)
Abstract
본 발명은 화장용으로 허용가능한 매질 중에 하기를 포함하는, 인간 케라틴 섬유용 조성물에 관한 것이다:
* 하기 화학식 (I) 및/또는 화학식 (II) 의 화합물, 또는 상기를 포함하는 식물 추출물:
(식 중, R1: 수소, (히드록시)메틸, 알데히드, -CO2R4 (R4: 수소, 알킬), -CH2-글루코오스; R2: 수소, 히드록실, 글루코오스; R3: 수소, 히드록실, 알킬옥시; n 은 1 내지 5 범위; R5: -CO2R'6 (R'6: 수소, 알킬, 양이온));
** 화학식 (i) 및 (ii) 의 하나 이상의 알데히드 또는 이민 화합물, 및 또한 하나 이상의 알데히드 또는 이민 관능기를 포함하는 산화 올리고당 또는 다당류:
(식 중, n 은 0 또는 1; X: O, NR"1; A: COOH, 임의로 치환된 아릴, 1 또는 2 개의 헤테로원자를 포함하는 양이온성 또는 비양이온성, 포화 또는 불포화 5- 또는 6-원 헤테로사이클, 임의로 치환된, 알킬, 알케닐; A2: 2가 알킬렌; 알데히드의 경우, 상기 화합물은 아세탈 또는 헤미아세탈 형태일 수 있음).
본 발명의 주제는 또한 상기와 같은 조성물을 사용하는 방법 및 화학식 (I) 및/또는 (II) 의 하나 이상의 화합물 또는 상기를 포함하는 식물 추출물을 함유하는 제 1 구획, 및 화학식 (i) 또는 (ii) 의 하나 이상의 화합물, 하나 이상의 알데히드 또는 이민 관능기를 포함하는 산화 올리고당 또는 다당류를 함유하는 제 2 구획을 포함하는 다중 구획 장치이다.The present invention relates to a composition for human keratinous fibers comprising in a cosmetically acceptable medium:
A compound of formula (I) and / or formula (II), or a plant extract comprising:
Wherein R 1 : hydrogen, (hydroxy) methyl, aldehyde, -CO 2 R 4 (R 4 : hydrogen, alkyl), -CH 2 -glucose; R 2 : hydrogen, hydroxyl, glucose; R 3 : Hydrogen, hydroxyl, alkyloxy, n ranges from 1 to 5 R 5 : -CO 2 R ' 6 (R' 6 : hydrogen, alkyl, cation));
** Oxidized oligosaccharides or polysaccharides comprising at least one aldehyde or imine compound of formulas (i) and (ii), and also at least one aldehyde or imine function:
Wherein n is 0 or 1; X: O, NR "1; A: COOH, optionally substituted aryl, cationic or non-cationic, saturated or unsaturated 5- or 6 comprising 1 or 2 heteroatoms -Membered heterocycle, optionally substituted alkyl, alkenyl; A 2 : divalent alkylene; for aldehydes, the compound may be in acetal or hemiacetal form).
The subject matter of the present invention also relates to a process for using such a composition and to a first compartment containing at least one compound of formula (I) and / or (II) or a plant extract comprising the same, and formula (i) or ( and a second compartment containing an oxidized oligosaccharide or a polysaccharide comprising at least one compound of ii), at least one aldehyde or imine function.
Description
본 발명은 화장용으로 허용가능한 매질 중에, 식물에서 추출된 비글리코실 이리도이드 (non-glycosyl iridoid) 계열의 하나 이상의 화합물, 및 하나 이상의 특정한 알데히드 또는 이민 화합물을 포함하는 염료 조성물, 및 또한 상기와 같은 조성물을 사용하는 염색 방법에 관한 것이다.The present invention relates to a dye composition comprising, in a cosmetically acceptable medium, at least one compound of the non-glycosyl iridoid family extracted from a plant, and at least one specific aldehyde or imine compound, and also It relates to a dyeing method using the same composition.
최근 모발 염료로서 사용될 수 있는 천연 화합물에 대한 관심이 증가하고 있다.There is an increasing interest in natural compounds that can be used as hair dyes in recent years.
예를 들어, 특허 출원 EP 440 494 에는 꼭두서니과 (Rubiaceae), 대극과 (Euphorbiaceae), 마타리과 (Valerianaceae), 층층나무과 (Cornaceae), 용담과 (Gentianaceae), 인동과 (Caprifoliaceae), 물푸레나무과 (Oleaceae), 진달래과 (Ericaceae), 마전과 (Loganiaceae) 등과 같은 식물에서 추출된, (세코)이리도이드-글리코시드 또는 비글리코실 (세코)이리도이드 (또한 아글리콘 (aglycone) 으로서 공지됨) 의 하나 이상의 화합물을 포함하는 조성물을 사용하는 모발 염색 방법이 개시되어 있다.For example, patent application EP 440 494 includes Rubiaceae, Euphorbiaceae, Valerianaceae, Cornaceae, Gentianaceae, Caprifoliaceae, Oleaceae, One or more compounds of (SECO) iridoid-glycoside or aglycosyl (SECO) iridoid (also known as aglycone) extracted from plants such as Ericaceae, Loganiaceae, etc. A hair dyeing method using a composition comprising is disclosed.
상기와 같은 착색이 갖는 문제는, 이들이 특히 강하지 않거나 또는 만족스러운 착색을 수득하기 위하여 몇 일 또는 몇 주에 걸쳐 조성물의 반복적인 적용이 요구된다는 점이다.The problem with such coloring is that they are not particularly strong or require repeated application of the compositions over days or weeks in order to obtain satisfactory coloring.
나아가, 이는 목적하는 이점인, 천연 색조를 달성하기가 어렵다. 더구나, 상기와 같은 색조가 달성된 경우, 시간에 따라 상당한 색상 변화가 관찰되는 것은 드문 일이 아니다.Furthermore, it is difficult to achieve a natural tone, which is the desired advantage. Moreover, it is not uncommon for significant color changes to be observed over time when such a hue is achieved.
따라서, 본 발명의 목적은 상기 기재된 단점을 극복하는 것이다.It is therefore an object of the present invention to overcome the disadvantages described above.
특히, 놀랍게도, 색상 강화 (build-up) 가 비글리코실 이리도이드 유형의 화합물 및 이의 유도체 및 일반적으로, 상기를 함유하는 임의의 천연 추출물을 사용하여, 상기 화합물을 특정한 알데히드 또는 이민 화합물과 조합함으로써, 실질적으로 개선될 수 있다고 발견되었다.In particular, surprisingly, the color build-up can be achieved by combining the compound with a particular aldehyde or imine compound, using compounds of the aglycosyl iridoid type and derivatives thereof and generally any natural extracts containing them. It has been found that it can be substantially improved.
또한, 처리된 섬유의 구조가 본 발명에 따른 착색에 의해 손상되지 않는다는 것을 확인하였다.It was also confirmed that the structure of the treated fibers was not damaged by the coloring according to the invention.
따라서, 본 발명의 일 주제는 화장용으로 허용가능한 매질 중에, 하기를 포함하는 인간 케라틴 섬유 염색용 조성물이다:Accordingly, one subject of the present invention is a composition for dyeing human keratin fibers comprising, in a cosmetically acceptable medium:
* 하기 화학식 (I) 및/또는 화학식 (II) 의 화합물 , 이의 광학 또는 기하학 이성질체, 이의 무기 또는 유기산 염, 이의 용매화물, 또는 상기를 포함하는 식물 추출물:A compound of formula (I) and / or formula (II) , an optical or geometric isomer thereof, an inorganic or organic acid salt thereof, a solvate thereof, or a plant extract comprising the same:
[화학식 (I) 및 (II) 에서:[Formula (I) and (II):
ㆍ R1 은 수소 원자, 메틸 라디칼, 히드록시메틸 라디칼, 알데히드기; -CO2R4 기 (여기서, R4 는 수소 원자 또는 C1-C2 알킬 라디칼을 나타냄); -CH2-글루코오스기를 나타내고;R 1 represents a hydrogen atom, a methyl radical, a hydroxymethyl radical, an aldehyde group; -CO 2 R 4 group, where R 4 represents a hydrogen atom or a C 1 -C 2 alkyl radical; -CH 2 -glucose group;
ㆍ R2 는 수소 원자, 히드록실 라디칼 또는 글루코오스 라디칼을 나타내고;R 2 represents a hydrogen atom, a hydroxyl radical or a glucose radical;
ㆍ R3 은, 동일하거나 상이할 수 있으며, 수소 원자, 히드록실 라디칼, (C1-C4)알킬옥시 라디칼을 나타내고; 상기 히드록실기의 수는 2 이하이고;R 3 , which may be the same or different, represents a hydrogen atom, a hydroxyl radical, a (C 1 -C 4 ) alkyloxy radical; The number of hydroxyl groups is 2 or less;
ㆍ n 은 1 내지 5 의 정수이고;N is an integer from 1 to 5;
ㆍ R5 는 -CO2R'6 기 (여기서, R'6 은 수소 원자 또는 C1-C2 알킬 라디칼; 알칼리 금속 양이온, 암모늄기를 나타냄) 를 나타내고;R 5 represents a —CO 2 R ′ 6 group wherein R ′ 6 represents a hydrogen atom or a C 1 -C 2 alkyl radical; an alkali metal cation, an ammonium group;
ㆍ R6 은 수소, -CO2R'6 기 (여기서, R'6 은 수소 원자, C1-C2 알킬 라디칼, 알칼리 금속 양이온, 암모늄기를 나타냄) 를 나타냄];R 6 represents hydrogen, a —CO 2 R ′ 6 group wherein R ′ 6 represents a hydrogen atom, a C 1 -C 2 alkyl radical, an alkali metal cation, an ammonium group;
** 하기 화학식 (i) 및 (ii) 로부터 선택되는 하나 이상의 알데히드 또는 이민 화합물 , 이의 광학 또는 기하학 이성질체, 이의 유기 또는 무기산 염, 이의 용매화물, 및 또한 하나 이상의 알데히드 또는 이민 관능기를 포함하는 산화 올리고당 또는 다당류: ** Oxidized oligosaccharides comprising at least one aldehyde or imine compound selected from formulas (i) and (ii) below, optical or geometric isomers thereof, organic or inorganic acid salts thereof, solvates thereof, and also at least one aldehyde or imine functional group Or polysaccharides:
[화학식 (i) 및 (ii) 에서,[Formula (i) and (ii),
ㆍ m 은 0 또는 1 의 정수이고,M is an integer of 0 or 1,
ㆍ X 는 산소 원자, NR"1 (여기서, R"1 은 수소 원자 또는 C1-C10 알킬 라디칼을 나타냄) 을 나타내고;X represents an oxygen atom, NR ″ 1 , wherein R ″ 1 represents a hydrogen atom or a C 1 -C 10 alkyl radical;
ㆍ X 가 산소 원자를 나타내는 경우, 상기 화합물은 하기의 형태일 수 있고:When X represents an oxygen atom, the compound may be of the form:
о 부가적인 1차 모노알코올 (R'3OH) (여기서, R'3 은 C1-C5 알킬 라디칼 또는 C2-C3 알킬 사슬을 함유하는 대칭형 1,2- 또는 1,3-디올을 나타냄) 의 축합에 의해 수득된 5- 또는 6-원 시클릭 또는 비시클릭 (acyclic) 아세탈의 형태,o additional primary monoalcohols (R ′ 3 OH), wherein R ′ 3 represents a symmetric 1,2- or 1,3-diol containing C 1 -C 5 alkyl radicals or C 2 -C 3 alkyl chains; Form of 5- or 6-membered cyclic or acyclic acetal obtained by condensation of
о A 또는 A1 이 알킬 라디칼을 나타내고, n 이 0 인 경우, A 또는 A1 상에 존재하는 히드록실기의 축합에 의해 수득된 헤미아세탈의 형태;о A or A 1 represents an alkyl radical, when n is 0, the form of a hemiacetal obtained by condensation of the hydroxyl groups existing on the A or A 1;
ㆍ 라디칼 R'1 및 R'2 는, 서로 독립적으로, 수소 원자 또는 비치환된 선형 C1-C6 알킬 라디칼을 나타내고;The radicals R ′ 1 and R ′ 2 independently of one another represent a hydrogen atom or an unsubstituted linear C 1 -C 6 alkyl radical;
ㆍ 1가 라디칼 A 및 2가 라디칼 A1 은 하기로부터 선택되는 기를 나타내고:Monovalent radical A and divalent radical A 1 represent a group selected from:
* 히드록시카르보닐기 (- CO - OH ):* Hydroxycarbonyl group (- CO - OH ):
* 적어도 하기로 임의로 치환된 C 6 아릴기:* C 6 optionally substituted by at least Aryl group :
- 히드록실기,-Hydroxyl group,
- C1-C4 알킬 라디칼,C 1 -C 4 alkyl radicals,
- 아릴-에틸레닐 라디칼 (상기 아릴기는 C6 이고, 하나 이상의 C1-C2 알킬 또는 C1-C2 알콕시 라디칼로 임의로 치환됨),Aryl-ethylenyl radicals (where the aryl group is C 6 and is optionally substituted with one or more C 1 -C 2 alkyl or C 1 -C 2 alkoxy radicals),
- -CO-OR'4 또는 -O-COR'4 기 (여기서, R'4 는 C1-C2 알킬 라디칼 또는 페닐기를 나타냄);-CO-OR ' 4 or -O-COR' 4 groups, wherein R ' 4 represents a C 1 -C 2 alkyl radical or a phenyl group;
- 산성 또는 염화된 형태의 -COOH 기,-COOH groups in acidic or chlorided form,
- -OR'5 기 (여기서, R'5 는 하나 이상의 히드록실기로 임의로 치환된 C1-C8 알킬 라디칼을 나타냄), -N+R"6 암모늄기 (여기서, R"6 은, 동일하거나 상이할 수 있으며, C1-C2 알킬 라디칼을 나타냄), -SiR'7 기 (여기서, R'7 은, 동일하거나 상이할 수 있으며, C1-C2 알킬 라디칼을 나타냄); 벤질 라디칼 (-CH2-C6H6),—OR ′ 5 group, wherein R ′ 5 represents a C 1 -C 8 alkyl radical optionally substituted with one or more hydroxyl groups, —N + R ″ 6 ammonium group, where R ″ 6 is the same or Which may be different and represent a C 1 -C 2 alkyl radical, a —SiR ′ 7 group wherein R ′ 7 may be the same or different and represent a C 1 -C 2 alkyl radical; Benzyl radical (-CH 2 -C 6 H 6 ),
- 일 특정 변형에 따라, C6 아릴기에 대하여 오르토 위치에 있는 2 개의 라디칼 -OR'5 는 2 개의 라디칼 R'5 에 의해 5- 또는 6-원 헤테로사이클을 형성할 수 있음,-According to one particular variant, two radicals -OR ' 5 in the ortho position relative to the C 6 aryl group can form a 5- or 6-membered heterocycle by two radicals R' 5 ,
- -N(R'8)2 기 (여기서, R'8 은, 동일하거나 상이할 수 있으며, 히드록실기, 산성 또는 염화된 형태의 카르복실기 (-COOH), 또는 산성 또는 염화된 형태의 술폰기 (-SO3H) 로 임의로 치환된 C1-C6 알킬 라디칼을 나타내고; 상기 라디칼 R'8 은 이를 함유하는 질소 원자와 함께, 임의로 O, N 및 NR'9 (여기서, R'9 는 C1-C2 알킬 라디칼을 나타냄) 로부터 선택되는 또 다른 헤테로원자를 포함하는 포화 또는 불포화 5- 또는 6-원 헤테로사이클을 형성할 수 있고; 상기 헤테로사이클은 히드록실기로 임의로 치환됨),—N (R ′ 8 ) 2 groups, wherein R ′ 8 may be the same or different and may be a hydroxyl group, an acidic or chlorinated carboxyl group (-COOH), or an acidic or chlorinated sulfone group Represents a C 1 -C 6 alkyl radical optionally substituted with (-SO 3 H), said radical R ' 8 together with the nitrogen atom containing it, optionally O, N and NR' 9 , wherein R ' 9 is C A saturated or unsaturated 5- or 6-membered heterocycle comprising another heteroatom selected from 1 -C 2 alkyl radical; wherein said heterocycle is optionally substituted with a hydroxyl group),
- -COR'10 기 (여기서, R'10 은 하나 이상의 C1-C2 알킬 라디칼로 임의로 치환된 6-원 탄화수소계 고리에 융합된 C6 아릴기를 나타냄),- -COR '10 group (where, R' 10 represents an optionally substituted 6-membered hydrocarbon ring fused to a C 6 aryl substituted with one or more C 1 -C 2 alkyl radical),
- -SR'11 기 (여기서, R'11 은 C1-C2 알킬 라디칼을 나타냄),- -SR '11 group (where, R' 11 represents a C 1 -C 2 alkyl radical),
- 바람직하게는 염소 및 브롬으로부터 선택되는 할로겐 원자,Halogen atoms, preferably selected from chlorine and bromine,
- -O-SO2-C6H6 기,-O-SO 2 -C 6 H 6 group,
- -SO3H 기,-SO 3 H group,
- O, N 및 NR'12 (여기서, R'12 는 포화 또는 불포화, 방향족 또는 비방향족 5- 또는 6-원 고리에 임의로 융합된 C1-C2 알킬기를 나타냄) 로부터 선택되는 1 또는 2 개의 헤테로원자를 포함하는 불포화 양이온성 또는 비양이온성 5- 또는 6-원 헤테로사이클 (상기 헤테로원자 중 하나는 2 개의 고리 내에 포함될 수 있고; 상기 헤테로사이클 또는 융합된 고리는 하나 이상의 C1-C2 알콕시 라디칼로 치환될 수 있음),One or two selected from O, N and NR '12 , wherein R' 12 represents a C 1 -C 2 alkyl group optionally fused to a saturated or unsaturated, aromatic or non-aromatic 5- or 6-membered ring; Unsaturated cationic or non-cationic 5- or 6-membered heterocycles comprising heteroatoms (one of the heteroatoms may be included in two rings; the heterocycle or fused ring is one or more C 1 -C 2 May be substituted with an alkoxy radical),
- 상기 아릴기는 O, N 및 NR'13 (여기서, R'13 은 C1-C4 알킬 라디칼을 나타냄) 으로부터 선택되는 1 또는 2 개의 헤테로원자를 포함하는 5- 또는 6-원 헤테로시클릭기에 임의로 융합되고, 상기 헤테로사이클은 C6 아릴기에 임의로 융합됨,- the aryl group O, N and NR '13 (wherein, R' 13 is C 1 -C 4 represents an alkyl radical), 1 or 2 cyclic 5-or 6-membered heterocycloalkyl containing heteroatoms selected from the groups Optionally fused, said heterocycle optionally fused to a C 6 aryl group,
- 상기 아릴기는 하나 이상의 C1-C2 알콕시기로 임의로 치환된 C6 아릴기에 임의로 융합됨;Said aryl group is optionally fused to a C 6 aryl group optionally substituted with one or more C 1 -C 2 alkoxy groups;
* 바람직하게는 O, N 및 NR'14 (여기서, R'14 는 수소 원자, (R'15)2NCO- 또는 (R'15)CO-NH- 기 (여기서 R'15 는, 동일하거나 상이할 수 있으며, C1-C2 알킬 라디칼을 나타냄) 로 임의로 치환된 C6 아릴 라디칼 또는 C1-C6 알킬 라디칼을 나타냄) 로부터 선택되는 1 또는 2 개의 동일하거나 상이한 헤테로원자를 포함하는, 양이온성 또는 비양이온성 , 포화 또는 불포화, 방향족 또는 비방향족 5- 또는 6-원 헤테로시클릭기;* Preferably from O, N and NR '14 (wherein, R' 14 represents a hydrogen atom, (R '15) 2 NCO- or (R' 15) CO-NH- group (wherein R '15 are the same or different and can be, represents a C 1 -C 2 alkyl radical) in an optionally substituted C 6 aryl radical or represents a C 1 -C 6 alkyl radical), comprising one or two identical or different heteroatoms selected from cationic or non cationic, saturated or unsaturated, aromatic or non-aromatic 5-or 6-membered heterocyclic group;
- 상기 헤테로시클릭기는 그 자체가 하나 이상의 C1-C2 알킬, C1-C4 알콕시 또는 페녹시기로 임의로 치환된 6-원 아릴기에 임의로 융합됨;Said heterocyclic group is optionally fused itself to a 6-membered aryl group optionally substituted with one or more C 1 -C 2 alkyl, C 1 -C 4 alkoxy or phenoxy groups;
- 상기 헤테로시클릭기는 적어도 하기로 임의로 치환됨:The heterocyclic group is optionally substituted with at least:
о 히드록실기,о hydroxyl group,
о 히드록실 라디칼로 임의로 치환된 C1-C2 알킬 라디칼;o C 1 -C 2 alkyl radicals optionally substituted with hydroxyl radicals;
о 아미노 라디칼 -N(R'16)2 (여기서, R'16 은, 동일하거나 상이할 수 있으며, 히드록실기로 임의로 치환된 C1-C4 알킬 라디칼을 나타내고, 상기 라디칼 R'16 은 이를 함유하는 질소 원자와 함께, 임의로 O, N 및 NR'17 (여기서, R'17 은 C1-C2 알킬 라디칼을 나타냄) 로부터 선택되는 또 다른 헤테로원자를 포함하는 포화 또는 불포화 5- 또는 6-원 헤테로사이클을 형성할 수 있음),o the amino radical —N (R ′ 16 ) 2 , wherein R ′ 16 represents a C 1 -C 4 alkyl radical which may be the same or different and optionally substituted with a hydroxyl group, said radical R ′ 16 together with the nitrogen atom-containing, and optionally O, N and NR '17 (wherein, R' 17 is C 1 -C 2 alkyl refers to the radical) or other heteroatoms, saturated or unsaturated 5-or 6-containing selected from Can form a heterocycle),
о 하나 이상의 COOH, R'18CONH- 기 (여기서, R'18 은 C1-C2 알킬 라디칼을 나타냄) 로 임의로 치환된 C6 아릴 라디칼 (상기 C6 아릴 라디칼은 헤테로시클릭기의 질소 원자에 임의로 연결되고; 아릴 라디칼이 상기 언급된 라디칼로 치환되지 않는 경우, 탄소 원자는 수소 원자로 치환됨);о one or more COOH, R '18 CONH- group (wherein, R' 18 is C 1 -C 2 alkyl radical represents a) an optionally substituted C 6 aryl radicals (wherein the C 6 aryl radical to the nitrogen atom of the heterocyclic group Optionally an aryl radical is substituted with a hydrogen atom as described above, where the carbon atom is substituted with a hydrogen atom;
* 선형 또는 분지형 C 1 - C 10 알킬 라디칼, 또는 하나 이상의 공액 또는 비공액 탄소-탄소 이중 결합을 포함하는 C 2 - C 10 알케닐 라디칼 (상기 알킬 또는 알케닐 라디칼은 하나 이상의 히드록실기로 임의로 치환됨);* Linear or branched C One - C 10 Alkyl RadicalOr one or more conjugated or nonconjugated carbon-carbon double bondsC 2 - C 10 Alkenyl Radical Wherein said alkyl or alkenyl radical is optionally substituted with one or more hydroxyl groups;
ㆍ 2가 라디칼 A2 는 탄소, 산소 또는 질소 원자를 통해 2 개의 라디칼 A1 을 연결하는 선형 C1-C10 알킬렌 사슬을 나타내고;Divalent radical A 2 represents a linear C 1 -C 10 alkylene chain connecting two radicals A 1 via a carbon, oxygen or nitrogen atom;
ㆍ 적합한 경우, 화학식 (i) 및 (ii) 의 화합물은 제형의 전기적 중성을 보장하는, 화장용으로 허용가능한 음이온 또는 음이온 An 의 혼합물을 포함함].Where appropriate, the compounds of formulas (i) and (ii) comprise cosmetically acceptable anions or mixtures of anions An, which ensure the electrical neutrality of the formulation.
본 발명의 또 다른 주제는 상기와 같은 조성물이 사용되는, 인간 케라틴 섬유의 염색 방법으로 제시된다.Another subject of the invention is presented as a method of dyeing human keratin fibres, wherein such a composition is used.
본 발명의 마지막 주제는 화학식 (I) 및/또는 (II) 의 하나 이상의 화합물 또는 상기를 포함하는 식물 추출물을 함유하는 제 1 구획, 및 화학식 (i) 또는 (ii) 의 하나 이상의 화합물, 하나 이상의 알데히드 또는 이민 관능기를 포함하는 산화 올리고당 또는 다당류를 함유하는 제 2 구획을 포함하는 다중 구획 장치로 이루어진다.A final subject of the invention is a first compartment containing at least one compound of formula (I) and / or (II) or a plant extract comprising the same, and at least one compound of formula (i) or (ii), at least one It consists of a multi-compartment device comprising a second compartment containing an oxidized oligosaccharide or polysaccharide comprising an aldehyde or imine function.
본 발명에 따른 조성물은 모발을 손상시키지 않는, 다양한, 샴푸 내성 (shampoo-fast) 착색의 수득을 가능하게 한다.The composition according to the invention makes it possible to obtain various, shampoo-fast colorings that do not damage the hair.
본 발명의 다른 특징 및 이점은 하기 상세한 설명 및 실시예를 통해 더욱 명백해질 것이다.Other features and advantages of the present invention will become more apparent from the following detailed description and examples.
달리 언급되지 않는 한, 상세한 설명에 제시된 값의 범위의 한계는 그 범위 내에 포함된다는 것에 주의해야 한다.Unless stated otherwise, it should be noted that the limits of the range of values given in the detailed description are included within the range.
본 발명에 따른 방법을 통해 처리되는 인간 케라틴 섬유는 바람직하게는 모발이다.The human keratin fibers treated via the method according to the invention are preferably hair.
하기 본문에서, 용어 "적어도 하나의" 및 "하나 이상의" 는 동의어로서 간주된다.In the following text, the terms "at least one" and "one or more" are considered synonymous.
무기산 염은 더욱 특히 염산염 (히드로클로라이드), 브롬화수소산염, 황산염 및 인산염이고; 유기산 염은 더욱 특히 시트레이트, 숙시네이트, 타르트레이트, 락테이트, 토실레이트, 벤젠술포네이트 및 아세테이트이다.Inorganic acid salts are more particularly hydrochloride (hydrochloride), hydrobromide, sulfate and phosphate; Organic acid salts are more particularly citrate, succinate, tartrate, lactate, tosylate, benzenesulfonate and acetate.
용매화물은 더욱 특히 수화물이다.Solvates are more particularly hydrates.
화학식 (I) 및 (Formula (I) and ( IIII ) 의 화합물 또는 상기를 포함하는 식물 추출물) Or a plant extract comprising the above
상기 제시된 바와 같이, 상기 조성물은, 화장용으로 허용가능한 매질 중에, 상기 언급된 화학식 (I) 및/또는 화학식 (II) 의 하나 이상의 화합물, 또는 상기를 포함하는 식물 추출물을 포함한다.As indicated above, the composition comprises, in a cosmetically acceptable medium, at least one compound of the above-mentioned formulas (I) and / or (II), or a plant extract comprising the above.
본 발명에 따른 방법에 사용되는 화합물, 및 특히 화학식 (I) 및/또는 화학식 (II) 의 화합물은, 이들이 유사-아노머 위치의 (고리내 (endocyclic) 산소 원자에 대하여 알파 탄소 원자 상에) 산소 원자 상에 당 단위를 함유하지 않는 한, 비(非)글리코실로 언급된다는 것에 주의해야 한다.The compounds used in the process according to the invention, and in particular the compounds of formula (I) and / or formula (II), are characterized in that they are in quasi-anomeric positions (on alpha carbon atoms relative to endocyclic oxygen atoms) Note that it is referred to as nonglycosyl unless it contains sugar units on the oxygen atom.
바람직하게는, R1 은 수소 원자, 메틸 라디칼, 히드록시메틸 라디칼, 알데히드기; 히드록시카르보닐 라디칼, 메톡시카르보닐기 또는 에톡시카르보닐기를 나타낸다.Preferably, R 1 is a hydrogen atom, a methyl radical, a hydroxymethyl radical, an aldehyde group; Hydroxycarbonyl radical, methoxycarbonyl group or ethoxycarbonyl group.
바람직하게는, R2 는 수소 원자 또는 히드록실 라디칼을 나타낸다.Preferably, R 2 represents a hydrogen atom or a hydroxyl radical.
바람직하게는, R3 은, 동일하거나 상이할 수 있으며, 수소 원자, 히드록실기, 메톡시기, 에톡시기 또는 n-부틸옥시기를 나타낸다.Preferably, R 3 may be the same or different and represents a hydrogen atom, a hydroxyl group, a methoxy group, an ethoxy group or an n-butyloxy group.
바람직하게는, R5 는 히드록시카르보닐 라디칼, 메톡시카르보닐 라디칼 또는 에톡시카르보닐 라디칼을 나타낸다.Preferably, R 5 represents a hydroxycarbonyl radical, methoxycarbonyl radical or ethoxycarbonyl radical.
바람직하게는, R6 은 수소, 히드록시카르보닐 라디칼, 메톡시카르보닐 라디칼 또는 에톡시카르보닐 라디칼을 나타낸다.Preferably, R 6 represents hydrogen, hydroxycarbonyl radical, methoxycarbonyl radical or ethoxycarbonyl radical.
본 발명의 특히 유리한 구현예에 따라, 화학식 (I) 및/또는 화학식 (II) 의 화합물은 제니핀 (genipin) (R1 은 메톡시카르보닐기를 나타냄) 및/또는 제니포스산 (geniposic acid) 또는 이의 염 (R1 은 산성 또는 염화된 형태의 카르복실산을 나타냄) 및/또는 제니프산 (genipic acid) (R5 는 히드록시카르보닐 라디칼을 나타내고, R6 은 수소 원자를 나타냄) 및/또는 제니핀산 (genipinic acid) (R5 는 히드록시카르보닐 라디칼을 나타내고, R6 은 메톡시카르보닐 라디칼을 나타냄) 이다.According to a particularly advantageous embodiment of the invention, the compounds of formula (I) and / or formula (II) are either genipin (R 1 represents a methoxycarbonyl group) and / or geniposic acid or Salts thereof (R 1 represents an acidic or chlorinated form of carboxylic acid) and / or genipic acid (R 5 represents a hydroxycarbonyl radical and R 6 represents a hydrogen atom) and / or Genipinic acid (R 5 represents a hydroxycarbonyl radical and R 6 represents a methoxycarbonyl radical).
화학식 (I) 및/또는 화학식 (II) 의 화합물은 일반적으로 하기 식물에서 유래한 식물 추출물에서 발견된다: 베로니카 페르시카 (Veronica persica); 제니파 아메리카나 (Genipa americana ); 아포디테스 디미디아타 (Apodytes dimidiata); 란디아 칸티오이데스 (Randia canthioides); 타레나 아테누아타 (Tarenna attenuata) 및 바람직하게는 제니파 아메리카나 (Genipa americana).Formula (I) and / or a compound of formula (II) are generally found in the plant extract originates from plants: Brassica V. FER (Veronica persica ); Zeni Americana ( Genipa americana ) ; Apodytes dimidiata ); Randia cantiides canthioides ); Tarenna Athenouata attenuata ) and preferably Genipa Americana ( Genipa) americana ).
용어 "추출물" 은 천연 식물 물질에서 출발하여, 식물의 식물성 부분의 분리, 강화 또는 농축 및 임의로 건조의 작업 중 하나 이상을 통해 수득된 즙 또는 분말을 의미한다는 것에 주의해야 한다.It should be noted that the term "extract" means juice or powder, starting from natural plant material, obtained through one or more of the operations of separation, consolidation or concentration and optionally drying of the plant part of the plant.
이러한 화학식 (I) 및/또는 화학식 (II) 의 화합물은 특히 그 자체가 공지된 방식으로 식물에서 추출된다.Such compounds of formula (I) and / or formula (II) are especially extracted from plants in a manner known per se.
특히 국제 특허 출원 WO 2005/105 020 에 기재된 절차를 참조할 수 있다. Reference is made in particular to the procedure described in international patent application WO 2005/105 020.
따라서, 지상부 (aerial part) 의 경우, 이를 세척하고, 요구되는 경우, 임의로 냉동된 형태로 분쇄하거나, 또는 실온에서 잘게 절단한 후, 적합한 용매, 특히 에탄올 또는 물 중에 침연한 (macerated) 후, 여과, 농축 및 임의로 건조시킨다.Thus, in the case of the aerial part, it is washed and, if desired, optionally crushed into frozen form, or chopped at room temperature, then macerated in a suitable solvent, in particular ethanol or water, and then filtered. , Concentrated and optionally dried.
보다 특정한 과실의 경우, 이를 임의로 냉동시키고, 존재하는 불순물을 제거하기 위해 물로 세정한다. 이를 임의로, 특히 에탄올 및 염소를 포함하는 용액을 이용하여 살균시킬 수 있다.For more specific fruits, they are optionally frozen and washed with water to remove impurities present. It may optionally be sterilized, in particular with a solution comprising ethanol and chlorine.
실질적인 추출을 위하여, 상기 과실을 해동시키고, 요구되는 경우, 예를 들어 특히 적합한 수압 프레스 (hydraulic press) 를 사용하여 압축시킨다. 상기와 같이 회수된 즙을 여과하고, 질소 존재 하에서 탈기시키는데, 이러한 작업은 용해된 기체의 양을 증가시킴으로써 제니핀 또는 이의 유도체의 산화를 방지한다. For substantial extraction, the fruits are thawed and, if desired, compressed, for example using a particularly suitable hydraulic press. The juice thus recovered is filtered and degassed in the presence of nitrogen, which operation prevents the oxidation of jennypin or its derivatives by increasing the amount of dissolved gas.
그 후, 상기 즙을 밀폐밀봉된 포장용기에 보관한다.Thereafter, the juice is stored in a hermetically sealed packaging.
그 후, 적합한 경우, 회수된 즙을 농축 및 건조시킨다.Then, if appropriate, the recovered juice is concentrated and dried.
본 발명의 바람직한 일 구현예에 따라, 사용되는 추출물은 제니파 아메리카나 (Genipa americana) 로부터 수득된다. 이러한 경우, 추출물은 제니파 아메리카나 (Genipa americana) 의 덜익은 과실로부터 수득된다. 추출물 제조의 제 1 단계는, 먼저 과실을 냉동시키고, 상기 냉동된 과일에 대하여, 예를 들어 -20℃ 내지 -200℃ 의 온도에서 동결분쇄를 수행하는 단계로 이루어진다. 따라서, 미세하고 균일한 분말이 수집된다.According to a preferred embodiment of the present invention, the extract used is Genipa Americana ( Genipa obtained from americana ). In such cases, the extract may be genipa americana ( genipa) unripe fruit of americana ) is obtained. The first step in the preparation of the extract consists of first freezing the fruit and performing freeze grinding on the frozen fruit, for example, at a temperature of -20 ° C to -200 ° C. Thus, a fine and uniform powder is collected.
상기 작업 수행시, 화학식 (I) 및/또는 (II) 의 활성제(들)은, 예를 들어 물을 이용하여 추출된다. 그 후, 상기 추출물은 농축되고, 임의로 건조된다.In carrying out this operation, the active agent (s) of the formulas (I) and / or (II) are extracted, for example with water. The extract is then concentrated and optionally dried.
건조 추출물 내 화학식 (I) 및/또는 화학식 (II) 의 화합물의 함량은 0.01 중량% 내지 30 중량% 범위이다.The content of compounds of formula (I) and / or formula (II) in the dry extract ranges from 0.01% to 30% by weight.
상기 조성물 내 화학식 (I) 및/또는 화학식 (II) 의 화합물의 함량은 조성물의 중량에 비례하여, 0.001 중량% 내지 20 중량% 이다.The content of compounds of formula (I) and / or formula (II) in the composition is from 0.001% to 20% by weight, in proportion to the weight of the composition.
부가적인 염료Additional dyes
염료 조성물은 또한 상기 언급된 화학식 (I) 및/또는 화학식 (II) 의 화합물 이외에, 부가적인 염료를 포함할 수 있다.The dye composition may also comprise additional dyes in addition to the compounds of formula (I) and / or formula (II) mentioned above.
상기 부가적인 염료 중에서, 천연 또는 합성 직접 염료, 임의로 연결기 (coupler) 와 조합된 염기를 갖는 산화 염료, 및 또한 이의 조합이 언급될 수 있다.Among these additional dyes, mention may be made of natural or synthetic direct dyes, optionally oxidizing dyes with bases in combination with couplers, and also combinations thereof.
상기 직접 염료는, 예를 들어 중성, 산성 또는 양이온성 니트로벤젠 직접 염료, 중성, 산성 또는 양이온성 아조 직접 염료, 테트라아자펜타메틴 염료, 중성, 산성 또는 양이온성 퀴논 및 특히 안트라퀴논 염료, 아진 직접 염료, 트리아릴메탄 직접 염료, 인도아민 직접 염료 및 천연 직접 염료로부터 선택될 수 있다.Said direct dyes are, for example, neutral, acidic or cationic nitrobenzene direct dyes, neutral, acidic or cationic azo direct dyes, tetraazapentamethine dyes, neutral, acidic or cationic quinones and especially anthraquinone dyes, azine direct Dyes, triarylmethane direct dyes, indoamine direct dyes, and natural direct dyes.
상기 천연 직접 염료 중에서, 로손 (lawsone), 쥬글론 (juglone), 알리자린 (alizarin), 푸르푸린 (purpurin), 카르민산 (carminic acid), 케르메스산 (kermesic acid), 푸르푸로갈린 (purpurogallin), 안트라갈롤 프로토카테크알데히드 (anthragallol protocatechaldehyde), 인디고 (indigo), 이사틴 (isatin), 쿠르쿠민 (curcumin), 스피눌로신 (spinulosin), 아피제니딘 (apigenidin), 엽록소, 클로로필린 (chlorophyllin), 오르세인 (orcein), 헤마틴 (hematin), 헤마톡실린 (hematoxylin), 브라질린 (brazilin), 브라질레인 (brazileine), 홍화 색소 (예를 들어 카르타민 (carthamine)), 플라보노이드 (예를 들어, 모린 (morin), 아피제니딘 및 샌들우드 (sandalwood) 포함), 안토시안 (예컨대 아피제니니딘 (apigeninidin)), 카르테노이드, 탄닌, 수수 및 코치닐 카르민 (cochineal carmine) 또는 이의 혼합물이 언급될 수 있다. 이러한 천연 염료 및 특히 헤나계 습포제 (poultice) 또는 추출물을 함유하는 추출물 또는 달인물 (decoction) 이 또한 사용될 수 있다.Among the natural direct dyes, lawsonone, juglone, alizarin, alipurin, purpurin, carminic acid, kermesic acid, purpurogallin, Antragalol protocatechaldehyde, indigo, isatin, curcumin, spinulosin, apigenidin, chlorophyll, chlorophyllin, Orcein, hematin, hematoxylin, hematoxylin, brazilin, brazileine, safflower pigments (e.g. carthamine), flavonoids (e.g. Mention may be made of morin, apigenidine and sandalwood, anthocyanins (such as apigeninidin), carotenoids, tannins, sorghum and cochineal carmine or mixtures thereof. have. Extracts or decoctions containing such natural dyes and in particular henna poultices or extracts may also be used.
상기 산화 염기 중에서, 파라-페닐렌디아민, 비스(페닐)알킬렌디아민, 파라-아미노페놀, 비스-파라-아미노페놀, 오르토-아미노페놀 및 헤테로시클릭 염기, 및 이의 부가 염이 언급될 수 있다.Among the above oxidizing bases, mention may be made of para-phenylenediamine, bis (phenyl) alkylenediamine, para-aminophenol, bis-para-aminophenol, ortho-aminophenol and heterocyclic bases, and addition salts thereof. .
상기 연결기 중에서, 특히 메타-페닐렌디아민, 메타-아미노페놀, 메타-디페놀, 나프탈렌 연결기 및 헤테로시클릭 연결기, 및 이의 부가 염이 언급될 수 있다.Among the linking groups, mention may in particular be made of meta-phenylenediamine, meta-aminophenol, meta-diphenol, naphthalene linking and heterocyclic linking groups, and addition salts thereof.
상기 염료 조성물에 존재하는 산화 염기(들)은 각각 일반적으로 염료 조성물의 총 중량에 비례하여, 0.001 중량% 내지 10 중량% 및 바람직하게는 0.005 중량% 내지 6 중량% 의 양으로 존재한다.The oxidizing base (s) present in the dye composition are each generally present in an amount of 0.001% to 10% by weight and preferably 0.005% to 6% by weight, relative to the total weight of the dye composition.
상기 연결기(들)은 각각 일반적으로 염료 조성물의 총 중량에 비례하여, 0.001 중량% 내지 10 중량% 및 바람직하게는 0.005 중량% 내지 6 중량% 의 양으로 존재한다.Each of the linker (s) is generally present in an amount of 0.001% to 10% by weight and preferably 0.005% to 6% by weight, relative to the total weight of the dye composition.
일반적으로, 본 발명의 맥락에서 사용될 수 있는 산화 염기 및 연결기의 부가 염은 특히 산을 갖는 부가 염, 예컨대 염산염, 브롬화수소산염, 황산염, 시트레이트, 숙시네이트, 타르트레이트, 락테이트, 토실레이트, 벤젠술포네이트, 인산염 및 아세테이트로부터 선택된다.In general, addition salts of oxidizing bases and linking groups which can be used in the context of the present invention are particularly suitable addition salts with acids such as hydrochlorides, hydrobromide, sulfates, citrate, succinates, tartrates, lactates, tosylates, Benzenesulfonate, phosphate and acetate.
알데히드/이민 화합물Aldehyde / Imine Compound
상기 제시된 바와 같이, 상기 조성물은 또한 상기 언급된 화학식 (i) 및 (ii) 로부터 선택되는 하나 이상의 알데히드 또는 이민 화합물, 및 또한 하나 이상의 알데히드 또는 이민 관능기를 포함하는 산화 올리고당 또는 다당류를 포함한다.As indicated above, the composition also comprises at least one aldehyde or imine compound selected from the above-mentioned formulas (i) and (ii), and also an oxidized oligosaccharide or polysaccharide comprising at least one aldehyde or imine function.
본 발명의 제 1 변형에 따라, 화학식 (i) 및 (ii) 의 화합물은, X 가 산소 원자를 나타내는 화합물이다.According to a first variant of the invention, the compounds of the formulas (i) and (ii) are compounds in which X represents an oxygen atom.
화합물 (i) 및 (ii) 는 또한 부가적인 1차 모노알코올 (R'3OH) (여기서, R'3 은 C1-C5 알킬 라디칼 또는 C2-C3 알킬 사슬을 함유하는 대칭형 1,2- 또는 1,3-디올을 나타냄) 의 축합에 의해 수득된 5- 또는 6-원 시클릭 또는 비시클릭 아세탈의 형태일 수 있다.Compounds (i) and (ii) also contain additional primary monoalcohols (R ′ 3 OH), wherein R ′ 3 is a symmetric type 1 containing C 1 -C 5 alkyl radicals or C 2 -C 3 alkyl chains, In the form of 5- or 6-membered cyclic or bicyclic acetals obtained by condensation of 2- or 1,3-diol).
상기 화합물은 또한 A 또는 A1 이 알킬 라디칼을 나타내고, n 이 0 인 경우, A 또는 A1 상에 존재하는 히드록실기의 축합에 의해 수득된 헤미아세탈의 형태일 수 있다.The compounds may also be in the A or A 1 represents a case of an alkyl radical, n is 0, A or in the form of a hemiacetal obtained by condensation of the hydroxyl groups present on the A 1.
화학식 (i) 및 (ii) 의 전기적 중성은, 요구되는 경우, 상기 화합물의 전하(들)을 평형시킬 수 있는, 하기로부터 선택되는, 유기 또는 무기 음이온 또는 음이온의 혼합물에 의해 확인된다는 것에 주의해야 한다: 예를 들어 할로겐화물, 예컨대 염화물, 브롬화물, 불화물 또는 요오드화물; 수산화물; 황산염; 황산수소염; 알킬 술페이트 (여기서, 선형 또는 분지형 알킬 부분은 C1-C6 임), 예컨대 메틸 술페이트 또는 에틸 술페이트 이온; 탄산염 및 탄산수소염; 카르복실산의 염, 예컨대 포르메이트, 아세테이트, 시트레이트, 타르트레이트 및 옥살레이트; 알킬술포네이트 (여기서, 선형 또는 분지형 알킬 부분은 C1-C6 임), 예컨대 메틸술포네이트 이온; 아릴술포네이트 (여기서, 아릴 부분, 바람직하게는 페닐은, 하나 이상의 C1-C4 알킬 라디칼로 임의로 치환됨), 예컨대 4-톨릴술포네이트; 및 알킬술포네이트, 예컨대 메실레이트.It should be noted that the electrical neutrality of formulas (i) and (ii) is identified by organic or inorganic anions or mixtures of anions, selected from below, which, if desired, can balance the charge (s) of the compound. For example halides such as chlorides, bromide, fluorides or iodides; hydroxide; sulfate; Hydrogen sulfate; Alkyl sulfates, wherein the linear or branched alkyl moiety is C 1 -C 6 , such as methyl sulfate or ethyl sulfate ions; Carbonates and hydrogencarbonates; Salts of carboxylic acids such as formate, acetate, citrate, tartrate and oxalate; Alkylsulfonates, wherein the linear or branched alkyl moiety is C 1 -C 6 , such as methylsulfonate ions; Arylsulfonates, wherein the aryl moiety, preferably phenyl, is optionally substituted with one or more C 1 -C 4 alkyl radicals, such as 4-tolylsulfonate; And alkylsulfonates such as mesylate.
비이온성 또는 음이온성 산화 다당류는 하나 이상의 알데히드기 및 임의로 하나 이상의 음이온성기를 포함한다. 상기 음이온성기는 바람직하게는 카르복실기 또는 카르복실레이트기이다.Nonionic or anionic oxidized polysaccharides comprise one or more aldehyde groups and optionally one or more anionic groups. The anionic group is preferably a carboxyl group or a carboxylate group.
사용되는 비이온성 또는 음이온성 산화 다당류는 하기 화학식 (I) 로 표시될 수 있다:The nonionic or anionic oxidized polysaccharides used can be represented by the following formula (I):
P-(CHO)m (COOX)n (I)P- (CHO) m (COOX) n (I)
[식 중,[In the meal,
P 는 탄소수 5 이상, 바람직하게는 탄소수 6 이상 및 더욱 특히 탄소수 6 의 단당류로 이루어진 다당류 사슬을 나타내고,P represents a polysaccharide chain consisting of monosaccharides of at least 5 carbon atoms, preferably at least 6 carbon atoms and more particularly at 6 carbon atoms,
X 는 수소 원자, 알칼리 금속 또는 알칼리 토금속, 예컨대 나트륨 또는 칼륨, 암모니아, 유기 아민, 예컨대 모노에탄올아민, 디에탄올아민, 트리에탄올아민 및 3-아미노-1,2-프로판디올 및 염기성 아미노산, 예컨대 리신, 아르기닌, 사르코신 (sarcosine), 오르니틴 (ornithine) 및 시트룰린 (citrulline) 으로부터 유래된 이온으로부터 선택되고,X is a hydrogen atom, an alkali metal or an alkaline earth metal such as sodium or potassium, ammonia, an organic amine such as monoethanolamine, diethanolamine, triethanolamine and 3-amino-1,2-propanediol and basic amino acids such as lysine, Is selected from ions derived from arginine, sarcosine, ornithine and citrulline,
m + n 은 1 이상이고,m + n is at least 1,
m 은 0.001 내지 2 및 바람직하게는 0.005 내지 1.5 범위 내인, 하나 이상의 알데히드기를 갖는 다당류의 치환도 (degree of substitution) (DS(CHO)) 이고,m is the degree of substitution (DS (CHO)) of the polysaccharide having one or more aldehyde groups, preferably in the range of 0.001 to 2 and preferably 0.005 to 1.5,
n 은 0 내지 2 및 바람직하게는 0.001 내지 1.5 범위 내인, 하나 이상의 카르복실기를 갖는 다당류의 치환도 (DS(COOX)) 임].n is the degree of substitution (DS (COOX)) of the polysaccharide having one or more carboxyl groups, in the range 0 to 2 and preferably in the range 0.001 to 1.5.
용어 "본 발명에 따른 다당류의 치환도 DS(CHO) 또는 DS(COOX)" 는 모든 반복 단위에 대하여 알데히드 또는 카르복실기로서 산화된 탄소의 수와 다당류를 구성하는 기본적인 단당류 (전산화 (preoxidation) 에 의해 개방됨) 의 수 사이의 비를 의미한다.The term "degree of substitution of polysaccharides according to the invention DS (CHO) or DS (COOX)" is the number of oxidized carbons as aldehyde or carboxyl groups and the basic monosaccharides (preoxidation) which constitute polysaccharides for all repeat units. Means the ratio between the numbers.
CHO 및 COOX 기는, 예를 들어 탄소수 6 의 당류 단위의, C2, C3 또는 C6 위치의 특정한 탄소 원자의 산화 중에 수득될 수 있다. 바람직하게는, 산화는 C2 및 C3 에서, 더욱 특히는 개방될 수 있는 고리의 수의, 0.01% 내지 75% 및 바람직하게는 0.1% 내지 50% 로 일어날 수 있다.CHO and COOX groups can be obtained, for example, during the oxidation of certain carbon atoms in the C2, C3 or C6 position of sugar units of 6 carbon atoms. Preferably, the oxidation can take place at C2 and C3, more particularly at 0.01% to 75% and preferably 0.1% to 50% of the number of rings which can be opened.
다당류 사슬은, 바람직하게는 이눌린 (inulin), 셀룰로오스, 전분, 펙틴, 구아검, 잔탄검, 풀루란검 (pullulan gum), 알기네이트검, 아가-아가검, 카라기난검, 겔란검 (gellan gums), 아라비아검, 자일로오스 및 트라가간트검, 및 이의 유도체로부터 선택된다.The polysaccharide chain is preferably inulin, cellulose, starch, pectin, guar gum, xanthan gum, pullulan gum, alginate gum, agar-agag gum, carrageenan gum, gellan gums , Gum arabic, xylose and tragaganth gum, and derivatives thereof.
용어 "유도체" 는 상기 언급한 화합물의 화학적 변형에 의해 수득된 화합물을 의미한다. 이는 상기 화합물의 에스테르, 아미드 또는 에테르일 수 있다.The term "derivative" means a compound obtained by chemical modification of the abovementioned compounds. It may be an ester, amide or ether of the compound.
산화는 당업계에 공지된 방법에 따라, 예를 들어 FR 2 842 200, FR 2 854 161 또는 논문 ["Hydrophobic films from maize bran hemicelluloses" by E. Fredon et al., Carbohydrate Polymers 49, 2002, pages 1 - 12] 에 기재된 방법에 따라 일어날 수 있다. 또 다른 산화 방법은 논문 ["Water soluble oxidized starches by peroxide reaction extrusion" Industrial Crops and Products 75 (1997) 45-52 - R. E. Wing, J. L. Willet] 에 기재되어 있다. 상기 산화 방법은 수행하기 간단하고, 효율적이며, 임의의 독성 부산물 또는 제거가 곤란한 부산물을 생성하지 않는다.Oxidation can be carried out according to methods known in the art, for example FR 2 842 200, FR 2 854 161 or the paper "Hydrophobic films from maize bran hemicelluloses" by E. Fredon et al., Carbohydrate Polymers 49, 2002, pages 1 -12] may occur according to the method described. Another oxidation method is described in the article "Water soluble oxidized starches by peroxide reaction extrusion" Industrial Crops and Products 75 (1997) 45-52-R. E. Wing, J. L. Willet. The oxidation process is simple to carry out, efficient, and does not produce any toxic by-products or by-products that are difficult to remove.
과산화물은 알칼리 금속 또는 알칼리 토금속 과탄산염 또는 과붕산염, 알킬 과산화물, 과아세트산 또는 과산화수소일 수 있다. 반응 매질 내 과산화물의 양은 일반적으로 다당류의 글루코오스 단위 당 0.05 내지 1 몰 당량이다.The peroxide can be an alkali metal or alkaline earth metal percarbonate or perborate, alkyl peroxide, peracetic acid or hydrogen peroxide. The amount of peroxide in the reaction medium is generally from 0.05 to 1 molar equivalent per glucose unit of polysaccharide.
단일 프탈로시아닌 또는 프탈로시아닌의 혼합물, 예를 들어 코발트 프탈로시아닌 및 철 프탈로시아닌의 혼합물이, 촉매로서 사용될 수 있다. 촉매의 양은 목적하는 치환도에 따라 달라진다. 일반적으로, 소량, 예를 들어 다당류의 100 글루코오스 단위 당 0.003 내지 0.016 몰 당량에 해당하는 양이 사용에 적합하다.A mixture of single phthalocyanine or phthalocyanine, for example a mixture of cobalt phthalocyanine and iron phthalocyanine, can be used as catalyst. The amount of catalyst depends on the degree of substitution desired. Generally, small amounts, for example amounts corresponding to 0.003 to 0.016 molar equivalents per 100 glucose units of polysaccharide, are suitable for use.
상기 방법은 또한 분말 형태의 다당류를 소량의 물에 용해된 촉매 및 과산화물과 접촉시킴으로써 수행될 수 있다. 상기 방법은 "반-건식 (semi-dry)" 방법으로서 언급된다.The process can also be carried out by contacting the polysaccharide in powder form with a catalyst and peroxide dissolved in a small amount of water. This method is referred to as the "semi-dry" method.
더욱 바람직하게는, 상기 다당류는 이눌린, 셀룰로오스, 카르복시메틸셀룰로오스, 히드록시에틸셀룰로오스, 히드록시프로필셀룰로오스, 히드록시프로필메틸셀룰로오스, 메틸셀룰로오스, 전분, 전분 아세테이트, 히드록시에틸 전분, 히드록시프로필 전분, 구아검, 카르복시메틸 구아검, 카르복시메틸히드록시프로필 구아검, 히드록시에틸 구아검, 히드록시프로필 구아검, 자일로오스, 잔탄검 또는 카라기난검, 또는 이의 혼합물의 산화에 의해 수득된다. More preferably, the polysaccharide is inulin, cellulose, carboxymethyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxypropyl methyl cellulose, methyl cellulose, starch, starch acetate, hydroxyethyl starch, hydroxypropyl starch, Obtained by oxidation of guar gum, carboxymethyl guar gum, carboxymethylhydroxypropyl guar gum, hydroxyethyl guar gum, hydroxypropyl guar gum, xylose, xanthan gum or carrageenan gum, or mixtures thereof.
본 발명에서 가장 특히 바람직한 다당류는 화학식 (I) 에 해당하는 것으로, 식 중, P 는 이눌린 및 전분으로부터 유래된 중합체 사슬을 나타내고; m 은 0.005 내지 2.5 범위 내인, 하나 이상의 알데히드기를 갖는 다당류의 치환도 (DS(CHO)) 이고; n 은 0.001 내지 2 범위 내인, 하나 이상의 카르복실기를 갖는 다당류의 치환도 (DS(COOX)) 이다.Most particularly preferred polysaccharides in the present invention correspond to formula (I), wherein P represents a polymer chain derived from inulin and starch; m is the degree of substitution (DS (CHO)) of the polysaccharide having at least one aldehyde group, in the range from 0.005 to 2.5; n is the degree of substitution (DS (COOX)) of the polysaccharide having one or more carboxyl groups, in the range of 0.001 to 2.
본 발명의 수행을 위해 특히 적합한, 화학식 (i) 및 (ii) 의 화합물, 하나 이상의 알데히드 또는 이민 관능기를 포함하는 산화 올리고당 및 다당류의 예로서, 하기 화합물, 이의 염, 이의 이성질체 및 이의 용매화물이 언급될 수 있고, 이러한 화합물은 단독으로 또는 혼합물로서 존재한다: As examples of oxidative oligosaccharides and polysaccharides comprising compounds of formulas (i) and (ii), at least one aldehyde or imine function, which are particularly suitable for the practice of the present invention, the following compounds, salts thereof, isomers thereof and solvates thereof Mention may be made of these compounds, alone or as mixtures:
바람직하게는, 상기 조성물은 화학식 (i) 의 하나 이상의 화합물을 포함한다.Preferably, the composition comprises one or more compounds of formula (i).
유리하게는, 화학식 (i) 은 하기와 같다:Advantageously, formula (i) is as follows:
* m 은 0 또는 1 이고;m is 0 or 1;
* 라디칼 R'1 및 R'2 는, 서로 독립적으로, 수소 원자 또는 비치환된 선형 C1-C6 알킬 라디칼을 나타내고;The radicals R ′ 1 and R ′ 2 independently of one another represent a hydrogen atom or an unsubstituted linear C 1 -C 6 alkyl radical;
* X 는 산소 원자를 나타내고;* X represents an oxygen atom;
A 는 하기를 나타냄:A represents:
* 하나 이상의 히드록실기로 임의로 치환된, 선형 또는 분지형 C 5 - C 10 알킬 라디칼; * Optionally substituted with one or more hydroxyl groups, linear or branched C 5 - C 10 Alkyl Radicals ;
* 탄소-탄소 이중 결합을 포함하는 C2-C8 알케닐 라디칼;C 2 -C 8 alkenyl radicals comprising carbon-carbon double bonds;
* 히드록시카르보닐기 (-COOH); Hydroxycarbonyl group (-COOH);
* 적어도 하기로 임의로 치환된 C 6 아릴기:* C 6 optionally substituted by at least Aryl group :
о 히드록실기,о hydroxyl group,
о C1-C4 알킬 라디칼,о C 1 -C 4 alkyl radicals,
о -CO-OR'4 또는 -O-COR'4 기 (여기서, R'4 는 C1-C2 알킬 라디칼을 나타냄),o -CO-OR ' 4 or -O-COR' 4 groups, wherein R ' 4 represents a C 1 -C 2 alkyl radical,
о -OR'5 기 (여기서, R'5 는 C1-C6 알킬 라디칼을 나타냄),o -OR ' 5 groups, wherein R' 5 represents a C 1 -C 6 alkyl radical,
о 아릴-에틸레닐 라디칼 (상기 아릴기는 C6 이고, 하나 이상의 C1-C2 알킬 또는 C1-C2 알콕시 라디칼로 임의로 치환됨),aryl-ethylenyl radicals (where the aryl groups are C 6 and optionally substituted with one or more C 1 -C 2 alkyl or C 1 -C 2 alkoxy radicals),
о O, N 및 NR'12 (여기서, R'12 는 포화 또는 불포화, 방향족 또는 비방향족 5- 또는 6-원 고리에 임의로 융합된 C1-C2 알킬기를 나타냄) 로부터 선택되는 1 또는 2 개의 헤테로원자를 포함하는 불포화 양이온성 또는 비양이온성 5- 또는 6-원 헤테로사이클 (상기 헤테로원자 중 하나는 2 개의 고리 내에 포함될 수 있고; 상기 헤테로사이클 또는 융합된 고리는 하나 이상의 C1-C2 알콕시 라디칼로 치환될 수 있음),o one or two selected from O, N and NR '12 , wherein R' 12 represents a C 1 -C 2 alkyl group optionally fused to a saturated or unsaturated, aromatic or non-aromatic 5- or 6-membered ring; Unsaturated cationic or non-cationic 5- or 6-membered heterocycles comprising heteroatoms (one of the heteroatoms may be included in two rings; the heterocycle or fused ring is one or more C 1 -C 2 May be substituted with an alkoxy radical),
- 상기 아릴기는 O, N 및 NR'13 (여기서, R'13 은 C1-C4 알킬 라디칼을 나타냄) 으로부터 선택되는 1 또는 2 개의 헤테로원자를 포함하는 5- 또는 6-원 헤테로시클릭기에 임의로 융합됨; - the aryl group O, N and NR '13 (wherein, R' 13 is C 1 -C 4 represents an alkyl radical), 1 or 2 cyclic 5-or 6-membered heterocycloalkyl containing heteroatoms selected from the groups Optionally fused;
* 바람직하게는 O, N 및 NR'14 (여기서, R'14 는 수소 원자, (R'15)2NCO- 또는 (R'15)CO-NH- 기 (여기서, R'15 는 C1-C2 알킬 라디칼을 나타냄) 로 임의로 치환된 C6 아릴 라디칼 또는 C1-C6 알킬 라디칼을 나타냄) 로부터 선택되는 1 또는 2 개의 동일하거나 상이한 헤테로원자를 포함하는, 양이온성 또는 비양이온성 , 포화 또는 불 포 화, 방향족 또는 비방향족 5- 또는 6-원 헤테로시클릭기 ; * Preferably from O, N and NR '14 (wherein, R' 14 represents a hydrogen atom, (R '15) 2 NCO- or (R' 15) CO-NH- group (wherein, R '15 is C 1 - It represents a C 2 alkyl radical) in an optionally substituted C 6 aryl radical or a C 1 -C 6 alkyl refers to the radical) containing 1 or 2 identical or different heteroatoms selected from cationic or non-cationic, saturated or non saturated, aromatic or non-aromatic 5-or 6-membered heterocyclic group;
- 상기 헤테로시클릭기는 그 자체가 하나 이상의 C1-C2 알킬 또는 C1-C4 알콕시기로 임의로 치환된 6-원 아릴기에 임의로 융합됨; Said heterocyclic group is optionally fused itself to a 6-membered aryl group optionally substituted with one or more C 1 -C 2 alkyl or C 1 -C 4 alkoxy groups;
- 상기 헤테로시클릭기는 적어도 하기로 임의로 치환됨:The heterocyclic group is optionally substituted with at least:
о 히드록실기,о hydroxyl group,
о 히드록실 라디칼로 임의로 치환된 C1-C2 알킬 라디칼,o C 1 -C 2 alkyl radicals optionally substituted with hydroxyl radicals,
о 아미노 라디칼 -N(R'16)2 (여기서, R'16 은, 동일하거나 상이할 수 있으며, 히드록실기로 임의로 치환된 C1-C4 알킬 라디칼을 나타내고, 상기 라디칼 R'16 은 이를 함유하는 질소 원자와 함께, 임의로 O, N 및 NR'17 (여기서, R'17 은 C1-C2 알킬 라디칼을 나타냄) 로부터 선택되는 또 다른 헤테로원자를 포함하는 포화 또는 불포화 5- 또는 6-원 헤테로사이클을 형성할 수 있음),o the amino radical —N (R ′ 16 ) 2 , wherein R ′ 16 represents a C 1 -C 4 alkyl radical which may be the same or different and optionally substituted with a hydroxyl group, said radical R ′ 16 together with the nitrogen atom-containing, and optionally O, N and NR '17 (wherein, R' 17 is C 1 -C 2 alkyl refers to the radical) or other heteroatoms, saturated or unsaturated 5-or 6-containing selected from Can form a heterocycle),
* 적합한 경우, 화학식 (i) 의 화합물은 제형의 전기적 중성을 보장하는, 화장용으로 허용가능한 음이온 또는 음이온 An 의 혼합물을 포함하고;Where appropriate, the compound of formula (i) comprises a cosmetically acceptable anion or mixture of anions An which ensures the electrical neutrality of the formulation;
* 화학식 (i) 의 화합물(들)은, 상기 기재된 바와 같은 아세탈 또는 헤미아세탈 형태일 수 있음.The compound (s) of formula (i) may be in acetal or hemiacetal form as described above.
바람직한 화합물 (i) 의 예로서, 하기 화합물, 이의 이성질체, 이의 염 또는 이의 용매화물이 언급될 수 있고, 이러한 화합물은 단독으로 또는 혼합물로서 존재할 수 있다:As examples of preferred compounds (i), mention may be made of the following compounds, isomers thereof, salts thereof or solvates thereof, which compounds may be present alone or as a mixture:
더욱 특히, 화학식 (i) 또는 (ii) 의 화합물(들), 또는 하나 이상의 알데히드 또는 이민 관능기를 포함하는 산화 올리고당 또는 다당류의 함량은 조성물의 중량에 비례하여, 0.001 중량% 내지 30 중량% 이다.More particularly, the content of the oxidized oligosaccharides or polysaccharides comprising the compound (s) of formula (i) or (ii), or at least one aldehyde or imine function, is from 0.001% to 30% by weight, in proportion to the weight of the composition.
바람직한 산화 올리고당 또는 다당류의 예로서, 하기 화합물이 언급될 수 있다:As examples of preferred oxidized oligosaccharides or polysaccharides, the following compounds may be mentioned:
- 산화 전분 (Rn 9047-50-1), 하기 상표명으로 공지된 전분: Caldas 10; Caldas 5; Caldas 5H; Caldas 5S; Caldas C 5; Caldas C 5GP; Caldas C 5GT; Caldas No. 5; DAS 100; Dialdehyde starch; Dialdehydostarch; Formamyl; Periodate starch; Polyaldehyde starch; Starch dialdehyde; Sumstar; Sumstar 150; Sumstar 190;Oxidized starch (Rn 9047-50-1), a starch known under the following trade names: Caldas 10; Caldas 5; Caldas 5H; Caldas 5S; Caldas C 5; Caldas C 5GP; Caldas C 5GT; Caldas no. 5; DAS 100; Dialdehyde starch; Dialdehydostarch; Formamyl; Periodate starch; Polyaldehyde starch; Starch dialdehyde; Sumstar; Sumstar 150; Sumstar 190;
- 하기 명칭으로 공지된, 산화 셀룰로오스 (Rn 9032-52-4): 2,3-Dialdehyde cellulose; 2,3-Dialdehydocellulose; Aldehydocellulose; Cellulose 2,3-dialdehyde; Cellulose dialdehyde; Dialdehyde cellulose; Oxidized cellulose (Rn 9032-52-4), known by the following designation: 2,3-Dialdehyde cellulose; 2,3-Dialdehydocellulose; Aldehydocellulose; Cellulose 2,3-dialdehyde; Cellulose dialdehyde; Dialdehyde cellulose;
- 산화 이눌린 (Rn 82446-43-3);Inulin oxide (Rn 82446-43-3);
- 덱스트란 디알데히드 (Rn 37317-99-0).Dextran dialdehyde (Rn 37317-99-0).
아민Amine
본 발명의 일 구현예에 따라, 상기 조성물은 하나 이상의 1차 또는 2차 아민 또는 이의 부가 염, 암모니아 또는 히드록실아민, 또는 이의 혼합물을 포함할 수 있다.According to one embodiment of the invention, the composition may comprise one or more primary or secondary amines or addition salts thereof, ammonia or hydroxylamine, or mixtures thereof.
일반적으로, 본 발명의 맥락에서 사용될 수 있는 이러한 아민 화합물의 부가 염은, 특히 산을 갖는 부가 염, 예컨대 염산염, 브롬화수소산염, 황산염, 시트레이트, 숙시네이트, 타르트레이트, 락테이트, 토실레이트, 벤젠술포네이트, 도데실벤젠술포네이트, 인산염 및 아세테이트, 및 바람직하게는 염산염, 시트레이트, 숙시네이트, 타르트레이트, 인산염 및 락테이트로부터 선택된다.In general, addition salts of such amine compounds which can be used in the context of the present invention are, in particular, addition salts with acids such as hydrochloride, hydrobromide, sulfate, citrate, succinate, tartrate, lactate, tosylate, Benzenesulfonate, dodecylbenzenesulfonate, phosphate and acetate, and preferably hydrochloride, citrate, succinate, tartrate, phosphate and lactate.
특히, 본 발명의 맥락에서 사용될 수 있는 1차 또는 2차 아민(들)은 하기 상세히 설명되는 화학식 (III) 의 아민, 아미노 중합체, 푸린 염기, 및 또한 이의 부가 염, 및 이의 조합으로부터 선택된다.In particular, the primary or secondary amine (s) that can be used in the context of the present invention are selected from amines of formula (III), amino polymers, purine bases, and also addition salts thereof, and combinations thereof, which are described in detail below.
특히, 화학식 (III) 은 하기와 같다:In particular, formula (III) is as follows:
R'7R'8NH (III)R ' 7 R' 8 NH (III)
[화학식 (III) 에서, R'7 및 R'8 은, 서로 독립적으로 하기를 나타냄: In formula (III), R ' 7 and R' 8 represent the following independently of each other:
- 수소 원자; Hydrogen atoms;
- 1 내지 5 개의 탄소-탄소 이중 결합을 함유할 수 있고/있거나 임의로 치환될 수 있고, 임의로 하나 이상의 헤테로원자 및/또는 하나 이상의 헤테로원자 또는 하나 이상의 헤테로원자를 포함하는 기를 포함하는 하나 이상의 기 (바람직하게는 산소, 질소, 황, C=O, C=S, SO 및 SO2 또는 이의 조합으로부터 선택됨) 가 삽입될 수 있는, 선형, 분지형 및/또는 시클릭, 포화 및/또는 불포화, 방향족 또는 비방향족 C1-C20 탄화수소계 라디칼; 상기 탄화수소계 라디칼 R'7 및 R'8 은, 각각에 부착된 질소 원자와 함께, 임의로 치환되고, 임의로 방향족이고, 임의로 또 다른 질소 또는 비(非)질소 헤테로원자를 포함하는 6-원 방향족 또는 헤테로방향족 핵에 융합되는 포화 또는 불포화 5- 또는 7-원 헤테로사이클을 형성할 수 있고; 상기 탄화수소계 라디칼은 어떤 니트로, 니트로소, 퍼옥소 또는 디아조 관능기도 포함하지 않음].At least one group containing 1 to 5 carbon-carbon double bonds and / or optionally substituted, optionally comprising a group comprising at least one heteroatom and / or at least one heteroatom or at least one heteroatom, Preferably selected from oxygen, nitrogen, sulfur, C═O, C═S, SO and SO 2 or a combination thereof), linear, branched and / or cyclic, saturated and / or unsaturated, aromatic Or non-aromatic C 1 -C 20 hydrocarbon-based radicals; The hydrocarbon radicals R ' 7 and R' 8 together with the nitrogen atom attached to each one are a six-membered aromatic, optionally substituted, optionally aromatic, optionally comprising another nitrogen or non-nitrogen heteroatom, or Can form a saturated or unsaturated 5- or 7-membered heterocycle fused to a heteroaromatic nucleus; The hydrocarbon-based radical does not contain any nitro, nitroso, peroxo or diazo functional groups.
화학식 (III) 의 화합물은 유리하게는, 케라틴 섬유의 염색에 이용되는 산화 염기 또는 산화 연결기가 아니다.The compound of formula (III) is advantageously not an oxidizing base or oxidative linking group used for dyeing keratin fibers.
헤테로시클릭 탄화수소계 기의 치환기로서 존재하는 기 중에서, 하기 기가 언급될 수 있다: Among the groups present as substituents for heterocyclic hydrocarbon-based groups, the following groups may be mentioned:
산성 또는 염화된 형태의 카르복실, 술폰, 포스폰, Carboxylic, sulfone, phosphone, in acidic or chlorided form,
히드록실, C1-C4 알콕시, (C1-C8)알콕시카르보닐, Hydroxyl, C 1 -C 4 alkoxy, (C 1 -C 8 ) alkoxycarbonyl,
(C1-C4)알킬술포네이트, (C1-C8)알킬포스포네이트, (C 1 -C 4 ) alkylsulfonate, (C 1 -C 8 ) alkylphosphonate,
트리(C1-C4)알킬실릴, 트리(C1-C4)알콕시실라닐, Tri (C 1 -C 4 ) alkylsilyl, tri (C 1 -C 4 ) alkoxysilanyl,
아미노, (디)(C1-C4)알킬아미노, 트리(C1-C4)알킬암모늄,Amino, (di) (C 1 -C 4) alkylamino, tri (C 1 -C 4) alkyl ammonium,
티올, (C1-C4)알킬티오,Thiols, (C 1 -C 4 ) alkylthio,
아미노술포닐, (디)(C1-C4)알킬아미노술포닐, Aminosulfonyl, (di) (C 1 -C 4) alkyl aminosulfonyl,
아미노카르보닐, (디)(C1-C4)알킬아미노카르보닐,Aminocarbonyl, (di) (C 1 -C 4) alkylamino-carbonyl,
(C1-C4)알킬카르보닐아미노, (C 1 -C 4 ) alkylcarbonylamino,
구아니딘,Guanidine,
우레이도 (N(R)2-CO-NR'-) (여기서, 라디칼 R 및 R' 는, 서로 독립적으로, 수소 원자 또는 C1-C4 알킬 또는 (C1-C4)알킬술포닐아미노 라디칼을 나타냄);Ureido (N (R) 2 -CO-NR'-) wherein the radicals R and R 'are independently of each other a hydrogen atom or a C 1 -C 4 alkyl or (C 1 -C 4 ) alkylsulfonylamino Represent radicals);
하나 이상의 C1-C2 알킬 또는 히드록실로 임의로 치환된, 페닐, 인돌릴, 피롤릴, 이미다졸릴.Phenyl, indolyl, pyrrolyl, imidazolyl, optionally substituted with one or more C 1 -C 2 alkyl or hydroxyl.
바람직하게는, 치환기로서 존재하는 기는 하기 기로부터 선택된다: 산성 또는 염화된 형태의 카르복실; 히드록실; C1-C4 알콕시; (C1-C8)알콕시 카르보닐; 티올; (C1-C4)알킬티오; 아미노; 모노- 및 디(C1-C4)알킬아미노; 아미노카르보닐; 모노- 및 디(C1-C2)알킬아미노카르보닐; (C1-C4)알킬카르보닐아미노; 하나 이상의 C1-C2 알킬 또는 히드록실로 임의로 치환된 페닐, 인돌릴, 피롤리닐, 이미다졸릴.Preferably, the groups present as substituents are selected from the following groups: carboxylic in acidic or chlorided form; Hydroxyl; C 1 -C 4 alkoxy; (C 1 -C 8 ) alkoxy carbonyl; Thiols; (C 1 -C 4 ) alkylthio; Amino; Mono- and di (C 1 -C 4 ) alkylamino; Aminocarbonyl; Mono- and di (C 1 -C 2 ) alkylaminocarbonyl; (C 1 -C 4 ) alkylcarbonylamino; Phenyl, indolyl, pyrrolinyl, imidazolyl, optionally substituted with one or more C 1 -C 2 alkyl or hydroxyl.
특히, 화학식 (III) 의 아민(들) 은, 동일하거나 상이할 수 있으며, 1 내지 5 개의 1차 및/또는 2차 아민 관능기를 포함하고; 상기 아민(들)은 어떤 N-N 결합도 포함하지 않는다. 또한, 화학식 (III) 의 아민(들)은 함께 결합된 둘 이상의 헤테로원자를 포함하지 않는다. In particular, the amine (s) of formula (III) may be the same or different and comprise 1 to 5 primary and / or secondary amine functional groups; The amine (s) do not contain any N-N bonds. In addition, the amine (s) of formula (III) do not comprise two or more heteroatoms bonded together.
바람직하게는, 상기 아민(들)은 화학식 (III) 의 화합물이고, 더욱 특히 하기 화학식 (IIIa) 내지 (IIIi), (IIIi') 의 화합물, 및 또한 이의 부가 염으로부터 선택된다.Preferably, the amine (s) is a compound of formula (III), more particularly selected from compounds of formulas (IIIa) to (IIIi), (IIIi '), and also addition salts thereof.
о 일반식 ( IIIa ) 의 아미노산 및/또는 유도체: o amino acids and / or derivatives of general formula ( IIIa ):
[화학식 (IIIa) 에서:In formula (IIIa):
- R9 는 수소 원자, 바람직하게는 하나 이상의 히드록실, 히드록시카르보닐, 티올, (C1-C4)알킬티오, 아미도, 아미노 또는 구아니딘기로 치환된 선형 또는 분지형 C1-C6 알킬 라디칼, 하나 이상의 히드록실로 임의로 치환된 페닐 라디칼, 하나 이상의 히드록실로 임의로 치환된 인돌릴 라디칼, 이미다졸릴 라디칼, C1-C2 알킬기로 임의로 치환된 피롤리닐 라디칼; 또는 비치환된 페닐 라디칼을 나타내고; R 9 is a linear or branched C 1 -C 6 substituted with a hydrogen atom, preferably at least one hydroxyl, hydroxycarbonyl, thiol, (C 1 -C 4 ) alkylthio, amido, amino or guanidine group Alkyl radicals, phenyl radicals optionally substituted with one or more hydroxyls, indolyl radicals optionally substituted with one or more hydroxyls, imidazolyl radicals, pyrrolinyl radicals optionally substituted with C 1 -C 2 alkyl groups; Or an unsubstituted phenyl radical;
- R"9 는 수소, C1-C4 알킬 라디칼 또는 비치환된 페닐 라디칼을 나타내고;R ″ 9 represents hydrogen, a C 1 -C 4 alkyl radical or an unsubstituted phenyl radical;
- R10 은 수소 또는 C1-C4 알킬 라디칼을 나타내고;R 10 represents hydrogen or a C 1 -C 4 alkyl radical;
- R"9 및 R9 는, 이들이 부착된 질소 원자와 함께, 포화 5- 또는 6-원 헤테로사이클을 형성할 수 있음]. R ″ 9 and R 9 together with the nitrogen atom to which they are attached may form a saturated 5- or 6-membered heterocycle.
가장 특히 언급될 수 있는 화학식 (IIIa) 의 화합물의 예로는 아스파라긴, 시스테인, 글루타민, 히스티딘, 리신, 메티오닌, 페닐알라닌, 프롤린, 피롤리신, 세린, 트레오닌, 트립토판 및 티로신, 및 이의 부가 염이 포함된다.Examples of compounds of formula (IIIa) that may be most particularly mentioned include asparagine, cysteine, glutamine, histidine, lysine, methionine, phenylalanine, proline, pyrrolysine, serine, threonine, tryptophan and tyrosine, and addition salts thereof. .
또 다른 변형에 따라, 화학식 (IIIa) 의 화합물은 유리하게는 2-아미노-2-메틸프로판산; α-메틸-D,L-페닐알라닌; D,L-α-(히드록시메틸)알라닌; D,L-α-메틸-메타-티로신; α-메틸-D,L-트립토판; D,L-α-메틸히스티딘 2염산염; L-2-메틸세린; (S)-2-메틸시스테인 2염산염; (S)-2-메틸-2-피롤리딘카르복실산으로부터 선택된다. According to another variant, the compound of formula (IIIa) is advantageously 2-amino-2-methylpropanoic acid; α-methyl-D, L-phenylalanine; D, L-α- (hydroxymethyl) alanine; D, L-α-methyl-meth-tyrosine; α-methyl-D, L-tryptophan; D, L-α-methylhistidine dihydrochloride; L-2-methylserine; (S) -2-methylcysteine dihydrochloride; (S) -2-methyl-2-pyrrolidinecarboxylic acid.
о 일반식 ( IIIb ) 의 아미노산으부터 유래된 에스테르 및/또는 유도체: о from amino acids of general formula ( IIIb ) Derived esters and / or derivatives:
[화학식 (IIIb) 에서:In formula (IIIb):
- R9 는 수소 원자, 바람직하게는 하나 이상의 히드록실, 히드록시카르보닐, (C1-C4)알콕시카르보닐, 티올, (C1-C4)알킬티오, 아미도, 아미노 또는 구아니딘기로 치환된 선형 또는 분지형 C1-C6 알킬 라디칼, 하나 이상의 히드록실로 임의로 치환된 페닐 라디칼, 하나 이상의 히드록실로 임의로 치환된 인돌릴 라디칼, 이미다졸릴 라디칼, C1-C2 알킬기로 임의로 치환된 피롤리닐 라디칼; 또는 비치환된 페닐 라디칼을 나타내고;R 9 is a hydrogen atom, preferably at least one hydroxyl, hydroxycarbonyl, (C 1 -C 4 ) alkoxycarbonyl, thiol, (C 1 -C 4 ) alkylthio, amido, amino or guanidine group Optionally substituted linear or branched C 1 -C 6 alkyl radicals, phenyl radicals optionally substituted with one or more hydroxyls, indolyl radicals optionally substituted with one or more hydroxyls, imidazolyl radicals, C 1 -C 2 alkyl groups Substituted pyrrolinyl radicals; Or an unsubstituted phenyl radical;
- R"9 는 수소, C1-C4 알킬 라디칼 또는 비치환된 페닐 라디칼을 나타내고;R ″ 9 represents hydrogen, a C 1 -C 4 alkyl radical or an unsubstituted phenyl radical;
- R10 은 수소 또는 C1-C4 알킬 라디칼을 나타내고;R 10 represents hydrogen or a C 1 -C 4 alkyl radical;
- R"9 및 R9 는, 이들이 부착된 질소 원자와 함께, 포화 5- 또는 6-원 헤테로사이클을 형성할 수 있고.R ″ 9 and R 9 together with the nitrogen atom to which they are attached may form a saturated 5- or 6-membered heterocycle.
- R11 은 하기를 나타냄:R 11 represents:
- 임의로 1 내지 5 개의 공액 또는 비공액 탄소-탄소 이중 결합을 포함하고, 임의로 상기 제시된 바와 같이 치환되고, 임의로 하나 이상의 헤테로원자 및/또는 바람직하게는 산소, 질소, 황, C=O, C=S, SO 및 SO2 또는 이의 조합으로부터 선택되는 하나 이상의 헤테로원자를 포함하는 하나 이상의 기가 삽입되는, 선형 또는 분지형, 포화 또는 불포화 C1-C18 탄화수소계 라디칼 (상기 알킬 라디칼은 어떤 니트로, 니트로소, 퍼옥소 또는 디아조 관능기도 포함하지 않음);Optionally comprising 1 to 5 conjugated or nonconjugated carbon-carbon double bonds, optionally substituted as set forth above, optionally one or more heteroatoms and / or preferably oxygen, nitrogen, sulfur, C═O, C═ Linear or branched, saturated or unsaturated C 1 -C 18 hydrocarbon-based radicals, wherein one or more groups containing one or more heteroatoms selected from S, SO and SO 2 or a combination thereof are inserted, wherein the alkyl radical is any nitro, nitro Bovine, peroxo or diazo functional groups are not included);
- 비치환된 벤질 라디칼]. Unsubstituted benzyl radicals.
일 특정 변형에 따라, R9 및 R11 은 임의로 포화 5-원 탄소계 고리를 형성할 수 있다. According to one particular variant, R 9 and R 11 may optionally form a saturated five-membered carbon-based ring.
바람직하게는, R11 은 선형 또는 분지형의, 임의로 치환된 C1-C10 알킬 라디칼; 벤질 라디칼; 및 보다 더욱 바람직하게는 하나 이상의 히드록실기, 바람직하게는 1 내지 2 개의 히드록실기로 임의로 치환된 선형 또는 분지형 C1-C4 알킬 라디칼; 벤질 라디칼을 나타낸다.Preferably, R 11 is a linear or branched, optionally substituted C 1 -C 10 alkyl radical; Benzyl radicals; And even more preferably a linear or branched C 1 -C 4 alkyl radical optionally substituted with one or more hydroxyl groups, preferably 1 to 2 hydroxyl groups; Benzyl radicals.
화학식 (IIIb) 의 예로서, 메톡시티로신, 2-에틸피페리딘 카르복실레이트; D,L-페닐알라닌 메틸 에스테르; L-시스틴 디메틸 에스테르 2염산염; L-류신 메틸 에스테르; 메틸 2-아미노-3-메틸부티레이트; L-페닐알라닌 에틸 에스테르 염산염; L-글루탐산 디에틸 에스테르 염산염; 에틸 (S)-2-아미노-3-메틸부타노에이트 염산염; D,L-세린 메틸 에스테르 염산염; 티로신 메틸 에스테르 염산염; L-시스테인 에틸 에스테르 염산염; L-히스티딘 메틸 에스테르 염산염; 메틸 (S)-피롤리딘-2-카르복실레이트 염산염; 메틸 2-아미노아세테이트 브롬화수소산염; 에틸글리신; H-D,L-알라닌 에틸 에스테르 염산염; D,L-티로신 에틸 에스테르 염산염; 메틸 2-(페닐아미노)아세테이트; 에틸 글루타메이트; 비스(α,β-tert-부틸) D,L-아스파르테이트 염산염; 에틸 L-α-아미노이소카프로에이트 염산염; 벤질 글리시네이트 파라-톨루엔술포네이트; D,L-알라닌 에틸 에스테르 염산염; 5-히드록시-D,L-트립토판 메틸 에스테르 염산염; D,L-트레오닌 메틸 에스테르 염산염; D,L-프롤린 tert-부틸 에스테르; D,L-페닐알라닌 메틸 에스테르 염산염이 언급될 수 있다.As examples of formula (IIIb), methoxytyrosine, 2-ethylpiperidine carboxylate; D, L-phenylalanine methyl ester; L-cystine dimethyl ester dihydrochloride; L-leucine methyl ester; Methyl 2-amino-3-methylbutyrate; L-phenylalanine ethyl ester hydrochloride; L-glutamic acid diethyl ester hydrochloride; Ethyl (S) -2-amino-3-methylbutanoate hydrochloride; D, L-serine methyl ester hydrochloride; Tyrosine methyl ester hydrochloride; L-cysteine ethyl ester hydrochloride; L-histidine methyl ester hydrochloride; Methyl (S) -pyrrolidine-2-carboxylate hydrochloride; Methyl 2-aminoacetate hydrobromide; Ethylglycine; H-D, L-alanine ethyl ester hydrochloride; D, L-tyrosine ethyl ester hydrochloride; Methyl 2- (phenylamino) acetate; Ethyl glutamate; Bis (α, β-tert-butyl) D, L-aspartate hydrochloride; Ethyl L-α-aminoisocaproate hydrochloride; Benzyl glycinate para-toluenesulfonate; D, L-alanine ethyl ester hydrochloride; 5-hydroxy-D, L-tryptophan methyl ester hydrochloride; D, L-threonine methyl ester hydrochloride; D, L-proline tert-butyl ester; D, L-phenylalanine methyl ester hydrochloride may be mentioned.
о 일반식 ( IIIc ) 의 아미노산으로부터 유래된 아미드 및 티오에스테르 및/또는 유도체: o amides and thioesters and / or derivatives derived from amino acids of general formula ( IIIc ) :
[화학식 (IIIc) 에서:In formula (IIIc):
- R9 는 수소 원자, 바람직하게는 하나 이상의 히드록실, (C1-C4)알콕시카르보닐, 히드록시카르보닐, 티올, (C1-C4)알킬티오, 아미도, 아미노 또는 구아니딘기로 치환된 선형 또는 분지형 C1-C6 알킬 라디칼, 하나 이상의 히드록실로 임의로 치환된 페닐 라디칼, 하나 이상의 히드록실로 임의로 치환된 인돌릴 라디칼, 이미다졸릴 라디칼, C1-C2 알킬기로 임의로 치환된 피롤리닐 라디칼을 나타내고;R 9 is a hydrogen atom, preferably at least one hydroxyl, (C 1 -C 4 ) alkoxycarbonyl, hydroxycarbonyl, thiol, (C 1 -C 4 ) alkylthio, amido, amino or guanidine group Optionally substituted linear or branched C 1 -C 6 alkyl radicals, phenyl radicals optionally substituted with one or more hydroxyls, indolyl radicals optionally substituted with one or more hydroxyls, imidazolyl radicals, C 1 -C 2 alkyl groups Substituted pyrrolinyl radicals;
- R"9 는 수소 또는 히드록시술포닐 라디칼로 임의로 치환된 C1-C4 알킬 라디칼을 나타내고; R ″ 9 represents a C 1 -C 4 alkyl radical optionally substituted with hydrogen or a hydroxysulfonyl radical;
- R10 은 수소 또는 C1-C4 알킬 라디칼을 나타내고;R 10 represents hydrogen or a C 1 -C 4 alkyl radical;
- R"9 및 R9 는, 이들이 부착된 질소 원자와 함께, 포화 5-원 헤테로사이클을 형성할 수 있고;R ″ 9 and R 9 together with the nitrogen atom to which they are attached may form a saturated five-membered heterocycle;
- R12 는 하기를 나타내고:R 12 represents:
* 수소 원자;Hydrogen atom;
* 바람직하게는 하나 이상의 히드록실, 티올, (C1-C4)알킬티오, 아미도 또는 아미노로 치환된 C1-C6 알킬 라디칼, 하나 이상의 히드록실로 임의로 치환된 페닐 라디칼, 하나 이상의 히드록실로 임의로 치환된 인돌릴 라디칼, 이미다졸릴 라디칼, C1-C2 알킬기로 임의로 치환된 피롤리닐 라디칼;* Preferably a C 1 -C 6 alkyl radical substituted with one or more hydroxyl, thiol, (C 1 -C 4 ) alkylthio, amido or amino, a phenyl radical optionally substituted with one or more hydroxyl, one or more hydroxides Indolyl radicals optionally substituted with hydroxyl, imidazolyl radicals, pyrrolinyl radicals optionally substituted with C 1 -C 2 alkyl groups;
- X 는 황 또는 질소 원자를 나타냄].X represents a sulfur or nitrogen atom.
일 특정 변형에 따라, R9 및 R12 는 임의로 포화 5-, 6- 또는 7-원 탄소계 고리를 형성할 수 있다.According to one particular variation, R 9 and R 12 may optionally form a saturated 5-, 6- or 7-membered carbon-based ring.
X 가 질소 원자를 나타내고, R12 가 상기와 같이 정의된 알킬 라디칼 및 가장 특히 알라닌, 아르기닌, 아스파라긴, 아스파르테이트, 시스테인, 글루타메이트, 글루타민, 글리신, 히스티딘, 리신, 메티오닌, 페닐알라닌, 프롤린, 피롤리신, 세린, 트레오닌, 트립토판, 티로신, 발린, 류신 또는 이소류신으로부터 선택되는 아미노산 잔기 및/또는 이의 해당 메틸 또는 에틸 에스테르를 나타내는 경우, 화학식 (IIIc) 의 화합물은 디펩티드 또는 올리고펩티드를 나타낸다.X represents a nitrogen atom, R 12 represents an alkyl radical as defined above and most particularly alanine, arginine, asparagine, aspartate, cysteine, glutamate, glutamine, glycine, histidine, lysine, methionine, phenylalanine, proline, pyrroli When the amino acid residue selected from shin, serine, threonine, tryptophan, tyrosine, valine, leucine or isoleucine and / or the corresponding methyl or ethyl esters thereof, the compound of formula (IIIc) represents a dipeptide or oligopeptide.
화학식 (IIIc) 의 화합물의 예로서, 3-아미노디히드로티오펜-2-온 염산염; D,L-호모시스테인 티오락톤; D,L-류실-D,L-알라닌, 아스파탐; (S)-피롤리딘-2-카르복사미드; [N-(-아세트아미도)]-2-아미노에탄술폰산; D,L-알라닐-D,L-페닐알라닌; 2-(2-아미노아세트아미도)-3-(4-히드록시페닐)프로판산; 2-(2-아미노아세틸아미노)아세트산; (R)-3-아미노아제판-2-온; 글리신아미드 염산염; L-류신 아미드 염산염; 2-아미노프로판디아미드; 2-(2-아미노-3-메틸부탄아미도)프로판산; L-티로실-L-알라닌; L-발릴-L-페닐알라닌; 사르코실-L-페닐알라닌; L-티로실-β-알라닌; 글리실-L-프롤린; 글리실-D,L-발린; 2-아미노말론아미드; L-메티온아미드 염산염; 2-아미노-3-메틸부탄아미드; D-알라닌아미드 염산염; L-티로신아미드 브롬화수소산염; 아스파르테이트 산 아미드; L-티로신 아미드 염산염; L-아르기닌 아미드 2염산염; 리신 아미드 2염산염; 트레오닌 아미드 염산염; 이소류신 아미드 염산염; 히스티딘 아미드 2염산염; D,L-알라닌 아미드 염산염; 2-아미노-3-(4-히드록시페닐)프로피온아미드; D,L-트립토판아미드 염산염; N-히드록시-L-아르기닌 아세테이트 (H-ARG-NH2 2AcOH); 아스파라긴 아미드 염산염; L-글루탐산 α,γ-디아미드 염산염; D-페닐알라닌 아미드; D-류신아미드 염산염; L-글루탐산 α-아미드; L-메티오닌아미드; L-시스틴 비스아미드 염산염; 글리신아미드 아세테이트; D-리신 아미드 2염산염; 글리신아미드; L-이소글루타민 γ-메틸 에스테르 염산염; D-아르기닌 아미드 2염산염; (S)-피롤리딘-2 카르복사미드; 프롤릴히스타민 염산염이 언급될 수 있다.Examples of compounds of formula (IIIc) include 3-aminodihydrothiophen-2-one hydrochloride; D, L-homocysteine thiolactone; D, L-leucine-D, L-alanine, aspartame; (S) -pyrrolidine-2-carboxamide; [N-(-acetamido)]-2-aminoethanesulfonic acid; D, L-alanyl-D, L-phenylalanine; 2- (2-aminoacetamido) -3- (4-hydroxyphenyl) propanoic acid; 2- (2-aminoacetylamino) acetic acid; (R) -3-aminoazepan-2-one; Glycinamide hydrochloride; L-leucine amide hydrochloride; 2-aminopropanediamide; 2- (2-amino-3-methylbutanamido) propanoic acid; L-tyrosyl-L-alanine; L-valyl-L-phenylalanine; Sarcosyl-L-phenylalanine; L-tyrosyl-β-alanine; Glycyl-L-proline; Glycyl-D, L-valine; 2-aminomalonamide; L-methionamide hydrochloride; 2-amino-3-methylbutanamide; D-alanineamide hydrochloride; L-tyrosineamide hydrobromide; Aspartate acid amide; L-tyrosine amide hydrochloride; L-arginine amide dihydrochloride; Lysine amide dihydrochloride; Threonine amide hydrochloride; Isoleucine amide hydrochloride; Histidine amide dihydrochloride; D, L-alanine amide hydrochloride; 2-amino-3- (4-hydroxyphenyl) propionamide; D, L-tryptophanamide hydrochloride; N-hydroxy-L-arginine acetate (H-ARG-NH 2 2AcOH); Asparagine amide hydrochloride; L-glutamic acid α, γ-diamide hydrochloride; D-phenylalanine amide; D-leucineamide hydrochloride; L-glutamic acid α-amide; L-methionineamide; L-cystine bisamide hydrochloride; Glycinamide acetate; D-lysine amide dihydrochloride; Glycinamide; L-isoglutamine γ-methyl ester hydrochloride; D-arginine amide dihydrochloride; (S) -pyrrolidine-2 carboxamide; Prolyl histamine hydrochloride may be mentioned.
о 일반식 ( IIId ) 의 아미노 화합물: o amino compounds of the general formula ( IIId ) :
[화학식 (IIId) 에서:In the formula (IIId):
- R13, R14, R15 및 R16 은, 서로 독립적으로 하기를 나타내고:R 13 , R 14 , R 15 and R 16 represent, independently of each other:
* 수소 원자;Hydrogen atom;
* 임의로 1 내지 5 개의 임의로 방향족 탄소-탄소 이중 결합을 함유할 수 있고, 임의로 상기 제시된 바와 같이 치환되고, 임의로 하나 이상의 헤테로원자 및/또는 바람직하게는 산소, 질소, 황, CO, C=S, SO 및 SO2 또는 이의 조합으로부터 선택되는 하나 이상의 헤테로원자를 포함하는 하나 이상의 기가 삽입되고, 임의로 하나 이상의 히드록실 또는 C1-C2 알콕시기를 함유하는, 선형, 분지형 및/또는 시클릭, 포화 및/또는 불포화 C1-C20 탄화수소계 라디칼 (상기 라디칼 R13 및 R14 또는 R14 및 R15 또는 R15 및 R16 은, 각각이 부착된 탄소 원자와 함께, 임의로 상기 제시된 바와 같이 치환되고, 임의로 방향족이고, 임의로 또 다른 질소 또는 비질소 헤테로원자를 포함하는 포화 또는 불포화 5- 또는 7-원 헤테로사이클을 형성할 수 있고; 상기 알킬 라디칼은 어떤 니트로, 니트로소, 퍼옥소 또는 디아조 관능기도 포함하지 않음); 더욱 특히 임의로 치환된 C1-C10 알킬 라디칼; 및 바람직하게는 하나 이상의 히드록실기, 바람직하게는 1 내지 2 개의 히드록실기로 임의로 치환된 선형 또는 분지형 C1-C8 알킬 라디칼, 히드록시카르보닐 라디칼, 우레이도 라디칼, (C1-C4)알콕시카르보닐 라디칼; 비치환된 페닐 라디칼; Optionally may contain 1 to 5 optionally aromatic carbon-carbon double bonds, optionally substituted as set forth above, and optionally one or more heteroatoms and / or preferably oxygen, nitrogen, sulfur, CO, C = S, One or more groups comprising at least one heteroatom selected from SO and SO 2 or a combination thereof are inserted, optionally containing one or more hydroxyl or C 1 -C 2 alkoxy groups, linear, branched and / or cyclic, saturated And / or unsaturated C 1 -C 20 hydrocarbon-based radicals (the radicals R 13 and R 14 or R 14 and R 15 or R 15 and R 16 , together with the carbon atom to which they are attached, are optionally substituted as indicated above and , Optionally aromatic, and optionally form a saturated or unsaturated 5- or 7-membered heterocycle comprising another nitrogen or non-nitrogen heteroatom; No tro, nitroso, peroxo or diazo functional groups); More particularly optionally substituted C 1 -C 10 alkyl radicals; And preferably at least one hydroxyl group, preferably from 1 to 2 hydroxyl groups, optionally a linear or branched C 1 -C 8 alkyl radical, a hydroxy carbonyl radical substituted with, ureido radical, a (C 1 - C 4 ) alkoxycarbonyl radical; Unsubstituted phenyl radicals;
- X 는 질소, 산소 또는 황 원자를 나타내고;X represents a nitrogen, oxygen or sulfur atom;
- R17 은 하기를 나타내고:R 17 represents:
* 수소 원자;Hydrogen atom;
* 임의로 1 내지 5 개의 공액 또는 비공액 탄소-탄소 이중 결합을 포함하고, 임의로 상기 제시된 바와 같이 치환되고, 임의로 하나 이상의 헤테로원자 및/또는 바람직하게는 산소, 질소, 황, CO, C=S, SO 및 SO2 또는 이의 조합으로부터 선택되는 하나 이상의 헤테로원자를 포함하는 하나 이상의 기가 삽입되는, 선형 또는 분지형, 포화 또는 불포화 C1-C18 탄화수소계 라디칼 (상기 알킬 라디칼은 어떤 니트로, 니트로소, 퍼옥소 또는 디아조 관능기도 포함하지 않고; 더욱 특히, R17 은 수소, 임의로 치환된 선형 또는 분지형 C1-C10 알킬 라디칼을 나타냄); 및 바람직하게는 수소, 하나 이상의 히드록실기, 바람직하게는 1 내지 2 개의 히드록실기로 임의로 치환된 선형 또는 분지형 C1-C4 알킬 라디칼을 나타내고;* Optionally comprising 1 to 5 conjugated or non-conjugated carbon-carbon double bonds, optionally substituted as set forth above, optionally one or more heteroatoms and / or preferably oxygen, nitrogen, sulfur, CO, C = S, Linear or branched, saturated or unsaturated C 1 -C 18 hydrocarbon-based radicals in which one or more groups comprising one or more heteroatoms selected from SO and SO 2 or a combination thereof are inserted, wherein the alkyl radical is any nitro, nitroso, No peroxo or diazo functional groups, more particularly R 17 represents hydrogen, an optionally substituted linear or branched C 1 -C 10 alkyl radical; And preferably a linear or branched C 1 -C 4 alkyl radical optionally substituted with hydrogen, one or more hydroxyl groups, preferably 1 to 2 hydroxyl groups;
- R18 은 하기를 나타내고:R 18 represents:
* 수소 원자;Hydrogen atom;
* 임의로 상기 제시된 바와 같이 치환되고, 임의로 하나 이상의 헤테로원자 및/또는 바람직하게는 산소, 질소, 황, CO, C=S, SO 및 SO2 또는 이의 조합으로부터 선택되는 하나 이상의 헤테로원자를 포함하는 하나 이상의 기가 삽입되고, 임의로 하나 이상의 히드록실 또는 C1-C2 알콕시기를 함유하는, 선형 또는 분지형 C1-C8 알킬 라디칼 (상기 알킬 라디칼은 어떤 니트로, 니트로소, 퍼옥소 또는 디아조 관능기도 포함하지 않음);* Optionally substituted as set forth above and optionally comprising one or more heteroatoms and / or one or more heteroatoms, preferably selected from oxygen, nitrogen, sulfur, CO, C = S, SO and SO 2 or combinations thereof Linear or branched C 1 -C 8 alkyl radicals, wherein at least one group is inserted and optionally contains one or more hydroxyl or C 1 -C 2 alkoxy groups, the alkyl radicals being any nitro, nitroso, peroxo or diazo functional group Not included);
- o 는 0 내지 5 의 정수임]. o is an integer from 0 to 5;
본 발명의 또 다른 변형에 따라, 라디칼 R16 및 R17 은, 임의로, 각각 R16 에 부착된 탄소 원자 및 라디칼 R17 에 부착된 X 원자와 함께, 임의로 상기 제시된 바와 같이 치환되고, 임의로 방향족이고, 임의로 또 다른 질소 또는 비질소 헤테로원자를 포함하는 포화 또는 불포화 5- 또는 6-원 헤테로사이클을 형성할 수 있다.According to another variant of the invention, the radicals R 16 and R 17 are optionally substituted as set forth above, optionally together with the carbon atom attached to R 16 and the X atom attached to the radical R 17 , respectively, and are optionally aromatic It may optionally form a saturated or unsaturated 5- or 6-membered heterocycle comprising another nitrogen or non-nitrogen heteroatom.
본 발명의 또 다른 변형에 따라, 라디칼 R18 및 R15 는, 임의로, 각각 R18 에 부착된 질소 원자 및 라디칼 R15 에 부착된 탄소 원자와 함께, 임의로 상기 제시된 바와 같이 치환되고, 임의로 방향족이고, 임의로 또 다른 질소 또는 비질소 헤테로원자를 포함하는 포화 또는 불포화 5- 또는 6-원 헤테로사이클을 형성할 수 있다.According to another variant of the invention, the radicals R 18 and R 15 are optionally substituted as indicated above, optionally together with the nitrogen atom attached to R 18 and the carbon atom attached to the radical R 15 , respectively, and are optionally aromatic It may optionally form a saturated or unsaturated 5- or 6-membered heterocycle comprising another nitrogen or non-nitrogen heteroatom.
화학식 (IIId) 의 화합물의 예로서, L-2-아미노헥사노산 아미드 염산염; L-페닐알라닌 아미드; (S)-(+)-아미노숙신산; (R)-2-(메틸아미노)숙신산; 에틸 니페코테이트; 3-피페리딘 카르복실산; 3-페닐-β-알라닌; 에틸 3-아미노부티레이트; 2-카르보에틸아민; D,L-β-아미노아디프산; β-알라닌 에틸 에스테르 염산염; 에틸 3-아미노-3-우레이도-N-부티레이트; 디메틸 (S)-아미노숙시네이트 염산염; β-L-알라닌 메틸 에스테르 염산염; 4-카르복시에톡시피페리딘; 4-아미노부티르산; D,L-β-아미노아디프산; 4-(메틸아미노)부티르산 염산염; 에틸 γ-아미노부티레이트 염산염; 헥사히드로니코틴아미드; 피페리딘-4-카르복사미드; 3-카르바모일-2,2,5,5-테트라메틸피롤리딘이 언급될 수 있다.Examples of the compound of formula (IIId) include L-2-aminohexanoic acid amide hydrochloride; L-phenylalanine amide; (S)-(+)-aminosuccinic acid; (R) -2- (methylamino) succinic acid; Ethyl nifekotate; 3-piperidine carboxylic acid; 3-phenyl-β-alanine; Ethyl 3-aminobutyrate; 2-carboethylamine; D, L-β-aminoadipic acid; β-alanine ethyl ester hydrochloride; Ethyl 3-amino-3-ureido-N-butyrate; Dimethyl (S) -aminosuccinate hydrochloride; β-L-alanine methyl ester hydrochloride; 4-carboxyethoxypiperidine; 4-aminobutyric acid; D, L-β-aminoadipic acid; 4- (methylamino) butyric acid hydrochloride; Ethyl γ-aminobutyrate hydrochloride; Hexahydronicotinamide; Piperidine-4-carboxamide; 3-carbamoyl-2,2,5,5-tetramethylpyrrolidine may be mentioned.
о 일반식 ( IIIe ) 의 아미노 화합물: o amino compounds of the general formula ( IIIe ):
[화학식 (IIIe) 에서:In formula (IIIe):
- R13, R14, R15, R16 및 R18 은 상기와 같은 동일한 의미를 갖고;R 13 , R 14 , R 15 , R 16 and R 18 have the same meaning as above;
- R19 는 하기를 나타내고:R 19 represents:
* 수소 원자;Hydrogen atom;
* 임의로 상기 제시된 바와 같이 치환되고, 임의로 하나 이상의 헤테로원자 및/또는 바람직하게는 산소, 질소, 황, CO, C=S, SO 및 SO2 또는 이의 조합으로부터 선택되는 하나 이상의 헤테로원자를 포함하는 하나 이상의 기가 삽입되고, 임의로 하나 이상의 히드록실 또는 C1-C2 알콕시기를 함유하는, 선형 또는 분지형 C1-C8 알킬 라디칼 (상기 알킬 라디칼은 어떤 니트로, 니트로소, 퍼옥소 또는 디아조 관능기도 포함하지 않음);* Optionally substituted as set forth above and optionally comprising one or more heteroatoms and / or one or more heteroatoms, preferably selected from oxygen, nitrogen, sulfur, CO, C = S, SO and SO 2 or combinations thereof Linear or branched C 1 -C 8 alkyl radicals, wherein at least one group is inserted and optionally contains one or more hydroxyl or C 1 -C 2 alkoxy groups, the alkyl radicals being any nitro, nitroso, peroxo or diazo functional group Not included);
- p 는 0 내지 7 의 정수이고;p is an integer from 0 to 7;
- u 는 1 또는 2 의 정수이고, u 가 2 인 경우, 라디칼 R18 은 수소를 나타냄].u is an integer of 1 or 2 and when u is 2 the radical R 18 represents hydrogen.
본 발명의 또 다른 변형에 따라, 라디칼 R13 및 R14 는 임의로, 상기 치환기가 부착된 R13 및 R14 의 탄소 원자와 함께, 포화 5- 또는 6-원 헤테로사이클을 형성할 수 있다.According to another variant of the invention, the radicals R 13 and R 14 may optionally form a saturated 5- or 6-membered heterocycle with the carbon atoms of R 13 and R 14 to which said substituents are attached.
화합물 (IIIe) 의 예로서, 하기 산, 존재하는 경우 이의 거울상이성질체, 및 또한 이의 염, 및 이의 수화물이 언급될 수 있다: (1-아미노에틸)포스폰산, (아미노메틸)포스폰산, (1-아미노에틸-1-시클로헥실)포스폰산, (1-아미노프로필)포스폰산, (1-아미노부틸)포스폰산, 이미노비스(메틸포스폰산), (1-아미노-2-메틸프로필)포스폰산, (1-아미노-2-페닐에틸)포스폰산, (1-아미노-1-메틸에틸)포스폰산, (1-아미노-3-메틸부틸)포스폰산, 1-아미노벤질포스폰산, 1-아미노헥실포스폰산, 디에틸(아미노에틸)포스폰산 (특히 옥살레이트 염), 테트라에틸(아미노메틸렌)비스포스폰산 (특히 이의 염), (1-아미노-2,2-디메틸프로필)포스폰산, N-메틸아미노메틸포스폰산, (1-아미노펜틸)포스폰산, (1-아미노-2-메틸부틸)포스폰산, (1-아미노옥틸)포스폰산, (1-아미노-1-메틸프로필)포스폰산, (1-아미노-1,2-디메틸프로필)포스폰산, (1-아미노-1,3-디메틸부틸)포스폰산, (1-아미노-1-메틸부틸)포스폰산, (1-아미노-1-시클로펜틸)포스폰산, (1-아미노히드록시카르보닐)프로필포스폰산, (1-아미노-1-메틸에틸)포스폰산, 1-아미노-2-메틸부틸포스폰산, 1-포스포노-2-페닐에틸아민, (아미노메틸)포스폰산, 3-아미노프로필포스폰산, 2-아미노-2-메틸-4-포스포노부타노산 및 이의 에틸 에스테르, (디에틸(3-아미노프로필)포스폰산 (특히 옥살레이트 염), 3-(N-히드록시아미노)프로필 포스폰산, 2-아미노-2-메틸-4-포스포노부티르산, 디에틸 (3-아미노프로필)포스포네이트, 2-아미노-4-포스포노부티르산, 2-아미노에틸포스폰산, 2-아미노-3-포스포노프로피온산, 디에틸 (2-아미노에틸)포스포네이트, 디에틸 (2-아미노에틸)포스폰산, (2-((2-피롤리디닐카르보닐)아미노)에틸)포스폰산, 디에틸 (2-아미노-1-메틸-2-페닐)에틸포스포네이트, 디에틸 (2-아미노-2-페닐)에틸포스포네이트, 및/또는 이의 혼합물.As examples of compound (IIIe), mention may be made of the following acids, their enantiomers, if present, and also their salts, and their hydrates: (1-aminoethyl) phosphonic acid, (aminomethyl) phosphonic acid, (1 -Aminoethyl-1-cyclohexyl) phosphonic acid, (1-aminopropyl) phosphonic acid, (1-aminobutyl) phosphonic acid, iminobis (methylphosphonic acid), (1-amino-2-methylpropyl) phosphonic acid , (1-amino-2-phenylethyl) phosphonic acid, (1-amino-1-methylethyl) phosphonic acid, (1-amino-3-methylbutyl) phosphonic acid, 1-aminobenzylphosphonic acid, 1-amino Hexylphosphonic acid, diethyl (aminoethyl) phosphonic acid (especially oxalate salts), tetraethyl (aminomethylene) bisphosphonic acid (especially salts thereof), (1-amino-2,2-dimethylpropyl) phosphonic acid, N -Methylaminomethylphosphonic acid, (1-aminopentyl) phosphonic acid, (1-amino-2-methylbutyl) phosphonic acid, (1-aminooctyl) phosphonic acid, (1-amino-1-methylpropyl) phosphonic acid , (1-amino-1,2-dimethylpropyl) phosphonic acid, (1-amino-1,3-dimethylbutyl) phosphonic acid, (1-amino-1-methylbutyl) phosphonic acid, (1-amino-1- Cyclopentyl) phosphonic acid, (1-aminohydroxycarbonyl) propylphosphonic acid, (1-amino-1-methylethyl) phosphonic acid, 1-amino-2-methylbutylphosphonic acid, 1-phosphono-2- Phenylethylamine, (aminomethyl) phosphonic acid, 3-aminopropylphosphonic acid, 2-amino-2-methyl-4-phosphonobutanoic acid and ethyl esters thereof, (diethyl (3-aminopropyl) phosphonic acid (especially Oxalate salt), 3- (N-hydroxyamino) propyl phosphonic acid, 2-amino-2-methyl-4-phosphonobutyric acid, diethyl (3-aminopropyl) phosphonate, 2-amino-4- Phosphonobutyric acid, 2-aminoethylphosphonic acid, 2-amino-3-phosphonopropionic acid, diethyl (2-aminoethyl) phosphonate, diethyl (2-aminoethyl) phosphonic acid, (2-((2 -Pyrrolidinylcarbonyl) amino) ethyl) force Phonic acid, diethyl (2-amino-1-methyl-2-phenyl) ethylphosphonate, diethyl (2-amino-2-phenyl) ethylphosphonate, and / or mixtures thereof.
о 일반식 ( IIIf ) 의 아미노 화합물: o amino compounds of the general formula ( IIIf ):
[화학식 (IIIf) 에서:In formula (IIIf):
- R13, R14, R15, R16 및 R18 은 상기와 같은 동일한 의미를 갖고, 또한, 상기 라디칼 R13, R14, R15 및 R16 은, 서로 독립적으로, 히드록시알킬 라디칼, (C1-C4)알콕시카르보닐 라디칼, 카르복스알데히드 라디칼, (C1-C3)알콕시를 나타내고;R 13 , R 14 , R 15 , R 16 and R 18 have the same meaning as above, and the radicals R 13 , R 14 , R 15 and R 16 are, independently of one another, a hydroxyalkyl radical, (C 1 -C 4 ) alkoxycarbonyl radicals, carboxaldehyde radicals, (C 1 -C 3 ) alkoxy;
- q 는 1 내지 18 의 정수이고;q is an integer from 1 to 18;
- X 는 산소 원자, SH 또는 OH 기, 또는 히드록실 라디칼로 임의로 치환된 메틸렌기를 나타내고;X represents an oxygen atom, an SH or OH group, or a methylene group optionally substituted with a hydroxyl radical;
- X 가 산소 원자인 경우, R18 는 하나 이상의 히드록시(메틸), 바람직하게는 1 내지 4 개의 히드록시(메틸)기로 임의로 치환된 5- 또는 6-원 고리를 형성함]. When X is an oxygen atom, R 18 forms a 5- or 6-membered ring optionally substituted with one or more hydroxy (methyl) groups, preferably 1 to 4 hydroxy (methyl) groups.
본 발명의 또 다른 변형에 따라, 라디칼 R16 및 R18 또는 R13 및 R18 은, 임의로, 각각 R16 에 (또는 R13 에) 부착된 탄소 원자 및 라디칼 R18 에 부착된 질소 원자와 함께, 임의로 상기 제시된 바와 같이 치환되고, 임의로 방향족이고, 임의로 또 다른 질소 또는 비질소 헤테로원자를 포함하는 포화 또는 불포화 5- 또는 6-원 헤테로사이클을 형성할 수 있다.According to another variant of the invention, the radicals R 16 and R 18 or R 13 and R 18 are optionally together with a carbon atom attached to R 16 (or to R 13 ) and a nitrogen atom attached to the radical R 18 , respectively. , Optionally substituted as set forth above, optionally aromatic, and optionally forming a saturated or unsaturated 5- or 6-membered heterocycle comprising another nitrogen or non-nitrogen heteroatom.
본 발명의 또 다른 변형에 따라, 화학식 (IIIf) 의 아민은 산 또는 에스테르 관능기의 상기 20 개의 에스테르화 또는 비(非)에스테르화 아미노산 중 하나의 알코올로의 환원으로부터 유래된 β-아미노 알코올일 수 있다.According to another variant of the invention, the amine of formula (IIIf) may be a β-amino alcohol derived from the reduction of an acid or ester functional group to an alcohol of one of said 20 esterified or nonesterified amino acids. have.
화합물 (IIIf) 의 예로서, 하기 화합물, 존재하는 경우 이의 거울상이성질체, 및 또한 이의 염 및 이의 수화물이 언급될 수 있다: 이소프로판올아민, 이소프로필아민, 메틸에탄올아민, 메틸글루카민, 스테아르아민, 트로메타민, 프로메타진, 1,3-디메틸펜틸아민, 옥토드린, 스페르미딘, 테아닌, 옥타밀아민, 2-아미노-1-페닐프로판-1,3-디올, 1,3-디히드록시-2-아미노-2-메틸프로판, 2-아미노-2-(히드록시메틸)프로판-1,3-디올 트리스, 2-아미노-1,3-디히드록시-2-에틸프로판, 2-아미노-3-메틸부탄-1-올, 2-아미노-2-메틸프로판-1-올, 페닐글리시놀, 2-아미노프로판올, 2-히드록시에틸아민, 2-아미노헥산-1-올, 1-아미노-1-시클로펜탄메탄올, 히스티디놀, 2-아미노-3-(3-인돌릴)프로판올, 3-(4-히드록시페닐)-2-아미노-1-프로판올, β-아미노이소부탄올, 2-아미노-1-프로판올, 2-아미노-1,3-프로판디올, 2-아미노-4-메틸-1-펜탄올, 2-아미노-3-메틸-1-부탄올, β-아미노벤젠프로판올, 2-아미노프로판-1-올, 2-아미노-1-부탄올, 2-아미노-4-메틸펜탄-1-올, 3-아미노프로판티올, 에틸 2-아미노-4-메르캅토부타노에이트, 6-히드록시헥실아민, β-D-갈락토피라노실아민, β-D-글루코피라노실아민, 1-아미노-2,5-안히드로-D-만니톨, 1-아미노-1-데옥시-D-푸룩토오스, D-글루코사민, 2-피롤리딘메탄올, 1-아미노-2,3-디히드록시프로판, 3-프로판올아민, 3-[(2-히드록시에틸)아미노]프로판-1-올, 디-β-히드로에틸아민, 비스(3-히드록시프로필)아민, N-2'-아미노에틸-N-프로판올아민, 4-아미노-N-부탄올, 메틸 3-아미노-3-데옥시-α-D-만노피라노시드, N-부틸-4-히드록시부틸아민, 4-아미노-4-(3-히드록시프로필)-1,7-헵탄디올, 1-헥실아민, 1-옥틸아민, 1-노닐아민, 1-데실아민, 라우릴아민, 1-테트라데실아민, 1-헥사데실아민, 3-아미노-2-히드록시프로피온산, 3-아미노-2-히드록시-4-페닐부타노산, 4-아미노-3-히드록시부티르산, 에틸 4-히드록시-2-피롤리딘카르복실레이트, 및 이의 혼합물.As examples of compound (IIIf), mention may be made of the following compounds, enantiomers thereof, and also salts and hydrates thereof, if present: isopropanolamine, isopropylamine, methylethanolamine, methylglucamine, stearamine, tro Metamine, promethazine, 1,3-dimethylpentylamine, octodrine, spermidine, theanine, octamilamine, 2-amino-1-phenylpropane-1,3-diol, 1,3-dihydroxy 2-amino-2-methylpropane, 2-amino-2- (hydroxymethyl) propane-1,3-diol tris, 2-amino-1,3-dihydroxy-2-ethylpropane, 2-amino -3-methylbutan-1-ol, 2-amino-2-methylpropan-1-ol, phenylglycinol, 2-aminopropanol, 2-hydroxyethylamine, 2-aminohexan-1-ol, 1 -Amino-1-cyclopentanmethanol, histidinol, 2-amino-3- (3-indolyl) propanol, 3- (4-hydroxyphenyl) -2-amino-1-propanol, β-aminoisobutanol , 2-amino-1-propanol, 2-amino-1 , 3-propanediol, 2-amino-4-methyl-1-pentanol, 2-amino-3-methyl-1-butanol, β-aminobenzenepropanol, 2-aminopropan-1-ol, 2-amino- 1-butanol, 2-amino-4-methylpentan-1-ol, 3-aminopropanethiol, ethyl 2-amino-4-mercaptobutanoate, 6-hydroxyhexylamine, β-D-galactopira Nosylamine, β-D-glucopyranosylamine, 1-amino-2,5-anhydro-D-mannitol, 1-amino-1-deoxy-D-fuructose, D-glucosamine, 2-pyrroli Dinmethanol, 1-amino-2,3-dihydroxypropane, 3-propanolamine, 3-[(2-hydroxyethyl) amino] propan-1-ol, di-β-hydroethylamine, bis (3 -Hydroxypropyl) amine, N-2'-aminoethyl-N-propanolamine, 4-amino-N-butanol, methyl 3-amino-3-deoxy-α-D-mannopyranoside, N-butyl 4-hydroxybutylamine, 4-amino-4- (3-hydroxypropyl) -1,7-heptanediol, 1-hexylamine, 1-octylamine, 1-nonylamine, 1-decylamine, la Urylamine, 1-tetradecylamine, 1-hexadecylamine, 3-amino-2-hydroxypropionic acid, 3-amino-2-hydroxy-4-phenylbutanoic acid, 4-amino-3-hydroxybutyric acid, ethyl 4- Hydroxy-2-pyrrolidinecarboxylate, and mixtures thereof.
о 일반식 ( IIIg ) 의 아미노 화합물: o amino compounds of the general formula ( IIIg ):
[화학식 (IIIg) 에서:In formula (IIIg):
- R13, R14, R15, R16 및 R18 은 상기와 같은 동일한 의미를 갖고;R 13 , R 14 , R 15 , R 16 and R 18 have the same meaning as above;
- R20 은 하기를 나타내고: R 20 represents:
* 선형 C1-C4 알킬 라디칼,Linear C 1 -C 4 alkyl radicals,
* 선형 C1-C4 알콕시 라디칼,Linear C 1 -C 4 alkoxy radicals,
- o 는 0 내지 5 의 정수이고,o is an integer from 0 to 5,
- v 는 1 또는 2 의 정수이고, v 가 2 인 경우, R18 은 수소를 나타냄].v is an integer of 1 or 2, and when v is 2, R 18 represents hydrogen.
화합물 (IIIg) 의 예로서, 아미노프로필트리에톡시실란, (아미노메틸)트리메틸실란, 2-(트리메틸실릴)에탄아민, 3-(트리메틸실릴)프로판-1-아민, 4-(트리에톡시실릴)부탄-1-아민, N-[3-(트리메톡시실릴)프로필]에틸렌디아민, 3-(트리메톡시실릴)프로필아민, 3-트리에톡시실릴-1-프로판아민 및 (3-메틸아미노프로필)트리메톡시실란, 및 이의 혼합물이 언급될 수 있다.Examples of compound (IIIg) include aminopropyltriethoxysilane, (aminomethyl) trimethylsilane, 2- (trimethylsilyl) ethanamine, 3- (trimethylsilyl) propan-1-amine, 4- (triethoxysilyl ) Butane-1-amine, N- [3- (trimethoxysilyl) propyl] ethylenediamine, 3- (trimethoxysilyl) propylamine, 3-triethoxysilyl-1-propanamine and (3-methyl Aminopropyl) trimethoxysilane, and mixtures thereof, may be mentioned.
о 일반식 ( IIIh ) 의 아미노 화합물: o amino compounds of the general formula ( IIIh ):
[화학식 (IIIh) 에서:In formula (IIIh):
- R13, R14, R15, R16 및 R18 은 상기와 같은 동일한 의미를 갖고, 또한, 상기 라디칼 R13, R14, R15 및 R16 은, 서로 독립적으로, 또한 히드록실 라디칼, (C1-C4)알콕시카르보닐 라디칼, 카르복스알데히드 라디칼, (C1-C3)알콕시를 나타낼 수 있고; R 13 , R 14 , R 15 , R 16 and R 18 have the same meaning as above, and in addition, the radicals R 13 , R 14 , R 15 and R 16 are, independently of one another, also hydroxyl radicals, (C 1 -C 4 ) alkoxycarbonyl radicals, carboxaldehyde radicals, (C 1 -C 3 ) alkoxy;
- R21 및 R22 는, 서로 독립적으로 하기를 나타내고:R 21 and R 22 independently of one another represent:
* 수소 원자;Hydrogen atom;
* 1 내지 5 개의 탄소-탄소 이중 결합을 함유할 수 있고, 임의로 상기 제시된 바와 같이 치환되고, 임의로 하나 이상의 헤테로원자 및/또는 바람직하게는 산소, 질소, 황, CO, C=S, SO 및 SO2 또는 이의 조합으로부터 선택되는 하나 이상의 헤테로원자를 포함하는 하나 이상의 기가 삽입되고, 임의로 하나 이상의 히드록실 또는 C1-C2 알콕시기를 함유하는, 선형, 분지형 및/또는 시클릭, 포화 및/또는 불포화 C1-C20 탄화수소계 라디칼, 더욱 특히 임의로 치환된 C1-C10 알킬 라디칼; 및 바람직하게는 하나 이상의 히드록실기, 바람직하게는 1 내지 2 개의 히드록실기로 임의로 치환된 선형 또는 분지형 C1-C4 알킬 라디칼; * May contain 1 to 5 carbon-carbon double bonds, optionally substituted as set forth above, and optionally one or more heteroatoms and / or preferably oxygen, nitrogen, sulfur, CO, C = S, SO and SO One or more groups comprising one or more heteroatoms selected from two or a combination thereof are inserted, optionally containing one or more hydroxyl or C 1 -C 2 alkoxy groups, linear, branched and / or cyclic, saturated and / or Unsaturated C 1 -C 20 hydrocarbon-based radicals, more particularly optionally substituted C 1 -C 10 alkyl radicals; And linear or branched C 1 -C 4 alkyl radicals optionally substituted with one or more hydroxyl groups, preferably 1 to 2 hydroxyl groups;
- R21 및 R22 는, 이들에 부착된 질소 원자와 함께, 임의로 상기 제시된 바와 같이 치환되고, 임의로 방향족이고, 임의로 또 다른 질소 또는 비질소 헤테로원자를 포함하는 포화 또는 불포화 5- 내지 7-원 헤테로사이클을 형성할 수 있고; 상기 알킬 라디칼은 어떤 니트로, 니트로소, 퍼옥소 또는 디아조 관능기도 포함하지 않고,R 21 and R 22 together with the nitrogen atom attached to them are saturated or unsaturated 5- to 7-membered, optionally substituted as set out above, optionally aromatic and optionally comprising another nitrogen or non-nitrogen heteroatom; Can form a heterocycle; The alkyl radical does not contain any nitro, nitroso, peroxo or diazo functional groups,
- w 는 1 내지 10 의 정수임].w is an integer from 1 to 10.
본 발명의 또 다른 변형에 따라, 알킬 라디칼 R16 및 R21 는, 임의로, 각각 R16 에 부착된 탄소 원자 및 라디칼 R21 에 부착된 질소 원자와 함께, 임의로 상기 제시된 바와 같이 치환되고, 임의로 방향족이고, 임의로 또 다른 질소 또는 비질소 헤테로원자를 포함하는 포화 또는 불포화 5- 또는 6-원 헤테로사이클을 형성할 수 있다.According to another variant of the invention, the alkyl radicals R 16 and R 21 are optionally substituted as indicated above, optionally together with the carbon atom attached to R 16 and the nitrogen atom attached to the radical R 21 , respectively, and optionally aromatic And optionally form a saturated or unsaturated 5- or 6-membered heterocycle comprising another nitrogen or non-nitrogen heteroatom.
본 발명의 또 다른 변형에 따라, 알킬 라디칼 R18 및 R21 은, 임의로, 각각 R18 에 부착된 첫 번째 질소 원자 및 라디칼 R21 에 부착된 마지막 질소 원자와 함께, 임의로 상기 제시된 바와 같이 치환되고, 임의로 방향족이고, 임의로 또 다른 질소 또는 비질소 헤테로원자를 포함하는 포화 또는 불포화 5- 내지 14-원 헤테로사이클을 형성할 수 있다.According to another variant of the invention, the alkyl radicals R 18 and R 21 are optionally substituted, as indicated above, together with the first nitrogen atom attached to R 18 and the last nitrogen atom attached to the radical R 21 , respectively; And, optionally, a saturated or unsaturated 5- to 14-membered heterocycle which is aromatic and optionally comprises another nitrogen or non-nitrogen heteroatom.
화학식 (IIIh) 의 화합물 중에서, 특히 하기 아민, 존재하는 경우 이의 거울상이성질체, 및 또한 이의 염 및 이의 수화물이 언급될 수 있다: 게론틴 (gerontine), N-[3-아미노프로필]-1,4-부탄디아민, 1,4-부탄디아민, 4-(에틸아미노)-N-부틸아민, 2-[3-(2-히드록시-1,1-비스-히드록시메틸에틸아미노)프로필아미노]-2-히드록시메틸프로판-1,3-디올, 1,4,8,11-테트라아자시클로테트라데칸, 1,4-디아자시클로헵탄, 1,3-디아미노-2-히드록시프로판, N,N'-비스(2-아미노에틸)프로판-1,3-디아민, 3-메틸아미노프로필아민, 1,3-디아미노프로판, N,N'-디메틸트리메틸렌디아민, 2,2-디메틸트리메틸렌디아민, 2,2-디메틸-1,3-디아미노프로판, N-(2-히드록시에틸)-1,3-디아미노프로판, N-(2-히드록시에틸)-1,3-디아미노프로판, 시스타민, 1,5-디아미노펜탄, 1,6-디아미노헥산, 라우라미노프로필아민, 2-메틸헵틸아민 (2-(N-메틸)헵틸아민), 에틸렌디아민, N,N-비스(2-히드록시에틸)에틸렌디아민, 3-아미노알라닌, 피페라진-2-카르복실산, β-N-메틸아미노알라닌, 메틸 피페라진-2-카르복실레이트, 에틸 3-아미노프롤리네이트, 2,4-디아미노-N-부티르산, N-[3-(트리메톡시실릴)프로필]에틸렌디아민, 또는 이의 혼합물.Among the compounds of the formula (IIIh), mention may be made in particular of the following amines, enantiomers thereof, if present, and also salts and hydrates thereof: gerontine, N- [3-aminopropyl] -1,4 -Butanediamine, 1,4-butanediamine, 4- (ethylamino) -N-butylamine, 2- [3- (2-hydroxy-1,1-bis-hydroxymethylethylamino) propylamino]- 2-hydroxymethylpropane-1,3-diol, 1,4,8,11-tetraazacyclotedecane, 1,4-diazahepheptane, 1,3-diamino-2-hydroxypropane, N , N'-bis (2-aminoethyl) propane-1,3-diamine, 3-methylaminopropylamine, 1,3-diaminopropane, N, N'-dimethyltrimethylenediamine, 2,2-dimethyltri Methylenediamine, 2,2-dimethyl-1,3-diaminopropane, N- (2-hydroxyethyl) -1,3-diaminopropane, N- (2-hydroxyethyl) -1,3-dia Minopropane, cystamine, 1,5-diaminopentane, 1,6-diaminohexane, lauraminopropylamine, 2-methyl Heptylamine (2- (N-methyl) heptylamine), ethylenediamine, N, N-bis (2-hydroxyethyl) ethylenediamine, 3-aminoalanine, piperazine-2-carboxylic acid, β-N- Methylaminoalanine, methyl piperazine-2-carboxylate, ethyl 3-aminoprolinate, 2,4-diamino-N-butyric acid, N- [3- (trimethoxysilyl) propyl] ethylenediamine, or Mixtures thereof.
о 일반식 ( IIIi ) 및/또는 ( IIIi' ) 의 아미노 화합물: о general meal ( IIIi ) And / or ( IIIi ' Amino Compounds of
[일반식 (IIIi) 및/또는 (IIIi') 에서:[In general formula (IIIi) and / or (IIIi '):
- R23 및 R24 는, 서로 독립적으로 하기를 나타내고: R 23 and R 24 independently represent the following:
* 임의로 하나 이상의 헤테로원자 및/또는 바람직하게는 산소, 질소, 황, CO, SO 및 SO2 또는 이의 조합으로부터 선택되는 하나 이상의 헤테로원자를 포함하는 하나 이상의 기가 삽입되는, 임의로 치환된 C1-C6 알킬 라디칼 (상기 알킬 라디칼은 어떤 니트로, 니트로소, 퍼옥소 또는 디아조 관능기도 포함하지 않음); Optionally substituted C 1 -C, wherein one or more groups are inserted, optionally including one or more heteroatoms and / or preferably one or more heteroatoms selected from oxygen, nitrogen, sulfur, CO, SO and SO 2 or a combination thereof 6 alkyl radicals (the alkyl radicals do not include any nitro, nitroso, peroxo or diazo functional groups);
* 알킬카르보닐 라디칼 (R-CO-) (여기서, R 은 C1-C4 알킬 라디칼을 나타냄);Alkylcarbonyl radicals (R—CO—), where R represents a C 1 -C 4 alkyl radical;
* 알킬술포닐 라디칼 (RSO2-) (여기서, R 은 C1-C4 알킬 라디칼을 나타냄);Alkylsulfonyl radicals (RSO 2- ), where R represents a C 1 -C 4 alkyl radical;
* (디)(알킬)아미노술포닐 라디칼 ((R)2N-SO2-) (여기서, 라디칼 R 은 독립적으로 수소 또는 C1-C4 알킬 라디칼을 나타냄);* (Di) (alkyl) aminosulfonyl radicals ((R) 2 N-SO 2- ), wherein the radicals R independently represent hydrogen or a C 1 -C 4 alkyl radical;
* (디)(알킬)아미노카르보닐 라디칼 ((R)2N-CO-) (여기서, 라디칼 R 은 독립적으로 수소 또는 C1-C4 알킬 라디칼을 나타냄);* (Di) (alkyl) aminocarbonyl radicals ((R) 2 N-CO-), wherein the radicals R independently represent hydrogen or a C 1 -C 4 alkyl radical;
* 바람직하게는 브롬, 염소 및 불소로부터 선택되는 할로겐 원자;Halogen atoms, preferably selected from bromine, chlorine and fluorine;
* C1-C4 알콕시기; A C 1 -C 4 alkoxy group;
* C2-C4 (폴리)히드록시알콕시기;A C 2 -C 4 (poly) hydroxyalkoxy group;
* 히드록시카르보닐기 (HO-CO-);Hydroxycarbonyl group (HO-CO-);
* 알콕시카르보닐기 (RO-CO-) (여기서, R 은 C1-C4 알킬 라디칼을 나타냄);Alkoxycarbonyl group (RO-CO-), wherein R represents a C 1 -C 4 alkyl radical;
* 알킬카르보닐아미노기 (RCO-NR'-) (여기서, 라디칼 R 은 C1-C4 알킬 라디칼을 나타내고, 라디칼 R' 는 수소 원자 또는 C1-C4 알킬 라디칼을 나타냄);An alkylcarbonylamino group (RCO-NR′-), wherein the radical R represents a C 1 -C 4 alkyl radical and the radical R ′ represents a hydrogen atom or a C 1 -C 4 alkyl radical;
* 알킬술포닐 라디칼 (RSO2-) (여기서, 라디칼 R 은 C1-C4 알킬 라디칼을 나타냄);Alkylsulfonyl radicals (RSO 2- ), wherein the radical R represents a C 1 -C 4 alkyl radical;
- Y 는 탄소 또는 질소 원자를 나타내고;Y represents a carbon or nitrogen atom;
- z, z' 및 z" 는, 서로 독립적으로, 탄소 원자, 질소 원자 또는 수소로 치환된 질소 원자를 나타내고; z, z 'and z ", independently of one another, represent nitrogen atoms substituted with carbon atoms, nitrogen atoms or hydrogen;
- x 는 0 내지 2 의 정수이고; x 가 2 미만인 경우, 비치환된 탄소 원자(들)은 수소 원자를 함유하고;x is an integer from 0 to 2; when x is less than 2, the unsubstituted carbon atom (s) contain a hydrogen atom;
- x' 는 0 또는 1 의 정수이고; x' 가 1 미만인 경우, 비치환된 탄소 원자(들)은 수소 원자를 함유함].x 'is an integer of 0 or 1; when x 'is less than 1, the unsubstituted carbon atom (s) contain a hydrogen atom.
화학식 (IIIi) 및/또는 (IIIi') 의 화합물 중에서, 특히 하기 나열된 화합물, 존재하는 경우 이의 거울상이성질체, 및 또한 이의 염 및 이의 수화물이 언급될 수 있다: α-피리딜아민, 2-아미노-3-히드록시피리딘, 2-아미노니코틴산, 2-아미노-3-메틸피리딘, 6-메톡시-3-피리딜아민, 3-아미노피리딘, 3-아미노-4-피리딜아민, 2,5-아미노피리딘, γ-피리딜아민, 2,3-디메틸피리딘-4-아민, 4-아미노살리실산, 메틸 파라-아미노벤조에이트, 벤조카인, 아미노벤조산, 4-아미노-m-아니스산, 4-아미노-3-히드록시벤조산, 메틸 3,4-디아미노벤조에이트, 메틸-4-아미노-3-메톡시벤젠카르복실산, 2-아미노아니솔-4-카르복실산, 3-아미노-4-히드록시벤조산, 에틸 3-아미노벤조에이트, 1-아미노-3-카르복시벤젠, 메틸 2-아미노벤조에이트, 에틸 안트라닐레이트, 1H-피라졸-3-일아민, 3-아미노-4-카르브에톡시-1H-피라졸, 5-아미노-1-에틸피라졸, 1H-벤즈이미다졸-2-아민, 2-이미다졸아민, 1-메틸벤즈이미다졸-2-아민, 및 이의 혼합물.Among the compounds of the formulas (IIIi) and / or (IIIi ′), mention may be made in particular of the compounds listed below, enantiomers thereof, if present, and also salts and hydrates thereof: α-pyridylamine, 2-amino- 3-hydroxypyridine, 2-aminonicotinic acid, 2-amino-3-methylpyridine, 6-methoxy-3-pyridylamine, 3-aminopyridine, 3-amino-4-pyridylamine, 2,5- Aminopyridine, γ-pyridylamine, 2,3-dimethylpyridin-4-amine, 4-aminosalicylic acid, methyl para-aminobenzoate, benzocaine, aminobenzoic acid, 4-amino-m-anisic acid, 4-amino 3-hydroxybenzoic acid, methyl 3,4-diaminobenzoate, methyl-4-amino-3-methoxybenzenecarboxylic acid, 2-aminoanisole-4-carboxylic acid, 3-amino-4- Hydroxybenzoic acid, ethyl 3-aminobenzoate, 1-amino-3-carboxybenzene, methyl 2-aminobenzoate, ethyl anthranilate, 1H-pyrazol-3-ylamine, 3-amino-4-car Bethoxy-1H-pyrazole, 5-amino-1-ethylpyrazole, 1H-benzimidazole-2-amine, 2-imidazolamine, 1-methylbenzimidazol-2-amine, and mixtures thereof .
염 형태이거나 또는 아닐 수 있는, 하기 아민이 또한 사용될 수 있다: 라우로일에틸렌디아민, 옥토파민, 올레아민, 팔미타민, 2-(2-아미노에톡시)에탄올, 2-아미노-4,5-디메틸티아졸, 헥세티딘, 메카밀아민 (mecamylamine), 트라닐시프로민 (tranylcypromine), 트리암테렌 (triamterene), 메틸[2-(3-트리메톡시실릴프로필아미노)에틸아민], 비스(트리에톡시실릴프로필)아민, N1-(3-(트리메톡시실릴)프로필)헥산-1,6-디아민, 디에틸렌트리아미노프로필트리메톡시실란, N-(3-트리에톡시실릴프로필)에틸렌디아민, N-(3-트리메톡시실릴에틸)에틸렌디아민.The following amines, which may or may not be in salt form, may also be used: lauroylethylenediamine, octopamine, oleamine, palmitamine, 2- (2-aminoethoxy) ethanol, 2-amino-4,5- Dimethylthiazole, hexetidine, mecamylamine, traylcypromine, triamterene, methyl [2- (3-trimethoxysilylpropylamino) ethylamine], bis (Triethoxysilylpropyl) amine, N1- (3- (trimethoxysilyl) propyl) hexane-1,6-diamine, diethylenetriaminopropyltrimethoxysilane, N- (3-triethoxysilylpropyl ) Ethylenediamine, N- (3-trimethoxysilylethyl) ethylenediamine.
본 발명의 또 다른 변형에 따라, 상기 아민은 아미노 중합체, 및 또한 이의 부가 염으로부터 선택된다. 용어 "아미노 중합체" 는 하나 이상의 1차 또는 2차 아민 관능기를 함유하는 다소 고분자량의 거대분자를 의미한다. 용어 "중합체" 는 공유 결합을 통해 차례로 연결된 5 개 이상의 반복 단위를 포함하는 화합물을 의미한다.According to another variant of the invention, the amine is selected from amino polymers, and also addition salts thereof. The term "amino polymer" means a rather high molecular weight macromolecule containing one or more primary or secondary amine functional groups. The term "polymer" means a compound comprising at least five repeating units linked in sequence via covalent bonds.
상기 아미노 중합체는 하기와 같이 합성될 수 있다:The amino polymer can be synthesized as follows:
- 라디칼 반응을 통해 (폴리아크릴레이트, 폴리메타크릴레이트, 폴리비닐 등),Through radical reactions (polyacrylates, polymethacrylates, polyvinyls, etc.),
- 축합 반응을 통해 (폴리에스테르, 폴리에테르, 폴리아미드, 폴리우레탄, 폴리디메틸실록산, 폴리펩티드 등),Through condensation reactions (polyesters, polyethers, polyamides, polyurethanes, polydimethylsiloxanes, polypeptides, etc.),
- 개환 반응을 통해 (폴리에스테르 등).Via ring-opening reaction (polyester, etc.).
이는 임의로 화학적으로 개질된 천연 기원, 예를 들어 다당류 (셀룰로오스, 덱스트란, 키토산, 구아) 및 이의 아미노 또는 티올 유도체일 수 있다. It may optionally be of chemically modified natural origin, for example polysaccharides (cellulose, dextran, chitosan, guar) and amino or thiol derivatives thereof.
상기 중합체는 임의의 유형의 위상기하학 (topology) 일 수 있다: 선형, 분지형, 별모양 또는 과분지형 사슬 (예를 들어 덴드리머), 블록, 랜덤 또는 교대 사슬.The polymer can be any type of topology: linear, branched, star or hyperbranched chains (eg dendrimers), blocks, random or alternating chains.
상기 화학기는 자연 발생적으로 중합체 사슬 상에, 주쇄 또는 측쇄를 따라 그래프트된 사슬 말단에, 또는 별모양 또는 과분지형 중합체의 분지 상에 존재할 수 있다.The chemical group may be naturally occurring on the polymer chain, at the chain end grafted along the main or side chain, or on the branch of the star or hyperbranched polymer.
하기가 가장 특히 바람직하다:Most particularly preferred are:
1/ 유리된 (free) OH 또는 NH2 또는 SH 또는 COOH 기를 함유하는 폴리아미노산, 예를 들어 폴리리신, 1 / polyamino acids containing free OH or NH 2 or SH or COOH groups, for example polylysine,
2/ NH2 또는 SH 관능기를 함유하는 천연 또는 개질된 다당류, 2 / natural or modified polysaccharides containing NH 2 or SH functionality,
3/ 아미노 실리콘, 3 / amino silicone,
4/ NH2 또는 SH 관능기를 함유하는 합성 중합체, 특히 아민 관능기로 치환된 폴리비닐 비닐류 및 하기 시판용 단량체로부터 제조된 중합체:4 / synthetic polymers containing NH 2 or SH functional groups, in particular polyvinyl vinyls substituted with amine functional groups and polymers prepared from the following commercially available monomers:
, ,
및 특히 폴리리신; 키토산; 폴리에톡실화 아민, 예컨대 카르복시PEG-8 아민, 카르복시PEG-12 아민 또는 카르복시PEG-24 아민; 또는 이의 조합.And especially polylysine; Chitosan; Polyethoxylated amines such as carboxyPEG-8 amines, carboxyPEG-12 amines or carboxyPEG-24 amines; Or combinations thereof.
본 발명의 또 다른 변형에 따라, 상기 아민(들)은 푸린 염기, 특히 아데닌, 아데노신, 구아닌, 구아노신 G, 티민, 티미딘 T, 우라실, 우리딘 U, 시토신, 시티딘 C, 이의 부가 염, 및 이의 조합으로부터 선택된다.According to another variant of the invention, said amine (s) are purine bases, in particular adenine, adenosine, guanine, guanosine G, thymine, thymidine T, uracil, uridine U, cytosine, cytidine C, addition salts thereof , And combinations thereof.
몇몇의 이들 변형을 조합하기 위해 본 발명의 맥락에서 벗어나도록 구성할 수는 없다.It may not be configured to depart from the context of the present invention to combine some of these variations.
바람직하게는, 상기 조성물이 하나 이상의 아민을 포함하는 경우, 이는 암모니아, 화학식 (IIIa), (IIIb), (IIIc), (IIIe) 및 (IIIg) 의 화합물, 특히 R20 이 선형 C1-C4 알콕시기를 나타내는 경우, 및 (IIIi'), 또는 이의 혼합물로부터 선택된다.Preferably, if the composition comprises at least one amine, it is ammonia, a compound of formula (IIIa), (IIIb), (IIIc), (IIIe) and (IIIg), in particular R 20 is linear C 1 -C 4 alkoxy group, and (IIIi '), or a mixture thereof.
상기 조성물이 하나 이상의 1차 또는 2차 아민, 암모니아 또는 히드록실아민을 포함하는 경우, 이의 함량은 조성물의 중량에 비례하여, 조성물 중에 0.001 중량% 내지 65 중량% 및 바람직하게는 0.001 중량% 내지 30 중량% 로 존재한다.If the composition comprises one or more primary or secondary amines, ammonia or hydroxylamine, the content thereof is proportional to the weight of the composition, from 0.001% to 65% by weight and preferably from 0.001% to 30% in the composition. Present in weight percent.
효소enzyme
본 발명에 따른 조성물은 임의로, 예를 들어 아이솔레이즈 (isolase), 예를 들어 스위트 아몬드로부터 유래된 β-글루코시다아제 (EC 3.2.1.21), 알코올 옥시다아제 (EC 1.1.3.13), 알코올 데히드로게나아제 (dehydrogenase) EC 1.1.1.1, 알코올 데히드로게나아제 EC 1.1.1.2, 알코올 데히드로게나아제 EC 1.1.1.71, 방향족 알코올 데히드로게나아제 EC 1.1.1.90 (또한 아릴 알코올 데히드로게나아제로서 공지됨), 방향족 알코올 데히드로게나아제 EC 1.1.1.97, 3-히드록시벤질 알코올 데히드로게나아제 EC 1.1.1.97, 코니페릴 알코올 데히드로게나아제 EC 1.1.1.194, 신나밀 알코올 데히드로게나아제 EC 1.1.1.195, 메탄올 데히드로게나아제 EC 1.1.1.244, 방향족 알코올 옥시다아제 EC 1.1.3.7 (또한 아릴 알코올 옥시다아제로서 공지됨), 알코올 옥시다아제 EC 1.1.3.13, 4-히드록시만델레이드 옥시다아제 EC 1.1.3.19, 긴-탄화수소-사슬 알코올 옥시다아제 EC 1.1.3.20, 메탄올 옥시다아제 EC 1.1.3.31, 알코올 데히드로게나아제 EC 1.1.99.20, 메틸글루타메이트 데히드로게나아제 EC 1.5.99.5, 2-옥소산 데카르복실라아제 EC 4.1.1.1, 벤조일포르메이트 데카르복실라아제 EC 4.1.1.7, 페닐피루베이트 데카르복실라아제 EC 4.1.1.43 및 트레오닌 알돌라아제 EC 4.1.2.5 로부터 선택되는 하나 이상의 효소를 포함할 수 있다.The composition according to the invention optionally comprises, for example, isolase, for example β-glucosidase (EC 3.2.1.21) derived from sweet almond, alcohol oxidase (EC 1.1.3.13), alcohol dehydro Dehydrogenase EC 1.1.1.1, alcohol dehydrogenase EC 1.1.1.2, alcohol dehydrogenase EC 1.1.1.71, aromatic alcohol dehydrogenase EC 1.1.1.90 (also known as aryl alcohol dehydrogenase) Aromatic alcohol dehydrogenase EC 1.1.1.97, 3-hydroxybenzyl alcohol dehydrogenase EC 1.1.1.97, coniferyl alcohol dehydrogenase EC 1.1.1.194, cinnamil alcohol dehydrogenase EC 1.1 .1.195, methanol dehydrogenase EC 1.1.1.244, aromatic alcohol oxidase EC 1.1.3.7 (also known as aryl alcohol oxidase), alcohol oxidase EC 1.1.3.13, 4-hydroxymandelaide oxidase EC 1.1 .3.19, long-hydrocarbon-chain alcohol oxidase EC 1.1.3.20, methanol oxidase EC 1.1.3.31, alcohol dehydrogenase EC 1.1.99.20, methylglutamate dehydrogenase EC 1.5.99.5, 2-oxo acid decarboxylase One or more enzymes selected from aze EC 4.1.1.1, benzoylformate decarboxylase EC 4.1.1.7, phenylpyruvate decarboxylase EC 4.1.1.43 and threonine aldolase EC 4.1.2.5.
존재하는 경우, 염료 조성물에 사용되는 효소의 농도는 상기 조성물의 총 중량에 비례하여 0.005 중량% 내지 40 중량% 이고, 바람직하게는 상기 조성물의 중량에 비례하여 0.05 중량% 내지 10 중량% 이다.If present, the concentration of enzyme used in the dye composition is from 0.005% to 40% by weight, relative to the total weight of the composition, preferably from 0.05% to 10% by weight, relative to the weight of the composition.
염salt
화학식 (I) 및/또는 (II) 의 화합물(들)을 포함하는 조성물은 임의로 하나 이상의 염을 포함할 수 있다.Compositions comprising the compound (s) of formula (I) and / or (II) may optionally comprise one or more salts.
존재하는 경우, 상기 염은 일반적으로 유기 용매 및/또는 무기 염, 및 또한 이의 조합으로부터 선택된다.When present, the salts are generally selected from organic solvents and / or inorganic salts, and also combinations thereof.
특히, 상기 염을 구성하는 음이온은 무기 (염화물, 탄산염, 탄산수소염, 황산염, 황산수소염, 수산화물, 규산염, 인산염, 인산수소염 등) 또는 유기 (아스파르테이트, 포르메이트, 아세테이트, 락테이트, 시트레이트, 글루코네이트, 숙시네이트, 말레이트, 푸마레이트, 오로테이트 등) 일 수 있다.In particular, the anion constituting the salt may be inorganic (chloride, carbonate, hydrogen carbonate, sulfate, hydrogen sulfate, hydroxide, silicate, phosphate, hydrogen phosphate, etc.) or organic (aspartate, formate, acetate, lactate, sheet Laterates, gluconates, succinates, maleates, fumarates, orotates, and the like.
상기 음이온과 함께, 상기 염을 구성하는 양이온은, 알칼리 금속 (바람직하게는 리튬, 나트륨 또는 칼륨), 알칼리 토금속 (바람직하게는 마그네슘 또는 칼슘) 또는 전이 금속 (스칸듐, 티타늄, 바나듐, 망간, 몰리브덴, 철, 코발트, 니켈, 구리, 아연, 은 또는 금) 으로부터 유래될 수 있다. 다른 양이온, 예를 들어 암모늄 또한 염을 형성할 수 있다. 바람직하게는, 상기 양이온은 알칼리 금속 (리튬, 나트륨 또는 칼륨), 알칼리 토금속 (마그네슘 또는 칼슘), 암모늄, 및 또한 하기 전이 금속 (망간, 몰리브덴, 철, 구리, 아연, 은 및 금) 으로부터 선택될 수 있다.Together with the anion, the cation constituting the salt may be an alkali metal (preferably lithium, sodium or potassium), alkaline earth metal (preferably magnesium or calcium) or transition metal (scandium, titanium, vanadium, manganese, molybdenum, Iron, cobalt, nickel, copper, zinc, silver or gold). Other cations such as ammonium may also form salts. Preferably, the cation is selected from alkali metals (lithium, sodium or potassium), alkaline earth metals (magnesium or calcium), ammonium, and also the following transition metals (manganese, molybdenum, iron, copper, zinc, silver and gold). Can be.
존재하는 경우, 상기의 함량은 조성물의 중량에 비례하여 0.001 중량% 내지 40 중량%, 및 보다 더욱 바람직하게는 조성물의 중량에 비례하여 0.001 중량% 내지 20 중량% 이다.When present, the content is from 0.001% to 40% by weight, and even more preferably from 0.001% to 20% by weight, relative to the weight of the composition.
기타 성분Other ingredients
화장용으로 허용가능한 매질은 일반적으로 적어도 물 또는 물과 하나 이상의 유기 용매의 혼합물을 포함한다. 언급될 수 있는 유기 용매의 예로는 C1-C4 저급 알칸올, 예컨대 에탄올 및 이소프로판올; 폴리올, 예컨대 1,3-프로판디올 또는 1,6-헥산디올 및 폴리올 에테르, 예를 들어 2-부톡시에탄올, 프로필렌 글리콜, 프로필렌 글리콜 모노메틸 에테르, 디에틸렌 글리콜 모노에틸 에테르 및 모노메틸 에테르, 및 또한 방향족 알코올, 예를 들어 벤질 알코올 또는 페녹시에탄올, 및 이의 혼합물이 포함된다.Cosmetically acceptable media generally comprise at least water or a mixture of water and one or more organic solvents. Examples of organic solvents that may be mentioned include C 1 -C 4 lower alkanols such as ethanol and isopropanol; Polyols such as 1,3-propanediol or 1,6-hexanediol and polyol ethers such as 2-butoxyethanol, propylene glycol, propylene glycol monomethyl ether, diethylene glycol monoethyl ether and monomethyl ether, and Also included are aromatic alcohols such as benzyl alcohol or phenoxyethanol, and mixtures thereof.
존재하는 경우, 상기 용매는 바람직하게는 조성물의 중량에 비례하여 1 중량% 내지 99 중량% 및 보다 더욱 바람직하게는 조성물의 중량에 비례하여 5 중량% 내지 95 중량% 의 비율로 존재한다.If present, the solvent is preferably present at a ratio of 1% to 99% by weight, and even more preferably 5% to 95% by weight, relative to the weight of the composition.
본 발명에 따른 방법에 사용되는 조성물은 또한 모발 염료 조성물에 통상적으로 사용되는 각종 보조제, 예컨대 음이온성, 양이온성, 비이온성, 양쪽성 또는 쌍성 (zwitterionic) 계면활성제 또는 이의 혼합물, 음이온성, 양이온성, 비이온성, 양쪽성 또는 쌍성 중합체 또는 이의 혼합물, 무기 또는 유기 증점제, 및 특히 음이온성, 양이온성, 비이온성 및 양쪽성 중합체성 혼합 증점제, 항산화제, 침투제, 격리제, 착향제, 완충제, 분산제, 조절제, 예를 들어 휘발성 또는 비휘발성, 개질된 또는 비개질된 실리콘, 예컨대 아미노 실리콘, 필름형성제, 세라미드, 보존제, 불투명화제 및 전도성 중합체를 함유할 수 있다.The compositions used in the process according to the invention also contain various auxiliaries commonly used in hair dye compositions, such as anionic, cationic, nonionic, amphoteric or zwitterionic surfactants or mixtures thereof, anionic, cationic , Nonionic, amphoteric or zwitterionic polymers or mixtures thereof, inorganic or organic thickeners, and especially anionic, cationic, nonionic and amphoteric polymeric mixed thickeners, antioxidants, penetrants, sequestrants, flavoring agents, buffers, dispersants And modifiers such as volatile or nonvolatile, modified or unmodified silicones such as amino silicones, film formers, ceramides, preservatives, opacifiers and conductive polymers.
상기 보조제는 일반적으로 각각, 조성물의 중량에 비례하여, 0.01 중량% 내지 20 중량% 의 양으로 존재한다.The adjuvants are generally present in amounts of from 0.01% to 20% by weight, respectively, in proportion to the weight of the composition.
말할 필요도 없이, 당업계의 기술자는 본 발명에 따른 염료 조성물이 본질적으로 갖는 유리한 특성이 구상 중에 있는 첨가(들)에 의해 부정적인 영향을 받거나 또는 실질적으로 부정적인 영향을 받지 않도록, 상기의 임의적 부가 화합물(들)을 선택할 것이다.Needless to say, one of ordinary skill in the art will appreciate that the optional additional compounds described above are such that the beneficial properties of the dye compositions according to the invention are essentially negatively affected or substantially not adversely affected by the envisioned addition (s). Will select (s).
상기 조성물의 pH 는 일반적으로 대략 3 내지 14, 바람직하게는 대략 4 내지 11 및 더욱 바람직하게는 6 내지 11 이다. 케라틴 섬유의 염색에 통상적으로 사용되는 산성 또는 염기성화제를 이용하여, 또는 대안적으로 표준 완충 시스템을 사용하여 목적하는 값으로 조정될 수 있다.The pH of the composition is generally about 3 to 14, preferably about 4 to 11 and more preferably 6 to 11. It can be adjusted to the desired value using acidic or basicizing agents conventionally used for dyeing keratinous fibers, or alternatively using standard buffer systems.
언급될 수 있는 산성화제 중에서, 예를 들어, 무기 또는 유기산, 예를 들어 염산, 오르토인산, 카르복실산, 예를 들어 아세트산, 타르타르산, 시트르산 또는 락트산, 및 술폰산이 있다.Among the acidifying agents that may be mentioned are, for example, inorganic or organic acids such as hydrochloric acid, orthophosphoric acid, carboxylic acids such as acetic acid, tartaric acid, citric acid or lactic acid, and sulfonic acid.
염기성화제 중에서, 언급될 수 있는 예로는 수성 암모니아, 알칼리 금속 탄산염 및 상기 언급된 아민이 포함된다.Among the basicizing agents, examples which may be mentioned include aqueous ammonia, alkali metal carbonates and the amines mentioned above.
상기 조성물은 각종 형태, 예컨대 액체, 크림 또는 겔, 습포제를 수득하기 위해 사용전 혼합되는 분말, 수액, 또는 케라틴 섬유, 및 특히 모발의 염색에 적합한 임의의 기타 형태일 수 있다.The composition may be in various forms, such as liquids, creams or gels, powders, sap, or keratin fibers mixed prior to use to obtain a poultice agent, and any other form particularly suitable for dyeing hair.
상기 언급된 조성물의 성분은 유리하게는 개별적으로 보관된다. 특히, 화학식 (I) 또는 (II) 의 화합물 또는 상기를 포함하는 식물 추출물 및 알데히드 또는 이민 화합물(들) 또는 알데히드 또는 이민 관능기를 함유하는 산화 올리고당 또는 다당류는 개별적으로 보관된다.The components of the abovementioned compositions are advantageously stored separately. In particular, the compounds of formula (I) or (II) or plant extracts comprising them and oxidized oligosaccharides or polysaccharides containing aldehyde or imine compound (s) or aldehyde or imine functional groups are stored separately.
또한, 하나 이상의 아민 화합물이 존재하는 경우, 이러한 화합물을 또한 화합물(들) (I) 및 (II) 또는 상기를 포함하는 식물 추출물과 개별적으로 보관된다는 것에 주의한다.It is also noted that when one or more amine compounds are present, these compounds are also stored separately from the compound (s) (I) and (II) or plant extracts comprising the same.
또한, 화학식 (I)/(II) 의 화합물(들) 또는 상기를 포함하는 식물 추출물은 적어도 밀폐 용기에 보관하는 것이 유리할 수 있다.It may also be advantageous to store the compound (s) of formula (I) / (II) or plant extracts comprising the above in at least a closed container.
본 발명에 따른 방법에 사용되는 조성물은 또한 하나 이상의 산화제를 포함할 수 있다. 이러한 경우, 이는 즉석식 (ready-to-use) 조성물로서 언급된다.The composition used in the process according to the invention may also comprise one or more oxidants. In this case it is referred to as a ready-to-use composition.
산화제Oxidant
특히, 산화제가 존재하는 경우, 상기 즉석식 조성물은 유리하게는 상기 기재된 바와 같은 조성물을, 적용 전, 하나 이상의 산화제를 포함하는 하나 이상의 조성물과 함께 즉석 혼합함으로써 수득된다.In particular, where an oxidant is present, the ready-to-eat composition is advantageously obtained by instant mixing the composition as described above with at least one composition comprising at least one oxidizing agent before application.
상기 산화제는 바람직하게는 과산화수소, 우레아 과산화물, 알칼리 금속 브로메이트 또는 페리시아니드 (ferricyanide), 과산화 염, 예를 들어 알칼리 금속 또는 알칼리 토금속, 예컨대 나트륨, 칼륨 및 마그네슘의 과황산염, 과붕산염 및 과탄산염으로부터 선택된다. The oxidizing agent is preferably hydrogen peroxide, urea peroxide, alkali metal bromate or ferricyanide, peroxide salts, for example persulfates, perborates and percarbonates of alkali or alkaline earth metals such as sodium, potassium and magnesium Is selected from.
사용에 적합한 산화제에는 또한 효소 유형의 산화제, 예를 들어, 적합한 경우, 각각 이의 공여체 또는 보조인자 존재 하에서, 4-전자 산화환원효소 (예컨대 라카아제 (laccase)), 2-전자 산화환원효소 (예컨대 우리카아제 (uricase)), 및 퍼옥시다아제가 포함된다.Oxidants suitable for use also include oxidizing agents of the enzyme type, eg, in the presence of a donor or cofactor, respectively, if appropriate, 4-electron redoxases (such as laccase), 2-electron redoxases (such as Uricases, and peroxidases.
과산화수소를 사용하는 것이 특히 바람직하다. Particular preference is given to using hydrogen peroxide.
상기 산화제는 유리하게는 수용액 (과산화수소 수용액) 중 과산화수소에 의해 형성되고, 이의 역가는 더욱 특히 1 내지 40 부피 및 보다 더욱 바람직하게는 5 내지 40 부피 범위일 수 있다.The oxidant is advantageously formed by hydrogen peroxide in an aqueous solution (aqueous hydrogen peroxide solution), the titer of which may be in particular in the range from 1 to 40 vol and even more preferably from 5 to 40 vol.
따라서, 본 발명에 사용되는 조성물이 몇몇의 조성물을 즉석 혼합함으로써 수득될 수 있다는 점에 주의해야 한다.Thus, it should be noted that the compositions used in the present invention can be obtained by instant mixing of several compositions.
따라서, 바로 상기에 기재된 조성물은 인간 케라틴 섬유, 특히 모발에 적용된다.Thus, the composition just described is applied to human keratinous fibers, in particular hair.
염색 방법Dyeing method
제 1 구현예에 따라, 적용되는 조성물은 어떤 산화제도 포함하지 않는다. According to the first embodiment, the composition to be applied does not contain any oxidizing agent.
상기 구현예는, 상기 조성물이 산화 염료 (염기 또는 연결기) 를 포함하지 않는 경우에 특히 적합하다.This embodiment is particularly suitable when the composition does not comprise an oxidizing dye (base or linking group).
제 2 구현예에 따라, 상기 상세화되고, 적용 전, 산화제가 없는 상기 기재된 조성물을 산화 조성물과 즉석 혼합함으로써 수득되는 즉석식 조성물이, 섬유에 적용된다. According to a second embodiment, an instant food composition which is specified above and obtained by instant mixing of the above-described composition without an oxidizing agent with an oxidizing composition, is applied to the fibers.
상기 구현예는, 상기 조성물이 하나 이상의 산화 염료 (염기 또는 연결기) 를 포함하는 경우 또는 라이트닝 효과를 수득하기는 것이 요구되는 경우에 특히 적합하다. This embodiment is particularly suitable when the composition comprises at least one oxidizing dye (base or linking group) or when it is desired to obtain a lightening effect.
상기 구현예의 제 2 변형에 따라, 산화제가 없는 조성물 및 산화 조성물은 중간 세척 없이 연속적으로 적용된다.According to a second variant of this embodiment, the oxidant free composition and the oxidizing composition are applied continuously without intermediate washing.
사용되는 산화 조성물은 상기 정의된 바와 같은 하나 이상의 산화제를 포함한다.The oxidizing composition used comprises one or more oxidizing agents as defined above.
상기 산화 조성물 내에 존재할 수 있는 유기 용매에 관하여, 본 발명에 따른 조성물의 설명의 맥락에서 상기 제시된 목록을 참조할 수 있다.With regard to organic solvents which may be present in the oxidizing composition, reference may be made to the list given above in the context of the description of the composition according to the invention.
통상적으로, 산화 조성물의 pH 는 7 미만이다.Typically, the pH of the oxidizing composition is less than 7.
상기 산화 조성물은 용액, 에멀젼 또는 겔의 형태를 취할 수 있다. The oxidizing composition may take the form of a solution, emulsion or gel.
이는 목적하는 생약 형태의 기능에 따라, 인간 케라틴 섬유의 염색 분야에 통상적으로 사용되는 하나 이상의 첨가제를 임의로 포함할 수 있다. 다시 한번, 상기 제시된 첨가제의 목록을 참조할 수 있다.It may optionally include one or more additives conventionally used in the field of dyeing human keratinous fibers, depending on the function of the desired herbal form. Once again, reference may be made to the list of additives presented above.
선택된 구현예 (산화제 포함 유무, 즉석 혼합 또는 조성물과 산화제의 연속 적용) 와 관계없이, 섬유에 적용되는 혼합물은 일반적으로 약 1 분 내지 5 시간 및 바람직하게는 10 분 내지 3 시간의 시간 동안 그 자리에 정치된다.Regardless of the selected embodiment (with or without oxidizing agent, instant mixing or continuous application of the composition and oxidizing agent), the mixture applied to the fiber is generally in place for a time of about 1 minute to 5 hours and preferably 10 minutes to 3 hours. To be politicized.
조성물(들)이 적용되는 온도에 관하여, 일반적으로 20 내지 200℃ 및 유리하게는 20℃ 내지 55℃ 이다.With respect to the temperature at which the composition (s) are applied, it is generally 20 to 200 ° C and advantageously 20 ° C to 55 ° C.
따라서, 상기 작업은, 예를 들어 가열 후드, 적외선 램프 또는 스트레이트닝 아이론 (straightening iron) 또는 컬링 아이론 (curling iron) 을 사용하여 수행될 수 있다.Thus, the operation can be carried out, for example, using a heating hood, an infrared lamp or a straightening iron or curling iron.
본 발명에 따른 방법은 유리하게는 광 자극의 존재 하에서 수행될 수 있다.The method according to the invention can advantageously be carried out in the presence of a light stimulus.
더욱 특히, 상기와 같이 UVA 방사선 (특히 연속-스펙트럼 램프 또는 선-스펙트럼 램프에 의해 전달되는, 0.01 내지 0.40 mW/cm2 및 바람직하게는 0.1 내지 0.2 mW/cm2 의 방사 조도) 및/또는 UVB 방사선 (특히 연속-스펙트럼 램프 또는 선-스펙트럼 램프에 의해 전달되는, 0.01 내지 0.20 mW/cm2 및 바람직하게는 0.01 내지 0.1 mW/cm2 의 방사 조도) 처리된 케라틴 섬유에 적용하는 것으로 이루어진다. More particularly, UVA radiation as described above (in particular irradiance of 0.01 to 0.40 mW / cm 2 and preferably 0.1 to 0.2 mW / cm 2 delivered by a continuous-spectrum lamp or a line-spectrum lamp) and / or UVB Application to radiation-treated keratinous fibers, in particular 0.01 to 0.20 mW / cm 2 and preferably 0.01 to 0.1 mW / cm 2 , delivered by a continuous-spectrum lamp or a line-spectrum lamp.
바람직하게는, 이러한 화합물은 알칼리 금속, 알칼리 토금속 또는 암모늄, 탄산염, 탄산수소염, 염화물, 황산염, 규산염, 단염기성 인산염 또는 아세테이트 염이다.Preferably, such compounds are alkali metal, alkaline earth metal or ammonium, carbonate, hydrogen carbonate, chloride, sulfate, silicate, monobasic phosphate or acetate salts.
본 발명의 바람직한 일 변형에 따라, 상기 자극은 화장용으로 허용가능한 매질 중에, 탄산리튬, 탄산나트륨, 탄산칼륨, 탄산칼슘 또는 탄산암모늄; 탄산수소나트륨 또는 탄산수소칼륨; 염화칼슘, 염화리튬 또는 염화나트륨; 황산암모늄, 황산나트륨 또는 황산마그네슘; 규산나트륨; 1염기성 인산나트륨 또는 인산칼륨; 아세트산나트륨으로부터 선택되는 하나 이상의 염을 포함하는 조성물을 사용함으로써 수행된다.According to one preferred variant of the invention, the stimulus is selected from the group consisting of lithium carbonate, sodium carbonate, potassium carbonate, calcium carbonate or ammonium carbonate in a cosmetically acceptable medium; Sodium bicarbonate or potassium bicarbonate; Calcium chloride, lithium chloride or sodium chloride; Ammonium sulfate, sodium sulfate or magnesium sulfate; Sodium silicate; Monobasic sodium or potassium phosphate; By using a composition comprising at least one salt selected from sodium acetate.
상기 조성물은 유리하게는 조성물의 중량에 비례하여 0.001 중량% 내지 40 중량%, 및 보다 더욱 바람직하게는 조성물의 중량에 비례하여 0.001 중량% 내지 20 중량% 범위의 염 함량을 갖는다.The composition advantageously has a salt content in the range of 0.001% to 40% by weight, and even more preferably in the range of 0.001% to 20% by weight relative to the weight of the composition.
서로 상이한 자극을 조합하는 몇몇의 연속적인 단계를 수행하기 위해 본 발명의 맥락에서 벗어나도록 구성할 수는 없다.It may not be configured to depart from the context of the present invention in order to perform several successive steps of combining different stimuli.
잔류 (leave-on) 시간 후, 상기 케라틴 섬유를 물로 헹구고, 임의로 샴푸로 세정하고, 물로 헹구고, 건조시키거나 또는 건조되도록 둘 수 있다.After the leave-on time, the keratinous fibers can be rinsed with water, optionally washed with shampoo, rinsed with water, dried or left to dry.
본 발명의 마지막 주제는 화학식 (I) 및/또는 (II) 의 하나 이상의 화합물 또는 상기를 포함하는 식물 추출물을 함유하는 제 1 구획, 및 화학식 (i) 또는 (ii) 의 하나 이상의 화합물, 하나 이상의 알데히드 또는 이민 관능기를 포함하는 산화 올리고당 또는 다당류를 함유하는 제 2 구획을 포함하는 다중 구획 장치로 이루어진다. A final subject of the invention is a first compartment containing at least one compound of formula (I) and / or (II) or a plant extract comprising the same and at least one compound of formula (i) or (ii), at least one It consists of a multi-compartment device comprising a second compartment containing an oxidized oligosaccharide or polysaccharide comprising an aldehyde or imine function.
바람직하게는, 화학식 (I)/(II)의 화합물(들) 또는 상기를 포함하는 식물 추출물은 공기로부터 보호되어, 유리하게는 불활성 분위기 하에서 보관된다.Preferably, the compound (s) of formula (I) / (II) or plant extracts comprising the same are protected from air and are advantageously stored under inert atmosphere.
상기 장치는 임의로 하나 이상의 아민, 또는 하나 이상의 염을 포함하는 제 3 구획을 포함할 수 있다.The device may optionally comprise a third compartment comprising one or more amines, or one or more salts.
하기에 본 발명을 예시하는 실시예가 제시되며, 이는 본 발명을 제한하려는 의도가 아니다.In the following Examples are presented which illustrate the invention, which are not intended to limit the invention.
실시예Example 1One
제니핀 중에 9.4% 농축된, 제니파 아메리카나 (Genipa americana) 의 추출물 (10 g%) 및 바닐린 (1.5 g%) 을, 수용액 중에서 초음파 분쇄기 (sonicator) 를 이용하여 30 분 동안 용해시켜 염료 조성물을 수득하였다. Genipa Americana, concentrated in 9.4% The extract (10 g%) and vanillin (1.5 g%) of americana were dissolved in an aqueous solution for 30 minutes using an ultrasonic sonicator to obtain a dye composition.
하기 방법을 수행하여 상기 추출물을 수득하였다:The extract was obtained by the following method:
덜익은 제니파 아메리카나 (Genipa americana) 과실 (100 g) 을 조각으로 잘게 자르고, 냉동시키고, 동결건조시키고, 분쇄한 후, milliQ 수로 추출하였다.Unripe Jenny Americana ( Genipa americana ) fruit (100 g) was chopped into pieces, frozen, lyophilized, ground and extracted with milliQ water.
배쓰 비는 1/20 (= 20 ml 의 용매 당 1 g 의 동결건조물) 이었다. The bath ratio was 1/20 (= 1 g lyophilisate per 20 ml of solvent).
상기 현탁액을 실온에서 1 시간 동안 교반하였다. 이어서, 출발 물질을 7500 rpm 에서 15 분 동안 원심분리하여 용매로부터 분리하고, 상청액을 Whatman GF/C 여과기를 통해 여과하였다.The suspension was stirred at rt for 1 h. The starting material was then separated from the solvent by centrifugation at 7500 rpm for 15 minutes and the supernatant was filtered through Whatman GF / C filter.
이어서, 상기 여과된 추출물을 냉동시킨 후, 동결건조시켰다.The filtered extract was then frozen and then lyophilized.
HPLC 분석은 상기 추출물이 제니핀 중에 9.4% 의 양으로 농축된 것으로 나타났다.HPLC analysis showed that the extract was concentrated in nippin in an amount of 9.4%.
다음으로, 유기 및/또는 무기 염을 상기 조성물에 첨가하였다. 상기 조성물을 다시 15 분 동안 초음파처리하였다.Next, organic and / or inorganic salts were added to the composition. The composition was again sonicated for 15 minutes.
각각의 조성물을 90% 백색 모발을 함유한 회색 모발에 적용하고 (5 g 의 용액 당 1 g 의 머릿단), 상기 머릿단을 40℃ (핫플레이트) 에서 2 시간 동안 위치시켰다.Each composition was applied to gray hair containing 90% white hair (1 g of tress per 5 g of solution) and the tress was placed at 40 ° C. (hotplate) for 2 hours.
실시예Example 22
제니핀 중에 9.4% 농축된 제니파 아메리카나 (Genipa americana) 의 추출물 (5x10-3 mol%) 및 상기 성분 (10-2 mol%) 을, 벤조산, 벤질 알코올, 에탄올 및 물의 혼합물 중에서 초음파 분쇄기를 이용하여 30 분 동안 용해시켜 염료 조성물을 수득하였다 (상기 조성물의 pH 는 9.5 임 (NaOH 의 첨가; 0.1M)).9.4% Concentrated Zenipa Americana ( Genipa extract of the americana (5x10 -3 mol%) and the component (10 -2 mol%) were dissolved in a mixture of benzoic acid, benzyl alcohol, ethanol and water for 30 minutes using an ultrasonic mill to obtain a dye composition (above PH of the composition is 9.5 (addition of NaOH; 0.1M)).
각각의 조성물을 90% 백색 모발을 함유한 천연 및/또는 파마머리 (permanent-waved) 회색 모발에 적용하고 (10 g 의 용액 당 1 g 의 머릿단), 상기 머릿단을 50℃ (핫플레이트) 에서 30 분 동안 위치시켰다.Each composition is applied to natural and / or permanent-waved gray hair containing 90% white hair (1 g of tress per 10 g of solution) and the tress is 30 at 50 ° C. (hotplate). Placed for minutes.
실시예Example 3: 3:
제니핀 중에 9.4% 농축된 제니파 아메리카나 (Genipa americana) 의 추출물 (3g%) 및 존재하는 경우, 바닐린 (0.4g%) 을, 물 중에서 초음파 분쇄기를 이용하여 20 분 동안 용해시켜 염료 조성물을 수득하였다 (상기 조성물의 pH 는 8 임 (KHCO3 의 첨가)).9.4% Concentrated Zenipa Americana ( Genipa if extract (3g%) and the presence of americana), the vanillin (0.4g%), by using an ultrasonic crusher in water to give the dye composition was dissolved for 20 minutes (the pH of the composition is 8 Im (KHCO 3 adding)).
각각의 조성물을 90% 백색 모발을 함유한 천연 회색 모발에 적용하고 (5 g 의 용액 당 1 g 의 머릿단), 상기 머릿단을 30℃ (핫플레이트) 에서 60 분 동안 위치시켰다.Each composition was applied to natural gray hair containing 90% white hair (1 g of tress per 5 g of solution) and the tress was placed at 30 ° C. (hotplate) for 60 minutes.
결과는 하기와 같았다:The results were as follows:
상기 결과로부터, 바닐린을 포함하는 경우 색상이 더욱 강렬하다는 것이 명백해졌다.From the above results, it became clear that the color was more intense when including vanillin.
실시예Example 4 4
이민 유형 화합물의 제조Preparation of Imine Type Compounds
물 (5ml) / 에탄올 (1ml) 의 혼합물 중의 바닐린 (0.4g%) 을, 아세트산의 존재 하에서, 3-아미노프로판올 (0.2g%) 과 주위 온도에서 30 분 동안 반응시켜 이민을 제조하였다.Imine was prepared by reacting vanillin (0.4 g%) in a mixture of water (5 ml) / ethanol (1 ml) with 3-aminopropanol (0.2 g%) at ambient temperature for 30 kPa in the presence of acetic acid.
이어서, 수득한 이민을 제니핀 중에 9.4% 농축된 제니파 아메리카나 (Genipa americana) (3g%) 의 추출물에 첨가하였다. 이어서, 상기 조성물의 pH 를 KHCO3 의 첨가에 의해 8 로 조정한 후, 초음파 분쇄기 내에 20 분 동안 두었다.The obtained imine was then added to an extract of Genipa americana (3 g%) concentrated 9.4% in nippin . The pH of the composition was then adjusted to 8 by the addition of KHCO 3 and then placed in an ultrasonic mill for 20 minutes.
상기 조성물을 90% 백색 모발을 함유한 천연 회색 모발에 적용하고 (6 g 의 용액 당 1 g 의 머릿단), 상기 머릿단을 40℃ (핫플레이트) 에서 60 분 동안 위치시켰다.The composition was applied to natural gray hair containing 90% white hair (1 g of tress per 6 g of solution) and the tress was placed at 40 ° C. (hotplate) for 60 minutes.
상기 모발의 색상은 진한 청색이었다.The color of the hair was dark blue.
실시예Example 5 5
제니핀 중에 9.4% 농축된 제니파 아메리카나 (Genipa americana) 의 추출물 (3g%) 및 산화된 이눌린 (0.3g%) 을, pH 8 의 수용액 (KHCO3 첨가) 중에서 초음파 분쇄기를 이용하여 20 분 동안 용해시켜 염료 조성물을 수득하였다. 9.4% Concentrated Zenipa Americana ( Genipa The extract of americana ) (3g%) and oxidized inulin (0.3g%) were dissolved in an aqueous solution of pH 8 (KHCO 3 addition) for 20 minutes using an ultrasonic mill to obtain a dye composition.
각각의 조성물을 90% 백색 모발을 함유한 천연 회색 모발에 적용하고 (5 g 의 용액 당 1 g 의 머릿단), 상기 머릿단을 40℃ (핫플레이트) 에서 60 분 동안 위치시켰다.Each composition was applied to natural gray hair containing 90% white hair (1 g of tress per 5 g of solution) and the tress was placed at 40 ° C. (hotplate) for 60 minutes.
상기 모발은 금빛 황색 (golden yellow) 이었다.The hair was golden yellow.
Claims (12)
* 하기 화학식 (I) 의 화합물 , 이의 광학 또는 기하학 이성질체, 이의 무기 또는 유기산 염, 이의 용매화물, 또는 상기를 포함하는 식물 추출물로서:
[화학식 (I) 에서:
ㆍ R1 은 수소 원자, 메틸 라디칼, 히드록시메틸 라디칼, 알데히드기; -CO2R4 기 (여기서, R4 는 수소 원자 또는 C1-C2 알킬 라디칼을 나타냄); -CH2-글루코오스기를 나타내고;
ㆍ R2 는 수소 원자, 히드록실 라디칼 또는 글루코오스 라디칼을 나타내고;
ㆍ R3 은, 동일하거나 상이할 수 있으며, 수소 원자, 히드록실 라디칼, (C1-C4)알킬옥시 라디칼을 나타내고; 상기 히드록실기의 수는 2 이하이고;
ㆍ n 은 1 내지 5 의 정수임]
상기 식물 추출물은 하기 식물로부터 수득됨: 베로니카 페르시카 (Veronica persica); 제니파 아메리카나 (Genipa americana); 아포디테스 디미디아타 (Apodytes dimidiata); 란디아 칸티오이데스 (Randia canthioides); 타레나 아테누아타 (Tarenna attenuata); 및
** 하기 화학식 (i) 및 (ii) 로부터 선택되는 하나 이상의 알데히드 또는 이민 화합물 , 이의 광학 또는 기하학 이성질체, 이의 유기 또는 무기산 염, 이의 용매화물, 또는 하나 이상의 알데히드 또는 이민 관능기를 포함하는 산화 올리고당 또는 다당류:
[화학식 (i) 및 (ii) 에서,
ㆍ m 은 0 또는 1 의 정수이고,
ㆍ X 는 산소 원자, NR"1 (여기서, R"1 은 수소 원자 또는 C1-C10 알킬 라디칼을 나타냄) 을 나타내고;
ㆍ 라디칼 R'1 및 R'2 는, 서로 독립적으로, 수소 원자 또는 비치환된 선형 C1-C6 알킬 라디칼을 나타내고;
ㆍ 1가 라디칼 A 및 2가 라디칼 A1 은 하기로부터 선택되는 기를 나타내고:
* 히드록시카르보닐기 (-CO-OH):
* 적어도 하기로 임의로 치환된 C6 아릴기:
- 히드록실기,
- C1-C4 알킬 라디칼,
- 아릴-에틸레닐 라디칼 (상기 아릴기는 C6 이고, 하나 이상의 C1-C2 알킬 또는 C1-C2 알콕시 라디칼로 임의로 치환됨),
- -CO-OR'4 또는 -O-COR'4 기 (여기서, R'4 는 C1-C2 알킬 라디칼 또는 페닐기를 나타냄);
- 산성 또는 염화된 형태의 -COOH 기,
- -OR'5 기 (여기서, R'5 는 하나 이상의 히드록실기로 임의로 치환된 C1-C8 알킬 라디칼을 나타냄), 벤질 라디칼 (-CH2-C6H5),
- 일 특정 변형에 따라, C6 아릴기에 대하여 오르토 위치에 있는 2 개의 라디칼 -OR'5 는 2 개의 라디칼 R'5 에 의해 5- 또는 6-원 헤테로사이클을 형성할 수 있음,
- -N(R'8)2 기 (여기서, R'8 은, 동일하거나 상이할 수 있으며, 히드록실기, 산성 또는 염화된 형태의 카르복실기 (-COOH), 또는 산성 또는 염화된 형태의 술폰기 (-SO3H) 로 임의로 치환된 C1-C6 알킬 라디칼을 나타내고; 상기 라디칼 R'8 은 이를 함유하는 질소 원자와 함께, 임의로 O 및 N 으로부터 선택되는 또 다른 헤테로원자를 포함하는 포화 또는 불포화 5- 또는 6-원 헤테로사이클을 형성할 수 있고; 상기 헤테로사이클은 히드록실기로 임의로 치환됨),
- -COR'10 기 (여기서, R'10 은 하나 이상의 C1-C2 알킬 라디칼로 임의로 치환된 6-원 탄화수소계 고리에 융합된 C6 아릴기를 나타냄),
- -SR'11 기 (여기서, R'11 은 C1-C2 알킬 라디칼을 나타냄),
- 염소 및 브롬으로부터 선택되는 할로겐 원자,
- -O-SO2-C6H5 기,
- -SO3H 기,
- O 및 N 으로부터 선택되는 1 또는 2 개의 헤테로원자를 포함하는 불포화 양이온성 또는 비양이온성 5- 또는 6-원 헤테로사이클 (상기 헤테로원자 중 하나는 2 개의 고리 내에 포함될 수 있고; 상기 헤테로사이클 또는 융합된 고리는 하나 이상의 C1-C2 알콕시 라디칼로 치환될 수 있음),
- 상기 아릴기는 O 및 N 으로부터 선택되는 1 또는 2 개의 헤테로원자를 포함하는 5- 또는 6-원 헤테로시클릭기에 임의로 융합되고, 상기 헤테로사이클은 C6 아릴기에 임의로 융합됨,
- 상기 아릴기는 하나 이상의 C1-C2 알콕시기로 임의로 치환된 C6 아릴기에 임의로 융합됨;
* O 및 N 으로부터 선택되는 1 또는 2 개의 동일하거나 상이한 헤테로원자를 포함하는, 양이온성 또는 비양이온성, 포화 또는 불포화, 방향족 또는 비방향족 5- 또는 6-원 헤테로시클릭기;
- 상기 헤테로시클릭기는 그 자체가 하나 이상의 C1-C2 알킬, C1-C4 알콕시 또는 페녹시기로 임의로 치환된 6-원 아릴기에 임의로 융합됨;
- 상기 헤테로시클릭기는 적어도 하기로 임의로 치환됨:
о 히드록실기,
о 히드록실 라디칼로 임의로 치환된 C1-C2 알킬 라디칼;
о 아미노 라디칼 -N(R'16)2 (여기서, R'16 은, 동일하거나 상이할 수 있으며, 히드록실기로 임의로 치환된 C1-C4 알킬 라디칼을 나타내고, 상기 라디칼 R'16 은 이를 함유하는 질소 원자와 함께, 임의로 O 및 N 으로부터 선택되는 또 다른 헤테로원자를 포함하는 포화 또는 불포화 5- 또는 6-원 헤테로사이클을 형성할 수 있음),
о 하나 이상의 COOH, R'18CONH- 기 (여기서, R'18 은 C1-C2 알킬 라디칼을 나타냄) 로 임의로 치환된 C6 아릴 라디칼 (상기 C6 아릴 라디칼은 헤테로시클릭기의 질소 원자에 임의로 연결되고; 아릴 라디칼이 상기 언급된 라디칼로 치환되지 않는 경우, 탄소 원자는 수소 원자로 치환됨);
ㆍ 2가 라디칼 A2 는 탄소, 산소 또는 질소 원자를 통해 2 개의 라디칼 A1 을 연결하는 선형 C1-C10 알킬렌 사슬을 나타내고;
적합한 경우, 화학식 (i) 및 (ii) 의 화합물은 제형의 전기적 중성을 보장하는, 화장용으로 허용가능한 음이온 또는 음이온 An 의 혼합물을 포함함].Cosmetic compositions for dyeing keratinous fibers in a cosmetically acceptable medium, comprising:
A compound of formula (I) , an optical or geometrical isomer thereof, an inorganic or organic acid salt thereof, a solvate thereof, or a plant extract comprising the above:
[Formula (I):
R 1 represents a hydrogen atom, a methyl radical, a hydroxymethyl radical, an aldehyde group; -CO 2 R 4 group, where R 4 represents a hydrogen atom or a C 1 -C 2 alkyl radical; -CH 2 -glucose group;
R 2 represents a hydrogen atom, a hydroxyl radical or a glucose radical;
R 3 , which may be the same or different, represents a hydrogen atom, a hydroxyl radical, a (C 1 -C 4 ) alkyloxy radical; The number of hydroxyl groups is 2 or less;
N is an integer from 1 to 5
The plant extract is obtained from the following plants: Veronica persica ; Genipa americana ; Apodytes dimidiata ; Randia canthioides ; Tarenna attenuata ; And
** at least one aldehyde or imine compound selected from formulas (i) and (ii), an optical or geometric isomer thereof, an organic or inorganic acid salt thereof, a solvate thereof, or an oxidized oligosaccharide comprising at least one aldehyde or imine functional group or Polysaccharides:
[Formula (i) and (ii),
M is an integer of 0 or 1,
X represents an oxygen atom, NR ″ 1 , wherein R ″ 1 represents a hydrogen atom or a C 1 -C 10 alkyl radical;
The radicals R ′ 1 and R ′ 2 independently of one another represent a hydrogen atom or an unsubstituted linear C 1 -C 6 alkyl radical;
Monovalent radical A and divalent radical A 1 represent a group selected from:
* Hydroxycarbonyl group (-CO-OH) :
* A C 6 aryl group optionally substituted by at least:
-Hydroxyl group,
C 1 -C 4 alkyl radicals,
Aryl-ethylenyl radicals (where the aryl group is C 6 and is optionally substituted with one or more C 1 -C 2 alkyl or C 1 -C 2 alkoxy radicals),
-CO-OR ' 4 or -O-COR' 4 groups, wherein R ' 4 represents a C 1 -C 2 alkyl radical or a phenyl group;
-COOH groups in acidic or chlorided form,
-OR ' 5 group, wherein R' 5 represents a C 1 -C 8 alkyl radical optionally substituted with one or more hydroxyl groups, benzyl radical (-CH 2 -C 6 H 5 ),
-According to one particular variant, two radicals -OR ' 5 in the ortho position relative to the C 6 aryl group can form a 5- or 6-membered heterocycle by two radicals R' 5 ,
—N (R ′ 8 ) 2 groups, wherein R ′ 8 may be the same or different and may be a hydroxyl group, an acidic or chlorinated carboxyl group (-COOH), or an acidic or chlorinated sulfone group A C 1 -C 6 alkyl radical optionally substituted with (-SO 3 H); said radical R ' 8 together with the nitrogen atom containing it contains a saturation comprising another heteroatom, optionally selected from O and N, or May form an unsaturated 5- or 6-membered heterocycle; the heterocycle is optionally substituted with a hydroxyl group),
- -COR '10 group (where, R' 10 represents an optionally substituted 6-membered hydrocarbon ring fused to a C 6 aryl substituted with one or more C 1 -C 2 alkyl radical),
- -SR '11 group (where, R' 11 represents a C 1 -C 2 alkyl radical),
Halogen atoms selected from chlorine and bromine,
-O-SO 2 -C 6 H 5 group,
-SO 3 H group,
Unsaturated cationic or noncationic 5- or 6-membered heterocycles comprising one or two heteroatoms selected from O and N (one of said heteroatoms may be included in two rings; said heterocycle or Fused ring may be substituted with one or more C 1 -C 2 alkoxy radicals),
Said aryl group is optionally fused to a 5- or 6-membered heterocyclic group comprising 1 or 2 heteroatoms selected from O and N, said heterocycle optionally fused to a C 6 aryl group,
Said aryl group is optionally fused to a C 6 aryl group optionally substituted with one or more C 1 -C 2 alkoxy groups;
Cationic or noncationic, saturated or unsaturated, aromatic or non-aromatic 5- or 6-membered heterocyclic groups comprising one or two identical or different heteroatoms selected from O and N;
Said heterocyclic group is optionally fused itself to a 6-membered aryl group optionally substituted with one or more C 1 -C 2 alkyl, C 1 -C 4 alkoxy or phenoxy groups;
Said heterocyclic group is optionally substituted with at least:
о hydroxyl group,
o C 1 -C 2 alkyl radicals optionally substituted with hydroxyl radicals;
o the amino radical —N (R ′ 16 ) 2 , wherein R ′ 16 represents a C 1 -C 4 alkyl radical which may be the same or different and optionally substituted with a hydroxyl group, said radical R ′ 16 Together with the containing nitrogen atom, it may form a saturated or unsaturated 5- or 6-membered heterocycle optionally comprising another heteroatom selected from O and N),
о one or more COOH, R '18 CONH- group (wherein, R' 18 is C 1 -C 2 alkyl radical represents a) an optionally substituted C 6 aryl radicals (wherein the C 6 aryl radical to the nitrogen atom of the heterocyclic group Optionally an aryl radical is substituted with a hydrogen atom as described above, where the carbon atom is substituted with a hydrogen atom;
Divalent radical A 2 represents a linear C 1 -C 10 alkylene chain connecting two radicals A 1 via a carbon, oxygen or nitrogen atom;
Where appropriate, the compounds of formulas (i) and (ii) comprise a cosmetically acceptable anion or mixture of anions An, which ensures the electrical neutrality of the formulation.
* m 은 0 또는 1 이고;
* 라디칼 R'1 및 R'2 는, 서로 독립적으로, 수소 원자 또는 비치환된 선형 C1-C6 알킬 라디칼을 나타내고;
* X 는 산소 원자를 나타내고;
A 는 하기를 나타냄:
* 히드록시카르보닐기 (-COOH);
* 적어도 하기로 임의로 치환된 C6 아릴기:
- 히드록실기,
- C1-C4 알킬 라디칼,
- -CO-OR'4 또는 -O-COR'4 기 (여기서, R'4 는 C1-C2 알킬 라디칼을 나타냄),
- -OR'5 기 (여기서, R'5 는 C1-C6 알킬 라디칼을 나타냄),
- 아릴-에틸레닐 라디칼 (상기 아릴기는 C6 이고, 하나 이상의 C1-C2 알킬 또는 C1-C2 알콕시 라디칼로 임의로 치환됨),
- O 및 N 으로부터 선택되는 1 또는 2 개의 헤테로원자를 포함하는 불포화 양이온성 또는 비양이온성 5- 또는 6-원 헤테로사이클 (상기 헤테로원자 중 하나는 2 개의 고리 내에 포함될 수 있고; 상기 헤테로사이클 또는 융합된 고리는 하나 이상의 C1-C2 알콕시 라디칼로 치환될 수 있음),
- 상기 아릴기는 O 및 N 으로부터 선택되는 1 또는 2 개의 헤테로원자를 포함하는 5- 또는 6-원 헤테로시클릭기에 임의로 융합됨;
* O 및 N 으로부터 선택되는 1 또는 2 개의 동일하거나 상이한 헤테로원자를 포함하는, 양이온성 또는 비양이온성, 포화 또는 불포화, 방향족 또는 비방향족 5- 또는 6-원 헤테로시클릭기;
- 상기 헤테로시클릭기는 그 자체가 하나 이상의 C1-C2 알킬 또는 C1-C4 알콕시기로 임의로 치환된 6-원 아릴기에 임의로 융합됨;
- 상기 헤테로시클릭기는 적어도 하기로 임의로 치환됨:
о 히드록실기,
о 히드록실 라디칼로 임의로 치환된 C1-C2 알킬 라디칼,
о 아미노 라디칼 -N(R'16)2 (여기서, R'16 은, 동일하거나 상이할 수 있으며, 히드록실기로 임의로 치환된 C1-C4 알킬 라디칼을 나타내고, 상기 라디칼 R'16 은 이를 함유하는 질소 원자와 함께, 임의로 O 및 N 으로부터 선택되는 또 다른 헤테로원자를 포함하는 포화 또는 불포화 5- 또는 6-원 헤테로사이클을 형성할 수 있음),
* 적합한 경우, 화학식 (i) 의 화합물은 제형의 전기적 중성을 보장하는, 화장용으로 허용가능한 음이온 또는 음이온 An 의 혼합물을 포함하고;
* 화학식 (i) 의 화합물(들)은 아세탈 또는 헤미아세탈 형태일 수 있음.The composition of claim 1 which is the compound (s) of formula (i) as follows:
m is 0 or 1;
The radicals R ′ 1 and R ′ 2 independently of one another represent a hydrogen atom or an unsubstituted linear C 1 -C 6 alkyl radical;
* X represents an oxygen atom;
A represents:
Hydroxycarbonyl group (-COOH);
* A C 6 aryl group optionally substituted by at least:
-Hydroxyl group,
C 1 -C 4 alkyl radicals,
A -CO-OR ' 4 or -O-COR' 4 group, wherein R ' 4 represents a C 1 -C 2 alkyl radical,
-OR ' 5 group, where R' 5 represents a C 1 -C 6 alkyl radical,
Aryl-ethylenyl radicals (where the aryl group is C 6 and is optionally substituted with one or more C 1 -C 2 alkyl or C 1 -C 2 alkoxy radicals),
Unsaturated cationic or noncationic 5- or 6-membered heterocycles comprising one or two heteroatoms selected from O and N (one of said heteroatoms may be included in two rings; said heterocycle or Fused ring may be substituted with one or more C 1 -C 2 alkoxy radicals),
Said aryl group is optionally fused to a 5- or 6-membered heterocyclic group comprising one or two heteroatoms selected from O and N;
Cationic or noncationic, saturated or unsaturated, aromatic or non-aromatic 5- or 6-membered heterocyclic groups comprising one or two identical or different heteroatoms selected from O and N;
Said heterocyclic group is optionally fused itself to a 6-membered aryl group optionally substituted with one or more C 1 -C 2 alkyl or C 1 -C 4 alkoxy groups;
The heterocyclic group is optionally substituted with at least:
о hydroxyl group,
o C 1 -C 2 alkyl radicals optionally substituted with hydroxyl radicals,
o the amino radical —N (R ′ 16 ) 2 , wherein R ′ 16 represents a C 1 -C 4 alkyl radical which may be the same or different and optionally substituted with a hydroxyl group, said radical R ′ 16 Together with the containing nitrogen atom, it may form a saturated or unsaturated 5- or 6-membered heterocycle optionally comprising another heteroatom selected from O and N),
Where appropriate, the compound of formula (i) comprises a cosmetically acceptable anion or mixture of anions An which ensures the electrical neutrality of the formulation;
The compound (s) of formula (i) may be in acetal or hemiacetal form.
* 알칼리 금속, 알칼리 토금속, 전이 금속, 또는 암모늄과 조합된,
* 염화물, 탄산염, 탄산수소염, 황산염, 황산수소염, 규산염, 인산염, 인산수소염, 수산화물 또는 아스파르테이트, 포르메이트, 아세테이트, 락테이트, 시트레이트, 글루코네이트, 숙시네이트, 말레이트, 푸마레이트, 오로테이트로부터 선택되는 유기 음이온.The composition of claim 1 further comprising at least one organic or inorganic salt selected from:
* In combination with alkali metals, alkaline earth metals, transition metals, or ammonium,
* Chlorides, carbonates, hydrogen carbonates, sulfates, hydrogen sulphates, silicates, phosphates, hydrogen phosphates, hydroxides or aspartates, formate, acetates, lactates, citrate, gluconates, succinates, malate, fumarates, Organic anions selected from orotates.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1158743A FR2980699B1 (en) | 2011-09-29 | 2011-09-29 | COLORING COMPOSITION COMPRISING A NON-GLYCOSYL IRIDOID COMPOUND AND A PARTICULAR ALDEHYDE OR IMINE, COLORING PROCESS, AND DEVICE |
FR1158743 | 2011-09-29 | ||
US201161548362P | 2011-10-18 | 2011-10-18 | |
US61/548,362 | 2011-10-18 | ||
PCT/EP2012/069365 WO2013045703A1 (en) | 2011-09-29 | 2012-10-01 | Dye composition comprising a non-glycosyl iridoid compound and a particular aldehyde or imine, dyeing process and device therefor |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20140084093A KR20140084093A (en) | 2014-07-04 |
KR102065332B1 true KR102065332B1 (en) | 2020-01-13 |
Family
ID=45524688
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020147011554A KR102065332B1 (en) | 2011-09-29 | 2012-10-01 | Dye composition comprising a non-glycosyl iridoid compound and a particular aldehyde or imine, dyeing process and device therefor |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP6612026B2 (en) |
KR (1) | KR102065332B1 (en) |
FR (1) | FR2980699B1 (en) |
WO (1) | WO2013045703A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3111814B1 (en) * | 2020-06-30 | 2023-10-20 | Oreal | Process for coloring keratin fibers using powder and/or coloring extract from indigiferous plants and compounds comprising at least one carbonyl group |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS53134824A (en) * | 1977-04-28 | 1978-11-24 | Taito Kk | Novel nitrogenncontaining monoterpene derivative |
JPH0660089B2 (en) * | 1990-01-23 | 1994-08-10 | 六郎 清原 | Hair dye cosmetics |
JP2842915B2 (en) * | 1990-02-02 | 1999-01-06 | 株式会社トキワ漢方製薬 | Hair dyes and hair cosmetics |
JPH0425723A (en) * | 1990-05-21 | 1992-01-29 | Shiseido Co Ltd | Ultraviolet-ray intensity measuring element |
JP2873518B2 (en) * | 1991-09-03 | 1999-03-24 | 台糖株式会社 | Method for producing gardenia red dye |
JPH05339134A (en) * | 1992-06-05 | 1993-12-21 | Kii Kasei Kk | Hair dye |
DE19618595A1 (en) * | 1996-05-09 | 1997-11-13 | Wella Ag | dye |
FR2842200B1 (en) | 2002-07-12 | 2005-12-16 | Centre Nat Rech Scient | PROCESS FOR OBTAINING MODIFIED POLYSACCHARIDES |
FR2854161B1 (en) | 2003-04-28 | 2008-02-22 | Centre Nat Rech Scient | CRYSTALLINE POLYSACCHARIDE DERIVATIVES, PROCESSES FOR THEIR PRODUCTION AND THEIR APPLICATIONS |
BRPI0402011A (en) * | 2004-05-04 | 2005-12-20 | Vedic Hindus Ind Com Imp E Exp | Process for manufacturing a non-permanent tattoo compound, process for using a tattoo compound |
FR2870731B1 (en) * | 2004-05-28 | 2006-07-28 | Oreal | COMPOSITION FOR COLORING KERATINIC FIBERS COMPRISING A PIGMENT AND POLYMERS SUITABLE FOR REACTING THE ONE WITH THE OTHER TO FORM COVALENT BONDS |
US8557319B2 (en) * | 2008-03-28 | 2013-10-15 | Wild Flavors, Inc. | Stable natural color process, products and use thereof |
FR2940656B1 (en) * | 2008-12-31 | 2011-03-11 | Lvmh Rech | COLORING MATERIALS AND THEIR USE IN COMPOSITIONS, ESPECIALLY COSMETIC COMPOSITIONS |
KR101191005B1 (en) * | 2009-12-31 | 2012-10-16 | 배영애 | A kit for dye and permanent wave and a method of dye and permanent using the same |
-
2011
- 2011-09-29 FR FR1158743A patent/FR2980699B1/en not_active Expired - Fee Related
-
2012
- 2012-10-01 KR KR1020147011554A patent/KR102065332B1/en active IP Right Grant
- 2012-10-01 WO PCT/EP2012/069365 patent/WO2013045703A1/en active Application Filing
- 2012-10-01 JP JP2014532432A patent/JP6612026B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
WO2013045703A1 (en) | 2013-04-04 |
JP6612026B2 (en) | 2019-11-27 |
JP2014528400A (en) | 2014-10-27 |
KR20140084093A (en) | 2014-07-04 |
FR2980699A1 (en) | 2013-04-05 |
FR2980699B1 (en) | 2013-09-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2011117554A1 (en) | Dyeing method using a glycosylated iridoid derivative | |
WO2014155016A1 (en) | Optionally protected iridoid-derived compounds, composition including same, use as a dye for keratin fibres and devices | |
CA2282674A1 (en) | Hair treatment method | |
KR102071728B1 (en) | Dye composition comprising a glycosyl iridoid compound and a particular aldehyde or imine, dyeing process and devices therefor | |
KR20150135528A (en) | Dyeing process using an iridoid compound and devices for the same | |
WO2013045701A2 (en) | Dyeing process using a composition comprising a glycosyl iridoid compound and a nucleophile or an amino or thio polymer, composition and devices therefor | |
FR2929112A1 (en) | Composition for dyeing keratin fibers, preferably human keratin fibers such as hair, comprises one or more heterocyclic compounds; and one or more alkoxysilanes in a medium | |
KR102222530B1 (en) | Dyeing method using a hair-dyeing precursor obtained from iridoids, composition, precursor and device including same | |
WO2011117553A1 (en) | Dyeing method using non-glycosylated iridoid dyes, dyeing composition and use thereof | |
KR102065332B1 (en) | Dye composition comprising a non-glycosyl iridoid compound and a particular aldehyde or imine, dyeing process and device therefor | |
WO2013045702A2 (en) | Dye composition comprising a non-glycosyl iridoid compound and a specific nucleophile or an amino or thio polymer, dyeing process, and device therefor | |
FR2901131A1 (en) | Preparing a cosmetic treatment formulation for keratinous material i.e. for hair coloring, comprises percolating a fluid at a specific pressure through a composition comprising a solid/pasty cosmetic compound and a anionic hydrotrope | |
FR3003760A1 (en) | COLORING METHOD USING IRIDOID COMPOUND AND DEVICES | |
FR3056105A1 (en) | BLUE POWDER AND ITS USE IN COSMETICS | |
EP3509704B1 (en) | Method for treating keratinous materials using aminated and oxidised polysaccharide | |
FR2980700A1 (en) | Composition, useful for dyeing human keratin fibers, comprises 1,4a,5,7a-tetrahydrocyclopenta(c)pyran-1-ol compounds and/or 3,4,5,6-tetrahydro-1H-cyclopenta(c)furan-3-ol compounds or their plant extracts, and amino or thiol polymer | |
FR2980704A1 (en) | Composition, useful for coloring human keratin fibers, preferably hair, comprises iridoid compounds or their plant extracts, and an amino or thiol polymer | |
FR2957797A1 (en) | Dyeing human keratin fibers, preferably hair, comprises applying a composition comprising plant extract containing at least one tetrahydro-cyclopenta(c)pyran compound in a medium | |
FR2980701A1 (en) | Composition, useful to color human keratin fibers, comprises substituted iridoid compounds and/or furanol compounds, and nucleophilic carbonyl compound i.e. optionally comprises anion mixture to ensure electrical neutrality of composition | |
JPH0329828B2 (en) | ||
FR2980703A1 (en) | Composition, useful to color human keratin fibers, comprises iridoid compounds or their plant extracts and a nucleophilic carbonyl compound, which optionally comprises anion or its mixture to ensure electrical neutrality of the composition | |
FR2957796A1 (en) | Method for dyeing human keratin fibers comprises applying a composition comprising, in a medium, at least one plant extract containing at least one heterocyclic compounds and at least one base comprising e.g. sodium hydroxide | |
FR2980706A1 (en) | Composition, useful for coloring human keratin fibers, comprises iridoid compounds and nucleophilic compounds optionally comprising anion(s) to ensure electrical neutrality of composition, and polyallylimidazolium oligomers or polymers | |
FR2980702A1 (en) | Composition, useful for coloring human keratin fibers, comprises substituted iridoid compounds and/or substituted furanol compounds, and nucleophilic compounds optionally comprising anion(s) to ensure electrical neutrality of composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0105 | International application |
Patent event date: 20140429 Patent event code: PA01051R01D Comment text: International Patent Application |
|
PG1501 | Laying open of application | ||
A201 | Request for examination | ||
AMND | Amendment | ||
PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20170926 Comment text: Request for Examination of Application |
|
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20181008 Patent event code: PE09021S01D |
|
AMND | Amendment | ||
E601 | Decision to refuse application | ||
PE0601 | Decision on rejection of patent |
Patent event date: 20190821 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20181008 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |
|
AMND | Amendment | ||
PX0901 | Re-examination |
Patent event code: PX09011S01I Patent event date: 20190821 Comment text: Decision to Refuse Application Patent event code: PX09012R01I Patent event date: 20190408 Comment text: Amendment to Specification, etc. Patent event code: PX09012R01I Patent event date: 20170926 Comment text: Amendment to Specification, etc. |
|
PX0701 | Decision of registration after re-examination |
Patent event date: 20191004 Comment text: Decision to Grant Registration Patent event code: PX07013S01D Patent event date: 20190920 Comment text: Amendment to Specification, etc. Patent event code: PX07012R01I Patent event date: 20190821 Comment text: Decision to Refuse Application Patent event code: PX07011S01I Patent event date: 20190408 Comment text: Amendment to Specification, etc. Patent event code: PX07012R01I Patent event date: 20170926 Comment text: Amendment to Specification, etc. Patent event code: PX07012R01I |
|
X701 | Decision to grant (after re-examination) | ||
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20200107 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20200108 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
PC1903 | Unpaid annual fee |
Termination category: Default of registration fee Termination date: 20231018 |